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Functional noncoding RNAs participate in a variety of biological processes: for example,
modulating translation, catalyzing biochemical reactions, sensing environments etc. Independent of conventional approaches such as transcriptomics and computational comparative analysis, we took advantage of the unusual genomic organization of the ciliated unicellular protozoan Oxytricha trifallax to screen for eukaryotic independent functional noncoding RNA genes. The Oxytricha macronuclear genome consists of thousands of gene-sized
“nanochromosomes”, each of which usually contains only a single gene. Using a draft
Oxytricha genome assembly and a custom-written noncoding nanochromosome classifier,
we identified a subset of nanochromosomes that lack any detectable protein-coding gene,
thereby strongly enriching for nanochromosomes that carry noncoding RNA genes. Surprisingly, we found only a small proportion of noncoding nanochromosomes, suggesting
that Oxytricha has few independent functional noncoding RNA genes besides homologs
of already known noncoding RNAs. Other than new members of known noncoding RNA

ii

classes including C/D and H/ACA box small nucleolar RNAs, our screen identified a single novel family of small RNA genes, named the Arisong RNAs, which share some of
the features of small nuclear RNAs. The small number of novel independent functional
noncoding RNA genes identified in this screen contrasts to numerous recent reports of a
large number of noncoding RNAs in a variety of eukaryotes. We think the difficulty of
distinguishing functional noncoding RNA genes from other sources of putative noncoding
RNAs has been underestimated.
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Chapter 1
Introduction
In a 2009 special review issue of Cell called RNA, Phillip Sharp stated the following at the
end of his introductory essay, The centrality of RNA:
“ The most surprising aspect of all of this is how late in the study of cell biology the importance and ubiquitous nature of RNA in gene regulation became
widely recognized.” [1]
Even though the potential functionality of noncoding RNAs as regulators and operators in
protein synthesis was first presumed in 1961 [2], their functional importance and abundance
in various cellular processes had been underappreciated for a long time.
Since ribosomal RNA (rRNA) was identified as the large RNA component of ribosomes
in 1955 and alanine transfer RNA (tRNA) was first characterized in 1965 [3], various functionally important noncoding RNAs (ncRNAs) have been studied in a wide range of organisms. For example, small nuclear RNAs (snRNAs) were isolated and first analyzed in
1968 as a single species of “U” RNA having a high content of uridylic acid [4]. Later,
it was found that snRNAs transcribed by RNA polymerase II or RNA polymerase III are
present in all vertebrates, and that among them, U1, U2 and U6 are highly conserved [5].
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Unlike other spliceosomal snRNAs which function in intron splicing, the function of 7SK
RNA, an abundant snRNA first discovered in 1976 [6], was relatively recently elucidated
as a negative regulator of the transcription elongation factor P-TEFb [7, 8]. Nonetheless,
until 2000-2001 or so, protein-coding gene-oriented viewpoints had been dominated in
biological research elucidating essential cellular processes. Up to that time, the number
of discovered and studied ncRNAs was much less than that of protein-coding genes in
a genome. While 3042 “ncRNA” nucleotide sequences (369 human ncRNAs) were deposited between 1986/1/1 and 2000/12/31 (Entrez nucleotide database), 215186 “protein”
nucleotide sequences (44634 human mRNAs) were deposited.
However, the realization of the abundance of ncRNAs in cell regulation was stimulated by the discovery of several hundred eukaryotic microRNA (miRNA) genes in various
genomes, which began to gain fame together with RNA interference (RNAi) in 2000, together with reports of more than a hundred new small nucleolar RNA (snoRNA) genes
[9–12] and riboswitches [13–17] in the same time period. The first miRNA, lin-4 in
Caenorhabditis elegans was positionally cloned in 1987 after being identified in genetic
screens for larval development-related regulatory genes [18]. Six years later, in 1993, the
Ambros group characterized its product as a small 21 nt ncRNA that functions as a posttranscriptional regulator (renamed later as miRNA) [19]. Seven years later, another miRNA,
let-7, was discovered which also encodes a small ∼ 21 nt RNA with partial complementarity to the 3′ untranslated region of target mRNAs [20]. In the next year, its conservation was
revealed in an astonishingly wide range of organisms including fly, fish, mouse and human
(but not in bacteria, yeast, sponge or plant) [21]. This suggested that lin-4 and let-7 were
not nematode-specific oddities, and led to finding hundreds of new instances of miRNA
genes in various other genomes from plants to human [22, 23] and also triggered a race to
2

find novel ncRNA genes by systematic approaches in a variety of genomes [24–28].
In 2002, a key paper from the FANTOM Consortium of the RIKEN Mouse Gene Encyclopaedia Project was published, in which the group claimed to have discovered over
10,000 novel ncRNA candidates by characterizing new cDNA clones with the previous
FANTOM I clone dataset [29]. After clustering cDNA clones into transcription units, representative cDNA clones from each cluster were examined for protein-coding potential by
matching to known mouse DNA and protein sequences. Among transcription units which
were not assigned some functional information, clones with computational predicted coding sequences (CDSs) of less than 100 amino acids (aa) were annotated as noncoding messages. Coupled with dramatic advances in sequencing capacity and the advent of microarray technology, subsequent genomics and transcriptomics approaches have reported more
than tens of thousands of ncRNAs in a wide variety of species [30–35]. These reports have
led some to hypothesize that regulatory networks by ncRNAs might explain most of the
complexity of higher eukaryotic organisms [36]. However, whether these newly emerging
RNA species are functional and whether they are even truly noncoding remains controversial [37] as I will discuss shortly in more detail, so a careful clarification on ncRNAs and
reexamination on noncoding transcripts are required to distinguish meaningful functional
ncRNAs among the collection of noise-prone transcription events in a genome.

1.1

Noncoding RNAs

The term “noncoding” seems to have been first used for tRNA and rRNA genes to contrast
them with the coding RNA components of the central dogma, messenger RNAs (mRNAs)
which produce proteins [38]. The dictionary definition is “not specifying the genetic code”.
3

As a generic term, “noncoding” can be used even to describe introns and untranslated
regions (UTRs) which are transcribed as parts of a protein-coding mRNA, and there is
no need for all such ncRNA to be functional. However, when people refer to the term
“noncoding RNA”, they generally mean an RNA transcript that has a specific biological
role, other than coding for protein as an mRNA; in other words, we use ncRNA, which is a
much broader concept, to indicate only functional ncRNA transcripts. However, to clarify
the notion of ncRNA, it is necessary to distinguish functional ncRNAs from other sources
of noncoding RNA in a transcriptome.

1.1.1 Functional ncRNAs
Functional ncRNAs can be roughly divided into two groups according to the origin of their
functionality: structural ncRNAs and guide ncRNAs. Many well-known ncRNAs adopt a
compact tertiary structure and exert their various functions much as proteins do, either by
themselves or by interacting with other biomolecules including proteins, other ncRNAs,
mRNAs or small molecules. Some structural ncRNAs are components in large ribonucleoproteins such as the signal recognition particle (SRP) RNA, which contributes in binding
and releasing of the signal peptide [39, 40]. Other structural ncRNAs are some catalytic
RNAs (ribozymes) such as RNase P RNA, which participates in tRNA precursor processing [41], and self-splicing group I introns [42], both of which contributed to the proposed
“RNA world hypothesis” [43]. RNase P RNA makes a complex with from one polypeptide chain (bacteria) to up to ten proteins (eukaryotes). Bacterial RNase P RNA still has
a catalytic activity without protein subunits, but isolated archaeal or eukaryotic RNase P
RNAs do not retain their biochemical activity even though they are functionally essen-
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tial in holoenzymes. A final example of structural ncRNAs are riboswitches, which are
naturally occurring RNA aptamers that sense the concentration of diverse small molecule
metabolites including coenzymes, nucleosides, amino acids and an aminosugar through
atomic interactions with well-positioned residues in a RNA tertiary structure. This RNA
aptamer communicates with an “expression platform” ,a cis-acting genetic control module,
to regulate the expression of a target gene. Most riboswitches are widespread only in bacteria [14–16], but the TPP riboswitch has been discovered in plants and certain fungi and
predicted in archaea [44].
snoRNAs are a broad class of guide ncRNAs that were first identified by their localization to the nucleolus, where ribosome assembly takes place. snoRNAs have two main
classes that have different sequence features, secondary structures and detailed functions:
C/D box snoRNAs and H/ACA box snoRNAs. snoRNAs guide site-specific chemical modification, such as methylation (for C/D box snoRNAs) and pseudouridylation (for H/ACA
box snoRNAs), or in a few cases, processing (for both) of mainly rRNAs and other RNAs
[45] by providing a guide sequence to find their target position by complementary base pairing. Other examples of guide ncRNAs are miRNAs and small Argonaute-bound RNAs such
as siRNA (small-interfering RNA) and piRNA (piwi-interacting RNA) which are functionally similar to miRNA genes in that they silence gene expression either by directing mRNA
destruction or by inhibiting their translation or both, called RNAi (RNA interference). Incorporated with a RNA-induced silencing complex (RISC), processed ∼ 22 nt small RNA
from a longer source RNA, for instance, pre-miRNA transcript for miRNA, find specific
target RNAs by binding to complementary sequences. siRNAs, like miRNAs, are broadly
distributed in both phylogenetic and physiological terms, and associate with the Ago clade
protein of Argonaute superfamily for RNA silencing. piRNAs are primarily found in an5

imals, and function most clearly in the germline, where they associate with Piwi clade
proteins [46].
There also exist functional ncRNAs for which both secondary structure and specific
complementary interactions with primary sequence are critical to their function. For example, one of many known bacterial small regulatory RNAs, the Escherichia coli MicF
gene, which was recognized in 1984 [47] and whose function in osmoregulatory expression of the OmpF gene was elucidated in 1987 [48], recognizes its target mRNA through
complementary sequences residing in the loop regions of a conserved secondary structure.
Not all functional ncRNAs are genes. A lexical definition of a gene is “the basic physical unit of heredity; a linear sequence of nucleotides along a segment of DNA that provides
the coded instructions for synthesis of RNA, which, when translated into protein, leads to
the expression of hereditary character” 1 . Like many other biological terms, the “gene” is a
vague concept. For example, in the 1900s, two terms had been used to indicate an indivisible unit of heredity: the English word “gene” and Johannsen’s German word “gen” which
originated from Darwin’s English word ”pangen” [49]. By the 1910s, the idea that a gene
is invariant and indivisible like an atom or a simple chemical compound had been refined:
“the gene is stable but changes similarly, by definite steps” [50]. In modern biology, the
definition has been expanded to include genes encoding functional RNA molecules, regulating operation of other genes or repressing such operation, and to include genes in viruses
with RNA genome. Thus we can define a functional ncRNA gene as a physical heredity
unit that is transcribed into RNA but not translated into protein, and which has a biological
functional role as an RNA – but the term nonetheless is still ambiguous. However, in many
cases, we can clearly recognize functional ncRNA “genes” such as the genes encoding
1

http://dictionary.reference.com
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RNase P RNA, snoRNAs and miRNAs. Among the above mentioned functional ncRNAs,
group I introns and riboswitches are nongenic functional ncRNAs. Both are found as parts
of protein-coding genes; group I introns are a special intron that has a self-splicing capability, and riboswitches are special UTRs that have the ability of regulating the expression
of a protein-coding gene in cis by detecting environmental changes. There are other instances of such nongenic functional ncRNAs, especially cis-regulatory RNA motifs. The
iron response element (IRE), a short conserved stem-loop structural sequence first found in
1987 [51, 52], is bound by iron response proteins (IRPs). IRE functions to either repress
downstream iron metabolism-related translation (for IRE in 5′ UTR) or increase upstream
mRNA stability (for IRE in 3′ UTR) [53, 54]. Internal ribosome entry sites (IRESs) were
first discovered in 1988 in RNA viruses [55, 56] and later found also in mammalian mRNAs
[57]. An IRES is an RNA structural motif allowing cap-independent eukaryotic translational initiation, including in the middle of a polycistronic mRNA. Some siRNAs that are
not associated with protein-coding genes are also nongenic functional ncRNAs that can be
found in a cell. They can be generated from exogenous sources such as long hairpin RNAs
or double stranded RNAs derived from the foreign DNAs or RNAs. There are also many
siRNAs generated from endogenous sources, such as piRNA, small-scanRNA (scnRNA),
trans-acting siRNA (tasiRNA) and repeat-associated siRNA (rasiRNA), where the question
of whether these are “genes” or not becomes purely semantic.
Functional ncRNAs may be transcribed from independent loci (“genes”), embedded in
other transcripts (cis-acting), or produced from the processing of other longer transcripts.
A good example of an independently transcribed functional ncRNA among the above mentioned functional ncRNAs is RNase P RNA. The genomic locus of the yeast 369 nt long
RNase P RNA has an independent transcription start site, promoters, and a terminator sig7

nal for RNA polymerase III [58]. Most nongenic functional ncRNAs such as group I introns
and riboswitches are associated with protein-coding genes. siRNAs arise from processing
of other RNA transcripts [59] for genome defense or genome organization unlike miRNAs
which are processed from the pre-miRNA products of endogenous pri-miRNA genes. However, some ncRNA genes show more complicated genomic distribution patterns. Most
miRNAs are located in intergenic regions often as a cluster, which contain their own promoter and regulatory sequences of RNA polymerase II [22, 60], but intronic miRNAs also
have been reported [61–63]. Among functional ncRNA genes, the most well-known representative genes that are associated with protein-coding genes are snoRNAs. But, actually,
their genomic locations vary among organisms. The majority of mammalian snoRNAs are
located in introns, but many yeast snoRNAs are transcribed independently in monocistronic
or polycistronic transcripts [64]. Some mammalian snoRNAs are located in an intronic region of a noncoding host gene that has no protein-coding potential and just has a role as a
carrier of snoRNA genes [65, 66]. In archaea, some snoRNAs are located in the 3′ UTR of
protein-coding genes [67]. Furthermore, intronic snoRNAs can mature differently. They
are usually processed from excised introns by digesting undesired sequences, but a few
snoRNAs are not dependent on splicing events and are endonucleolytically excised from
introns [68].

1.1.2 Nonfunctional ncRNAs
It is not clear that every RNA transcript that a cell makes necessarily has a meaningful
biological function. Nonfunctional ncRNAs can be transcribed from all other genomic
regions aside from coding sequences and functional noncoding sequences. These non-
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functional noncoding sequences include introns, UTRs, pseudogenes, repeat sequences,
transposons and integrated viral elements excluding those introns and UTRs that contain
functional ncRNAs such as snoRNAs, miRNAs and cis-acting RNA motifs as we described
above. These sequences comprise the majority of the genome, especially in mammals; for
example, approximately 24% of the human genome is intronic and over 40% is derived
from transposons, whereas the exonic coding region of the human genome is less than 2%
[69, 70]. Therefore, it is possible that random transcription in these regions generate nonfunctional ncRNAs as “noisy” products. Alternatively, these genomic regions may contain
as-yet undiscovered functional elements and the resulting transcripts may be functional
ncRNAs.
Nonfunctional ncRNAs can also be generated as side-products of other functional transcriptional events. For example, transient ncRNA transcripts divergent from the adjacent
genes can be generated due to the intrinsic bidirectional nature of some (and possibly most)
eukaryotic promoters [71].

1.2

Noncoding transcripts

One of the methods used to search for new functional ncRNAs is to identify new apparently
noncoding transcripts. However, it is neither easy to segregate noncoding transcripts from
coding transcripts, nor to distinguish functional transcripts from nonfunctional transcripts
and false positive signals.

9

1.2.1 Experimental noncoding transcripts detection methods
Experimental approaches for ncRNA gene identification were initiated by isolating highly
abundant ncRNA species by size-separation in denaturing gels more than 45 years ago [72].
RNA populations can now be systematically enumerated by high-throughput sequencing
or microarray methods, applied to various specialized cDNA libraries. Various approaches
have been used to try to enrich cDNA libraries for novel ncRNAs by depleting mRNA
and abundant rRNA and tRNA. For example, one approach is size selection. To remove
mRNAs typically longer than ncRNA genes’ transcripts, small size-selected cDNA libraries
have been constructed and sequenced beginning with mouse [25] through other eukaryotes
[73–76] and archaeal species [28, 77], and these studies found hundreds of novel ncRNA
gene candidates including novel snoRNAs. As an example, lengths of the annotated protein
and ncRNAs transcripts in human genome are listed in Table 1.1. The size-selected cDNA
library construction approach was further improved by subtraction of rRNA fragments and
other unwanted species using magnetic bead-attached complementary oligos [78]. Size selection has also been used in a narrow size range to identify members of specific subclasses
of ncRNA genes such as miRNAs [22, 79–82]. Another ncRNA enrichment approach is to
use immunoprecipitation of a RNA-binding protein to enrich specific classes of transcript.
For example, several novel C/D and H/ACA snoRNA genes have been identified by coimmunoprecipitation with a snoRNA-binding protein such as fibrillarin in Trypanosoma
brucei [9] or human [83, 84].
One drawback of cDNA sequencing is a non-uniform and biased cloning efficiency
across the entire target population of ncRNAs due to their structure, chemical modification,
variable abundance and/or tissue- or developmental stage-specificity. Thanks to advances
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Table 1.1: Length (nt) of annotated protein and ncRNAs transcripts in the human genome,
according to GENCODE v4.
# Gene class

min.

max.

avg.

num.

protein

30

21,723

2,414

20,631

tRNA

36

105

68

730

rRNA

35

161

113.1

531

snRNA

39

230

108.2

1,944

snoRNA

34

420

110.5

1,521

miRNA

47

195

92.5

1,756

lincRNA

232

9,047

2,293

1,451

62

518

154.1

1,187

.

.

438

1

RNaseP RNA

293

333

316

3

vault RNA

89

103

97.6

9

all
telomerase RNA (TERC)
misc RNA

According to GENCODE v4 transcript annotation available at http://www.gencodegenes.org/,
each gene type was retrieved. For tRNA gene type, only mitochondrial tRNAs, mitochondrial tRNA pseudogenes and tRNA pseudogenes are annotated. For other gene type, pseudogenes are removed, but some
pseudogenes are accidently included because they are annotated as pseudogenes in this Gencode annotation
version. For miRNA gene type, the annotated feature length seems to be not the length of mature miRNA
transcripts but that of pre-miRNA transcripts. A majority of gene type “misc RNA” is recently described
“novel” ncRNA and the next most popular genes are Y RNA and 7SKRNA. The first two columns show the
names of gene or gene type (gene family). Other columns represent the smallest length, largest length, and
average length among genes. Last column shows the total number of genes in each gene type.

in high-throughput next-generation sequencing technologies, recently developed RNA-Seq
deep-sequencing technology mitigates some of these problems by increasing sequence coverage. The sensitivity of RNA-seq raises other issues such as reduced specificity by amplifying biological noise, such as partially processed mRNAs, degradation products, or even
random transcriptional products by RNA polymerases, and experimental noise, for example, occurring in the manipulation of fragile RNAs [85–88]. Several approaches to reduce
such false positives have been attempted, such as RNPomics [89, 90] and dRNA-seq [91]
which are RNA-Seq versions of the specialized cDNA library sequencing approach. RN11

Pomics expands target RNA of sequencing from specific subclasses of RNA genes which
bind a specific RNA-binding protein through immunoprecipitation into all protein-bound
RNAs by size-fractionation, and dRNA-seq selects a specific population of ncRNA transcripts which have an unprocessed 5′ tri-phosphate end on their primary transcripts. The
improved specificity of these approaches comes at the expense of reduced sensitivity because only a subpopulation of ncRNAs are sampled. In addition, a more fundamental
problem in cDNA sequencing, RNA-Seq and variants of RNA-seq is that the isolated RNA
sequences themselves are not informative about their function: sequencing alone cannot
determine if a transcript is noncoding or coding (mRNA), nor whether it is functional (as
RNA) or nonfunctional transcriptional noise which is not biologically meaningful.
Another branch of experimental methods for transcriptomics uses microarrays. Microarrays, also known as DNA chips or expression arrays, were mostly used for mRNA expression profiling by hybridizing labeled samples to 25-70 nt oligonucleotide probes. First
in bacteria E. coli, commercially available microarrays that had previously been limited
to coding regions were expanded into the intergenic regions to create a technology called
“tiled microarrays”, enabling the discovery of novel transcribed regions including ncRNAs
[24, 92, 93]. The advent of customized tiling arrays with a few nucleotides resolution made
it possible to annotate novel transcripts from the entire genomes of higher eukaryotes, ranging from worms to human [94–96]. Despite the merits of microarrays such as inexpensive
cost and nonredundant readout of transcription level, microarray experiments share many
of the same drawbacks with cDNA sequencing or RNA-Seq as mentioned above; in particular, detection of a transcript does not resolve whether it is coding or not, or functional or
not.
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1.2.2 Possible sources of false positives
Recent detailed studies have highlighted the issue of false positives resulting from technical
and biological drawbacks found in transcriptomic analysis [97–99], challenging transcriptomic results that have reported large numbers of ncRNAs and pervasive noncoding transcription [100, 101]. The source of false positives is various: biological noise, technical
artifacts and coding transcript classification error.
All biological systems produce varying levels of errors due to biochemical limitation of
their components. For essential processes that require a high fidelity, the cell devises several
proof-reading and correction mechanisms. However, it is impossible to make error-free
cellular machinery. Transcriptional machinery can produce partially processed transcripts
or generate random transcripts due to proximity to other promoters or cryptic promoters
which are not genuine promoters. Splicing machinery could result in partially or totally
unspliced transcripts. Degradation machinery could miss some introns that are spliced
out from coding transcripts or generate partially degraded transcripts. Struhl extrapolated
the fidelity of yeast RNA polymerase II (pol II) through chromatin immunoprecipitation
experiments to measure the pol II and TATA-binding protein occupancy in vivo: by Struhl’s
calculation, around 90% of pol II transcribed loci are expected to be nonfunctional “noise”
in transcription and an ∼ 104 -fold pol II initiation difference between an optimal site and an
average noisy site is similar to the specificity of sequence-specific DNA-binding proteins
and other biological processes [102]. Also, through a careful characterization of RNA-Seq
results, Bakel and Hughes reported that most reported “ncRNA” transcripts are intronic
transcripts that might be fragments of mRNAs or intergenic transcripts which are located
near known genes, that is, byproducts of adjacent transcriptional machinery, and that the
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remaining singletons have characteristics of random sampling from a low-level background
[103]. Furthermore, in the analysis of human chromosome 21 and/or 22 transcription, it
was shown that only ∼7-20% of the novel transcribed regions are conserved in the mouse
genome whereas ∼44% of the transcribed regions overlapping known genes are conserved
[104, 105].
Several technical/experimental artifacts affect various steps of transcriptomics. RNA
samples have low-level genomic DNA contamination, even after DNase treatment. Due to
the fragile nature of RNA samples, fragments of coding transcripts could be generated. In
the step of first-strand cDNA synthesis, wrongly primed products could be generated. For
example, about 47% of FANTOM III “noncoding” transcripts, many of which are intronic
transcripts, seem to be internally primed from genomically-encoded poly-A stretches in
longer coding pre-mRNA transcripts by the oligo dT primer [98]. In a study by Kampa et
al. to compare different sample preparation methods by using different oligo probes and
hybridization materials (RNA vs. DNA) on the same microarray platform, only ∼35% of
the positive probes overlapped with each other [105], which indicates a high false positive
rate, probably resulting from both biological noise and technical artifacts. In microarray experiments, both sequence-specific and non-specific cross-hybridization are an important potential source of error. Attempting to increase sensitivity to detect low-copy RNA
transcripts exacerbates the problem of distinguishing true signals from background crosshybridization. A careful reanalysis on microarray data by Bakel and Hughes showed that a
small increase in sensitivity can cause a dramatic loss in specificity for detection of exons
over a broad range of parameter settings and that the estimated proportion of transcription events in microarray experiments is consistently higher than that found in RNA-seq
experiments [103].
14

Coding region classification errors can result from the use of overly simple criteria to
distinguish noncoding RNA from coding mRNAs; for example, as mentioned above, the
FANTOM II project designated transcripts that have a less than 100 aa long open reading
frame (ORF) as noncoding transcripts after eliminating coding transcripts detected by homology in DNA or protein level [29] even though many real proteins are smaller than 100
aa. Surveying several methods for discriminating protein-coding and noncoding, Dinger
et al. systematically documented the existence of coding mRNAs that escape detection by
simple criteria of ORF length or by ORF conservation constraint [106]. It was reported
that in mammalian proteomes, the ORF length of ∼ 3700 protein genes is smaller than
100 aa [107], and that many yeast “orphan” ORFs, which have no known homologs, have
detectable transcripts and/or translated products [108]. Some examples of small proteins
are 11 aa long TAL protein which has a role in fruit fly development [109], a less than 33
aa long Cg-1 protein controlling tomato-nematode interaction [110], and 75-140 aa long
CLE family proteins involved in Arabidopsis meristem development [111].

1.3

Newly emerging ncRNAs: Results of pervasive transcription

Transcriptomic analyses have been accumulating many instances of two new (but very general and crude) kinds of ncRNA populations, long ncRNAs (lncRNAs) and small ncRNAs
(sRNAs), together with novel protein genes, new alternatively splicing exons, and antisense
transcripts, implicating that almost whole genome is pervasively transcribed [112, 113].
Many of those ncRNAs are partially or entirely overlapped by another transcript in sense
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or antisense direction or located close to a neighboring gene in antisense direction. Some
lncRNAs reside within an intron of another transcript or in the intergenic region (lincRNA)
[114]. According to Bakel and Hughes’s study on pervasive transcription [103], only 2.22.5% of reads of RNA-Seq transcriptome data are mapped into non-protein related genomic
locations and most intergenic transcripts are adjacently located to annotated protein-coding
genes either as extended transcripts or separate noncoding transcripts. Whether these RNAs
have functions is still controversial: those could be confused with byproducts of natural
transcripts such as cis-natural antisense transcripts or mRNA fragments as we discussed
above [115, 116].
A large number of sRNAs are associated with protein-coding genes in a variety of
ways: promoter-associated sRNAs (PASRs)[112], transcription start site (TSS) antisense
RNAs (TSSa-RNAs) [117], nuclear run-on assay derived RNAs (NRO-RNAs) mapping
20-50 bp downstream of TSS [118], tiny transcription initiation RNAs (tiRNAs) mapping
20 bp downstream of TSS [87], promoter upstream transcripts (PROMPTs) mapping 0.5-2
kb upstream of TSS [119] and termini-associated sRNAs (TASRs) [112]. Dissection of the
function of sRNAs might be highly challenging technically because biological effects of
individual sRNA species may not be substantial enough to be detected by current experimental approaches [37]. Therefore, it is difficult to distinguish genuine functional ncRNAs
from these ncRNAs even though a few of them are functionally elucidated.
Among recently reported ncRNAs, lincRNAs which are easily separable from adjacent
coding loci are relatively more probable to be novel independently transcribed functional
ncRNA genes compared to other small RNA species in a transcriptome. Several previously recognized large ncRNA genes that regulate protein-coding genes epigenetically or
at the transcriptional level also might be considered as lincRNA. For example, HSR1 (heat16

shock RNA-1) forms a complex with translation elongation factor eEF1A and stimulates
trimerization of heat-shock transcription factor 1 (HSF1) to induce the transcription of
heat-shock-induced genes indirectly [120]. The Xist gene and Tsix gene (antisense to Xist)
are critical for dosage compensation in eutherian mammals as a component of the Xic (Xchromosome inactivation center) [121, 122]. However, although a few lincRNAs defined
by the transcriptomic analysis such as a HOTAIR RNA have been functionally elucidated
[123, 124], for others we generally only know a tissue-specific expression profile [125] and
most remain poorly characterized.

1.4

Transcriptome-independent ncRNA finding: Computational analysis

Besides transcriptomic approaches, which have generated an astonishingly large number
of controversial ncRNAs, an alternative approach to find ncRNAs is computational prediction of putative structural ncRNAs and cis-regulatory protein-binding structural motifs in
mRNAs by identifying conserved patterns or stability of predicted RNA secondary structure [126–128]. These computational approaches have also generated large numbers of
ncRNA candidates, relatively few of which have been experimentally validated, as described below in more detail.

1.4.1 Computational search by comparative analysis
One way to computationally find ncRNA genes is a homology search using the evolutionary constraint information imposed by the secondary structure and/or primary sequence
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of known ncRNA gene instances in a particular gene class or family. In addition to general homology search programs based on RNA family-specific models, such as the Infernal
package [129], or other ncRNA homology search programs taking a single RNA sequence
with its secondary structure as a query to search homologous sequences in database [130],
several family-specific ncRNA genefinders [131–138] have been developed for higher sensitivity and specificity by adopting a probabilistic or heuristic model of family-specific
features. Even though these ncRNA genefinders are specially trained and tuned homology
detectors, some are still limited by a high false positive rate. Of course, homology detection
by similarity search is not suitable for de novo novel ncRNA genefinding.
De novo ncRNA genefinding is a more difficult problem than that of protein-coding
gene finding [139]. Whereas protein-coding genes have lots of known signals on the
gene structure such as start/stop codons and splicing sites, ncRNA genes do not have such
common primary sequence features. Moreover, poor primary sequence conservation of
ncRNA genes across species makes the problem harder for comparative approaches as
well. So, current de novo ncRNA genefinders fundamentally rely on phylogenetic secondary structural conservation information with or without thermodynamic structural stability information [126–128, 140] to find structural ncRNAs and cis-regulatory proteinbinding structural motifs in mRNAs. For example, QRNA [126] assigns a class to a homologous sequence alignment by comparing scores of three probabilistic models: a pairSCFG (stochastic context-free grammar) “RNA” model capturing co-evolutionary patterns
of secondary structure, a pair-HMM (hidden Markov model) “protein” model representing
triplet codon preservation, and a null “other” model emitting pair sequences independently
from patterns. One problem of these phylogenetic approaches is the difficulty of detecting ncRNAs that are too conserved to show structure-induced conservation or too diverged
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to be accurately aligned, or that are unstructured or less structured, such as the C/D box
snoRNA family. Another more serious problem is high false positive prediction rates of
the current programs. For example, Babak et al.’s tests on several ncRNA search tools with
shuffled alignments while preserving dinucleotide frequency showed high false positive
rates; the score distributions on tiling windows of human-mouse alignments of chromosome 19 and the shuffled alignments are not distinguishable [141].

1.4.2 Computational search by gene composition
Some special organisms, specifically hyperthermophiles, have allowed some unusual approaches independent of conventional ncRNA discovery methodology. A simple screen
for GC-rich regions in the AT-rich Methanococcus jannaschii and Pyrococcus furiosus
genomes provided ncRNA gene candidates, due to a strong DNA compositional bias toward G/C residues in structured ncRNA genes of some hyperthermophile genomes [26] to
make more stable RNA structures in a high temperature environment. This screen found approximately five novel ncRNA genes in each organism. The small number of novel ncRNA
genes is a stark contrast to ncRNA discovery efforts in other organisms with conventional
transcriptomic or computational approaches, but it may be due to the characteristics of
these hyperthermophiles: such as, selection against the use of ncRNA genes due to the
constraints given by a high temperature environment and/or a relatively small genome in
which the predicted protein-coding gene count is about half of that of Escherichia coli.
Alternatively, a small number of ncRNAs might be predicted because of limitations in the
ncRNA genefinders. This computational search using the difference in gene composition
also has been applied into other AT-rich genomes, and similar to these hyperthermophiles,
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only a small number of novel ncRNA genes has been discovered in each genome [142, 143].

1.5

Conclusion

Even though computational ncRNA predictions by using base composition difference in hyperthermophiles or other AT-rich genomes provided a few novel ncRNA candidates, both
transcriptomic approaches and other computational predictions for ncRNA detection have
resulted in controversial reports of surprisingly large numbers of ncRNAs in a wide variety of species. These ncRNAs are a mixture of functional ncRNAs, biological background
noises, technical artifacts, novel coding mRNAs, and/or computational false positives. Although some putative ncRNA candidates show cell-type specific expression, developmentally regulated expression and/or subcellular localization, these correlations cannot necessarily imply biological functionalities. Without a detailed careful examination of the identities and functions of these putative ncRNA candidates, it is neither possible to accurately
estimate the functional ncRNA content in a genome, nor to conclude whether a genome is
pervasively transcribed or not.
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Chapter 2
Our approach
Independent of conventional transcriptomics and computational ncRNA prediction approaches
that generates an overwhelming number of ncRNA candidates, including many false positives, a different systematic ncRNA identification approach might help to address a currently unsolved issue, the number of independent functional ncRNA genes in a genome.
Transcriptomics does not distinguish genic from nongenic transcripts, noncoding from coding, functional from nonfunctional. Though these are many things that RNA could be doing, it would be nice to at least be confident of ncRNA genes - this is what a Oxytricha
screen looks for. Although several studies show specific expression profiles on some of
ncRNAs resulted from the transcriptomics [100, 144, 145], these patterns itself could not
provide information about their functions. They provide hypotheses about the possible
functions solely based on the correlation. Also, other ncRNAs from the transcriptomics
might be byproducts of noisy eukaryotic transcriptional events that have no function as
ncRNAs although transcriptional event itself may have a biological functionality, which is
difficult to be distinguished from independent ncRNA genes of which transcribed products
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itself have a function on the cellular process. Moreover, the challenge is to figure out how
these ncRNAs are generated exactly. For example, there appear to be ncRNAs produced
from enhancers of coding genes [146], but because enhancers can be distant from their
gene, it is difficult to distinguish enhancer-associated ncRNA transcription from an independent ncRNA gene. Distinguishing independent functional ncRNA genes from other
sources of putative ncRNAs would be a step towards focusing effort on specific classes
of ncRNAs and RNA function, rather than treating all “ncRNAs” and “ncRNA genes”
as a homogeneous class. Therefore, an important question that has not been addressed
well by current approaches, “How many independent functional ncRNA genes exist in the
genome?”, could be answered by O. trifallax at least in part.

2.1

Oxytricha trifallax

Oxytricha trifallax (also known as Sterkiella histriomuscorum [147]) is a unicellular ciliated protozoan in class Spirotrichea, one of the extensively studied classes among 10 ciliate
classes (Figure 2.1.A). Ciliates, known as a birthplace of telomere biochemistry [148] and
self-splicing Group I intron RNA study [42], diverged from other microbial eukaryotes,
so they are a phylogenetic outgroup of the crown eukaryotes, including metazoans, plants,
and fungi. Oxytricha is also quite diverged from two other sequenced oligohymenophoran
ciliates, Tetrahymena thermophila [149] and Paramecium tetraurelia [150].
Ciliates (phylum Ciliophora) have a nuclear dimorphism: a diploid meiotic germ-line
nucleus (micronucleus) and a somatic nucleus (macronucleus). The number of each nuclear
type per cell varies among ciliates: O. trifallax has two micronuclei and two macronuclei.
The micronucleus mainly serves as the template material during conjugation and is almost
22

transcriptionally silent. Conversely, the macronucleus is a highly specialized expression
organelle providing all genes for normal cell function during vegetative growth and asexual reproduction [151, 152]. After several cycles of asexual reproduction, some ciliates
entirely lacking micronuclei occur in the wild [153]. The life cycle of ciliates is simple:
in the absence of food, it forms a cyst, a biologically inert form of the ciliate that retains
only one macronucleus and one micronucleus, or undergoes cell mating, and otherwise, it
proliferates continuously (Figure 2.1.B) [154].

2.1.1 The genomic characteristics of O. trifallax
The micronuclear genome consists of several large chromosomes similar to typical eukaryotic chromosomes. Genes are scattered along the chromosome and are separated by large
stretches of “spacer DNA”, which seems to provide a safe place for the invasion of foreign DNA sequences, as a defense mechanism. The micronuclear genes are enigmatically
interrupted by multiple A/T-rich noncoding sequences called internal eliminated segments
(IESs), which will be spliced out during macronucleus development [155] (Figure 2.2.A).
Most IESs are intact ∼ 4-5 kb long transposons, and short IESs (less than 0.5 kb) seem to
be degenerated non-autonomous transposons that retain the cis-acting sequences required
for precise excision. Most IESs in hypotrichs are less than 100 bp long. It is estimated that
there are 100,000 to 200,000 IESs per haploid genome [154]. The telomeres of micronuclear chromosomes are made up of hundreds of duplex repeats of the sequence 5′ -C4 A4 3′ /3′ -G4 T4 -5′ and terminate with a “t-loop” that provides a general mechanism for chromosomal end protection and telomere replication [156, 157]. The t-loop is stably formed by a
foldback of a single-stranded 3′ tail into the downstream double-stranded telomere repeat
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A. Light micrograph of

Oxytricha trifallax

cilium

digestive vacuole
cytostome

B. Life cycle of

Oxytricha trifallax

Micronucleus:
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cyst
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~120 long chromosomes
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Figure 2.1: Life cycle of O. trifallax
A. A light micrograph of the stretched Oxytricha trifallax due to Protoslo (protozoa quieting solution) slowing
the movement of cells to keep them in focus and in the field of view while preserving characteristic motion of
cells. Several structural features are detectable under a light microscope without staining. B. The macronuclei
are represented as big circles and the micronuclei are represented as tiny circles to express their cytological
size although the haploid complexity of the macronuclear genome sequence is much less than that of the
micronuclear genome sequence.
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region. The micronucleus undergoes meiosis during cell mating. Two haploid micronuclei
exchanged between two cells in a mating pair are fused to form a diploid zygotic nucleus
in each cell. After separated from a mating pair, unused haploid micronuclei and the old
macronuclei are destroyed, and at the same time, a new macronucleus develops from a
mitotic copy of the newly formed diploid micronucleus (Figure 2.1.B) [154].
The macronuclear genome consists of many small, linear, acentric chromosomes which
are produced from the micronuclear genome by a baroque ncRNA-dependent process of
splicing out the micronucleus limited sequences during sexual conjugation. This process
includes not only genome fragmentation and spacer DNA elimination, but also rearrangement and unscrambling of the macronucleus destined sequences (MDSs) that are separated
by an IES, in some ciliates including Oxytricha [153, 158–161] (Figure 2.2.A). These
DNA processing events apparently depend both on the pairs of repeats that flank IESs for
recombination and on nongenic transcription of long RNAs [160, 162], even though the detailed mechanism in each gene in each ciliate might be different. At least in Tetrahymena,
these events involve large numbers of Argonaute-bound small RNAs [163–166]. The degree of genome fragmentation varies among ciliates. It reaches an extreme in the spirotrich
ciliates including Oxytricha, Stylonychia, and Euplotes, where the macronuclear genome
is composed of many thousands of gene-sized nanochromosomes [167, 168]. In Oxytricha
trifallax, the micronuclear haploid DNA content of ∼1 Gb is reduced by 95% to ∼50-55
Mb of sequence complexity in the macronucleus. The macronucleus is thought to contain
∼17,000-25,000 different nanochromosomes almost entirely in the range of 1-8 kb, with
a mean of 2.2-2.5 kb [153, 169, 170]. Each nanochromosome is amplified to an average
copy number of ∼ 1000. Remarkably, each nanochromosome usually contains only a single gene, which usually has just a few small introns with an average 118 nt, and also has
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very short 5′ and 3′ UTRs with a median length of about 130 nt and short subtelomeric noncoding sequences and telomeres [171–174]. A typical example of a nanochromosome that
represents well these characteristics is shown in Figure 2.2.B. Some macronuclear chromosomes are generated by alternative fragmentation of the polytene chromatids during differentiation, reproducibly [175, 176]. One alternative fragmentation mechanism seems to be
correlated with a variant form of telomere addition within ∼ 100bp subtelomeric regions.

2.2

Our approach

If eukaryotes generally have a large proportion of independent ncRNA genes, then the
Oxytricha macronucleus should have a large proportion of noncoding nanochromosomes.
In effect, in these ciliates with gene-sized nanochromosomes, the organism itself has solved
the hard eukaryotic genefinding problem for us. Most genes and their cis-regulatory signals
have been isolated on individual chromosomes, their locations demarcated by telomere addition, and most of their nonessential noncoding DNA has been eliminated [173]. Given
the assumption that most nanochromosomes contain a single gene in it, we can identify and
discard nanochromosomes carrying protein-coding genes among the macronuclear genome
sequences, because identifying coding genes computationally is far easier than identifying
ncRNA genes. Coding gene identification in Oxytricha is even easier than in many eukaryotes, because its protein-coding gene structures are simple, with few introns, and those
introns that do occur are small, with a mean length of 118 nt [168, 174]. The resulting subset of apparently noncoding nanochromosomes should be enriched for nanochromosomes
carrying independently transcribed ncRNA genes. We took advantage of the availability
of a draft macronuclear O. trifallax genome sequence assembly [168] to conduct such a
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Figure 2.2: The micronuclear and macronuclear genome of O. trifallax
A. Organization of micronuclear chromosomes and genes. The micronuclear genome is processed to generate
the macronuclear genome. Arrows and numbers below or above the macronucleus destined segments (MDSs)
indicate the relative direction and order of segments in the macronuclear genome to explain the rearrangement
process of the scrambled MDSs. Dark gray regions in the MDSs represent the subtelomeric regions in the
macronuclear nanochromosome. B. An example of a macronuclear nanochromosome with GC ratio over the
chromosome, gene structure, and genome sequence. The average GC ratio of the O. trifallax draft genome
assembly is 0.34 which is indicated as a dotted line in graph. GC ratio is calculated by sliding 50 nt segment
window with 10 nt step size.
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screen.
To winnow out nanochromosomes containing protein-coding genes, we developed a
nanochromosome classifier “nanoclassifier” based on a Hidden Markov Model (HMM)
that is easier to train and adjust for a desired sensitivity/specificity tradeoff, than conventional custom-trainable genefinders. We conducted comparative analyses on the related
ciliate Stylonychia lemnae to remove false positives from the nanoclassifier, to find functional conserved ncRNA genes, and to refine the possible genic regions within a noncoding
nanochromosome. For the final ncRNA candidate gene sets, we experimentally validated
their in vivo transcripts with Northern and RACE-PCR and manually analyzed the consensus secondary structures and regulating elements if possible.

2.3

Outline of this work

Chapter 3 surveys non-redundant full-length nanochromosomes from the draft genome assembly of O. trifallax and describes how the known ncRNA genes are distributed on the
nanochromosomes and the experiment used to characterize how complete and how biased
our sample of nanochromosomes is.

Chapter 4 details the computational ncRNA screens we designed and executed. Technical specifications of nano-classifier and nano-genefinder we built are described and how
the comparative analysis was conducted with S. lemnae genome is illustrated.

Chapter 5 describes how the ncRNA candidates in the computationally-identified final data
set were verified with Northern and RACE-PCR experiments and details the characteristics
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of ncRNA candidates.

Chapter 6 describes the conservation and transcriptional features of a novel ncRNA family,
which we called the Arisong RNA, in four ciliate species and speculates about the possible
function of this family.

Chapter 7 investigates other ncRNA genes in O. trifallax which are not detected in this
screen to examine the soundness or weakness of this screen.

Chapter 8 offers a brief description of the result of this screen and concluding thoughts
on the number of independently-transcribed ncRNA genes on Oxytricha and other eukaryotic genomes.

Appendix A describes tRNA gene analysis on the total O. trifallax dataset; Appendix B
lists coordinates of telomere endpoints of a subset of full-length Oxytricha nanochromosomes (WGS2.1.1 dataset among stage 3 dataset); Appendix C catalogs all the Oxytricha
genes which were mentioned in this screen; Appendix D displays Northern blot of some
of known ncRNA genes in Oxytricha and lists all Northern blot oligonucleotide probes;
Appendix E lists RACE-PCR gene-specific probes; Appendix F displays the results of
comparative analysis on the final candidate data set (stage 5 dataset); Appendix G shows
sequence alignments of regulatory motifs in O. trifallax and S. lemnae; and Appendix H
mentions programs and databases we used, and data availability.

Chapters 2 to 8 and the appendices are derived from a published paper:
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S. Jung, E. C. Swart, P. J. Minx, V. Magrini, E. R. Mardis, L. F. Landweber, and S. R.
Eddy. Exploiting Oxytricha trifallax nanochromosomes to screen for non-coding RNA
genes. Nucl. Acids Res., in press, first published online June 28, 2011
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Chapter 3
O. trifallax genome sequence
O. trifallax macronuclear genome sequencing is an ongoing project through collaboration
between the Genome Center at Washington University and the Landweber laboratory at
Princeton [http://genome.wustl.edu/genomes/view/oxytricha_trifallax/].
We utilized the draft genome assembly data and conducted several analyses on this incomplete dataset as a computational screen for independent functional ncRNA genes.

3.1

O. trifallax draft genome assembly

We obtained two draft datasets for O. trifallax genome sequence: a “WGS” dataset and a
“pilot” dataset.
The WGS dataset is a prepublication whole genome shotgun draft assembly version
2.1.1 (June 2007), comprising 54982 contig sequences (79.2 Mb) averaging 1.44 kb in
length. Whole cell DNA were prepared from vegetatively growing O. trifallax strain
JRB310 [173] and <7kb nanochromosomes were selected by gel purification to avoid the
abundant rDNA nanochromosome. Nonetheless, this size fractionation captures the great
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majority of the macronuclear genome, which is primarily pieces in 1-8 kb [153, 169, 170].
After excluding singletons, PCAP[177] assembled 728,035 ABI 3730 shotgun reads (583.7
Mb) into contigs. Overall assembly contiguity is less than that expected given the 7.4X
mean shotgun coverage in part because macronuclear nanochromosomes have variable
copy numbers and coverage per nanochromosome is non-uniformly distributed. The assembly also appears to be contaminated with a second Oxytricha strain, 510, and with bacterial DNA from food in the culture. Surprisingly, a substantial fraction of contigs retains
vector sequences at both or either ends of contigs of various length. For instance, among
contigs that have detectable telomeres at the both ends, 848 contigs contain ≥ 100nt vector
sequence on one or both ends.
The “pilot” dataset is a collection of pilot sequencing data comprising 1976 complete nanochromosome sequences (1.96 Mb) averaging 0.9 kb in length. It consists of
254 complete nanochromosome sequences from a Princeton/Utah pilot genome project
[168, 173, 174], 1707 nanochromosomes generated by paired-end sequencing of fulllength plasmid inserts cloned from a size-selected <1kb nanochromosome fraction, the
7.6 kb ribosome DNA nanochromosome, and 14 additional full-length nanochromosome
sequences.
Overall, the combination of the WGS and pilot datasets consists of 56,958 sequences
(total 81,114,275 nt), with contigs ranging from 42 to 13,846 nt and averaging 1.42 kb in
length.
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3.2

Non-redundant full-length nanochromosomes: stage 1
dataset

Our screening strategy involves classification of full-length nanochromosomes as coding or
noncoding, so we should begin the screen with full-length nanochromosomes. The genome
assembly is somewhat crude, with a large amount of untrimmed vector sequence, many incomplete contigs, and some bacterial contamination. From our WGS and pilot genome
datasets, we extracted a nonredundant, merged set of presumptive full-length Oxytricha
nanochromosomes (the “stage 1” dataset). All 1976 contigs in the pilot dataset were assumed to be full length. In the WGS 2.1.1 assembly, we searched the terminal 400 nt of
each contig end for matches to partial telomere consensus sequences ([CCCCAAAA]3 at
each contig’s 5′ end and [GGGGTTTT]3 at the 3′ end) after removing any flanking x’s by
requiring a local Smith/Waterman alignment score of ≥ 80 using gapcost = -3, match = 5,
mismatch = -4. If a telomere was identified internal to the contig, we required that the extra
flanking sequence matched the known cloning vector with at least 80% identity through a
glocal (global with respect to the vector, local with respect to the nanochromosome) alignment using gapcost = -2, match = 5, mismatch = 1. This defined the minimal telomere
endpoint coordinate. A small number of nanochromosomes were additionally defined as
“full length” after further inspection of borderline results. We identified 8565 complete
nanochromosomes in the WGS 2.1.1 assembly by this procedure. The telomere endpoints
coordinates of a subset of them (stage 3 dataset) are listed in Appendix B.
To remove nanochromosomes that appear redundantly in both the pilot and WGS datasets,
we used WU-BLASTN with default parameters to identify near-identical pairs that satisfied
E ≤ 10−100 and % identity ≥ 98% and which differ in length by ≤ 10% of the longer se33

quence. We chose one sequence of such pairs at random, thereby removing 894 redundant
sequences.
The stage 1 dataset consists of 9647 full-length nanochromosome sequences of average
length 1.9kb. Four typical examples of Oxytricha full-length nanochromosome organization are shown in Figure 3.1, including annotations by methods we describe below.

3.3

Quasialleles in the draft assembly and stage 1 dataset

There are usually several identical or near-identical copies of each locus in the assembly.
Highly identical contigs were removed from the stage 1 dataset. However, even after this
step, the stage 1 dataset still includes some very similar copies of each locus. The fulllength chromosomes in the stage 1 dataset can be grouped in up to seven nanochromosomes
with approximately 3.4% mean sequence difference. There could be several explanations
for this.
Oxytricha is a diploid. The sequenced Oxytricha culture was an inadvertent mixture of
two mating types, 310 and 510 (Laura Landweber; personal communication). The study
on IESs and introns of Oxytricha 81 locus by Seegmiller et al. estimated the divergence of
these two strains at about 0.1 changes/site, but did not address the allelic difference within
each strain [179]. However, this divergence rate was calculated from non-coding regions
of DNA, so it is not directly applicable to distinguish alleles of ncRNA genes. There
also appears to be a substantial fraction of alternatively processed nanochromosomes with
different sizes and breakpoints. Without a micronuclear genome sequence and a more
complete assembly, we cannot distinguish alleles, products of alternative DNA processing,
and highly identical paralogs.
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Figure 3.1: Examples of O. trifallax nanochromosomes.
A. A typical nanochromosome containing a single protein-coding gene (telomere-end binding protein α);
B. A typical nanochromosome containing a single ncRNA gene (U2 snRNA); C. A nanochromosome containing both a protein-coding gene (histone H3) and an ncRNA gene (a tRNA-His); D. A nanochromosome
containing two protein-coding genes (omyb1 and orpb9). Data tracks below each nanochromosome show
some of the features we used in suggesting regions of coding potential, conservation, and/or functionality,
as follows. nano-chr. structure: gene structures as annotated in GenBank (A,D) or predicted by us by
similarity (B,C). GC%: calculated GC% in sliding 50nt windows with 10nt step size (the average GC%
of O. trifallax is 34%, and a higher GC ratio tends to correlate with genic regions); ID% S. lemnae DNA:
best WU-BLASTN matches to Stylonychia lemnae shotgun sequence data (see Methods); prediction: coding gene prediction from our Oxytricha genefinding program (nanogenefinder); protein/RNA DB similarity:
best significant WU-BLASTX matches to NCBI NR protein database excluding O. trifallax proteins (black)
or Infernal cmsearch [129] matches to the Rfam RNA database [178] (blue).
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Operationally, we manually grouped highly identical loci (roughly >85% identical in
DNA sequence flanking each locus) into what we call “quasiallele” groups. In this threshold, we generally identify up to four apparent “alleles” of any given sequence, which can
be reasonably interpreted to include two alleles for each strain. For each quasiallele group,
we assign a representative locus. In subsequent sections, we refer to numbers of “distinct” (representative) loci versus total numbers of sequences including “quasialleles”. We
named and numbered each distinct locus “Onc1”, “Onc2”, etc. (for “Oxytricha noncoding
candidate”), and numbered each additional quasiallele “Onc1.2”, “Onc1.3”, etc. Names,
coordinates, and other information for all examined loci, including candidate loci described
in the screen below, are listed in Appendix C.

3.4

The “known” ncRNA gene distribution in the stage 1
dataset

Previous studies indicate that Oxytricha nanochromosomes usually contain just a single
gene [168, 172, 174, 180] with a few exceptions [172, 179, 181, 182], but these studies were
largely focused on coding genes and were based on small numbers of nanochromosomes.
Our screening strategy depends crucially on an assumption that ncRNA genes usually occur
alone on their own nanochromosome, with no coding gene on the same nanochromosome.
To test this assumption, we first investigated the 24 publicly available O. trifallax nanochromosomes for their potential to contain ncRNA genes on the same chromosome. Among 24
NCBI-retrieved O. trifallax nanochromosomes, only two nanochromosomes encode two
protein-coding genes. We cannot detect any prominent known ncRNA homologs by using
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the cmsearch program of Infernal 1.0.2 [129] against 1372 ncRNA models in the Rfam 9.1
database [178].
Next, we identified homologs of known ncRNA genes in the stage 1 dataset and examined those ncRNA-containing nanochromosomes for protein-coding potential. The cmsearch program was also used to search 9647 stage 1 nanochromosomes at an E≤ 0.001
threshold per query model and 461 hits met this threshold. We manually removed 324 hits
that we judged to be either redundant (different Rfam models for the same family: snoU18
and SNORD18) or false positives, including 318 weak miRNA similarities (most of which
fell in telomeric repeats, and all of which appear to be false positives). Remaining were
135 ncRNA homologs from 11 Rfam families on 134 different nanochromosomes, including 106 transfer RNA (tRNA) genes (Table 3.1). In all but one case that has homologs of
two known ncRNA genes, RNase MRP and snoZ 196, we found a single ncRNA homolog
per nanochromosome.
To estimate how many of these 134 nanochromosomes contain coding genes in addition to an ncRNA gene, we masked the homologous ncRNA regions plus an extra 20nt on
each side of the identified Infernal alignment, by converting the sequence to N’s and any
vector sequence was removed using telomere endpoint coordinates described above. One
nanochromosome carrying the ribosomal RNA genes, which were identified by the presence of 5.8S rRNA, was manually masked for SSU rRNA and LSU rRNA by comparing
with Tetrahymena ribosomal RNA gene sequence because Rfam does not include complete
models of the large SSU and LSU rRNAs.
Three different methods were used to look for possible coding genes: (1) BLASTX for
the identification of significantly similar regions to the annotated proteins in the database.
(2) BLASTN for the examination of significant sequence conservation with Stylonychia
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Table 3.1: Coding potential of ncRNA gene-containing nanochromosomes.
ncRNA
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35
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2

1

.

.

.

.

2

1

2
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.

.

134

60

37

21

45

25

74

40

76

41

37

21

Total

# nanos

X/NR

N/Sty
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any

all

The first two columns show the names of known ncRNAs and their accession numbers in the Rfam database
[178]; the third column, “# nanos” is the number of nanochromosomes found to contain homologs of these
known ncRNAs; both the total number of loci including all quasialleles, followed (in bold) by the number of
distinct loci. “X/NR”, “N/Sty”, and “nanocl” columns show the number of these nanochromosomes that have
significant similarity to known proteins by BLASTX, the number with another region of significant DNA
conservation with Stylonychia by BLASTN, and the number with coding genes called by our nanoclassifier.
The final two columns show the number that are called coding by at least one of the three methods (any), and
the number called coding by all three methods (all).

lemnae1 . (3) Our nanoclassifier for the detection of protein coding gene potential. For
detection of the similarity to known proteins, WU-BLASTX was used on the NCBI NR
database with “filter=seg filter=xnu C=6” (C=6 is the ciliate genetic code) options and
with a E < 10−5 threshold. For investigating genome sequence conservation on the close
ciliate genome, WU-BLASTN was used to our Stylonychia shotgun data with “filter=seg
filter=dust” options and with an E < 10−10 threshold, and additionally required > 70%
sequence identity for the best alignment. For the nanoclassifier, we used a P ≤ 0.09
threshold, based on the benchmark ROC curve which will be described in the next chapter
in Figure 4.2.
1

a description of this genome assembly will be discussed in the next chapter in detail
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Results are summarized in Table 3.1. BLASTX detects 37/134 (28%) with significant
similarity to protein sequences in the NCBI NR database. BLASTN detects 45/134 (34%)
with additional DNA conservation to Stylonychia. The nanoclassifier calls 74/134 (55%)
of these as containing coding sequence.
Each method for detecting coding genes has limitations, in terms of both sensitivity
and specificity. In terms of sensitivity, rapidly evolving or “Oxytricha-specific” genes will
not be detected by BLASTX to the protein database or even by BLASTN to Stylonychia.
Some will not show BLASTN hits to Stylonychia due to the partial coverage of our Stylonychia shotgun data. Our nanoclassifier has an estimated coding sensitivity of about 94%
(Chapter 4). Analysis of a randomly chosen set of 200 stage 1 nanochromosomes showed
130/200 (65%) with BLASTX hits to NR; 148/200 (74%) with Stylonychia BLASTN hits;
and 189/200 (94%) called coding by the nanoclassifier. If almost all Oxytricha nanochromosomes carry at least one coding gene, these numbers would approximate the sensitivity
of each method. In terms of specificity for coding regions, some ncRNAs show BLASTX
hits to the “protein” databases because some noncoding RNA genes have been erroneously
translated and deposited in the databases. BLASTN conservation to Stylonychia can have
multiple interpretations besides a conserved coding region, including an ncRNA or a large
regulatory DNA sequence. Finally, we determined that our nanoclassifier has about a 17%
false positive rate (Figure 4.2).
Using these expected false negative and false positive rates, we can extrapolate a corrected rough estimate of the total number of coding regions in these ncRNA-containing
nanochromosomes. Correcting the BLASTX results for a 65% sensitivity (and assuming that essentially 100% of BLASTX conservation is truly due to coding regions) gives
0.28/0.65 = 43% of ncRNA-carrying nanochromosomes estimated to also carry one or more
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coding genes. Correcting the BLASTN results for 74% sensitivity (and ignoring possible
false positives from noncoding conservation) gives 0.34/0.74 = 46%. Correcting the nanoclassifier results for 94% sensitivity and 17% false positives gives (0.55 - 0.17) / (0.94 0.17) = 49%. Therefore we conclude that about 50-60% of ncRNA-containing Oxytricha
nanochromosomes carry no coding gene, at least for the known types of ncRNAs we can
identify by homology searches.

3.5

The completeness and bias of the stage 1 dataset

The stage 1 dataset is an incomplete sample of the macronuclear genome. It was not feasible to obtain a complete assembly. One difficulty is that the unusual properties of Oxytricha
nanochromosomes tend to violate assumptions made by standard production-scale genome
sequencing methods. Improving the quality of the assembly likely will require a nonstandard assembly effort beyond the scope of this work. However, because our main question is
about the relative proportion of independent functional ncRNA genes versus coding genes,
not absolute numbers, a statistical sample of the genome will suffice, provided it is sufficiently unbiased. We therefore sought to characterize the completeness and the two most
important sources of potential bias in the stage 1 dataset, as follows.
We estimate that the dataset includes 40-65% of the macronuclear genome, based on
two different estimates. First, by dividing the kinetic complexity of the macronucleus (5055 Mb) by the average nanochromosome size (2.2-2.5kb) [153, 169, 170], Oxytricha is
thought to contain about 20,000-25,000 different nanochromosomes; 9,647 would represent around 40-50% coverage of the genome. Second, we measured coverage of a set of
conserved core single-copy eukaryotic protein genes [183].
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Parra et al. described a method to estimate the completeness of a eukaryotic genome
assembly by assessing the presence of 248 “core eukaryotic genes” (CEGs), chosen for
their wide orthologous conservation but low frequency of paralogous duplication [183].
We modified and simplified their method described in [184] for use on a low-pass, lowcontiguity shotgun assembly without full-length gene predictions. We searched each CEG
with TBLASTX against each of our ciliate datasets, collected all hits of E < 10−10 , calculated what fraction of each CEG sequence was covered by these alignments. We considered
the CEG “present” if this fraction was >70%. By this definition, 215 (∼87% coverage) in
the combined Oxytricha WGS+pilot dataset, and 162 (∼65% coverage) in the Oxytricha
stage 1 dataset.
Similarly, completeness can be estimated by counting the conserved single-copy coding genes (CSCCGs) using the Tetrahymena genome sequences as a outgroup reference
genome among the available sequenced ciliate genomes. Note that the Paramecium genome
is problematic due to whole genome duplications. Using the simple TBLASTN approach
to detect conserved coding genes from Oxytricha and Stylonychia to Tetrahymena, each
CSCCG can be used to estimate the coverage of each other genome. However, this gives
much higher coverage estimation than expected (∼89% coverage in Stylonychia and ∼97%
coverage in Oxytricha). Also, when using the resulting CSCCGs sets as a reciprocal data
set to reestimate coverage in each other genome, it gives very different coverage estimation
(∼47% coverage in Stylonychia and ∼84% coverage in Oxytricha). So this approach using
simple schematics was not deemed reliable.
Even though the dataset of full length nanochromosomes is estimated to be only 4065% complete, in principle even just a small sample of about a hundred would suffice to
investigate the proportion of noncoding nanochromosomes, so long as that sample was
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random and unbiased. However, there are two important sources of bias to consider in the
stage 1 dataset as follows.
We expect a bias towards shorter nanochromosomes. Shorter nanochromosomes are
easier to assemble, and the WGS part of the assembly is from a size-selected <7 kb fraction of macronuclear DNA. We compared the length distribution of the stage 1 dataset to
two different estimates of the actual length distribution of the overall macronuclear genome
(Figure 3.2). The actual distribution has been characterized previously by measuring the
contour lengths of ∼1000 individual nanochromosomes in electron micrographs [170]. We
extracted the EM contour length histogram from reference [170]. The actual distribution
also can be obtained through digitizing an ethidium-stained agarose electropherogram used
generally for nanochromosome detection. We extracted pixel intensities from a digital image of an ethidium-stained agarose electropherogram of Oxytricha DNA and averaged over
sections of 0.1 kb as measured from adjacent size standards, assuming a logarithmic relationship between gel migration distance and DNA length in nucleotides. Intensity values
were assumed to be proportional to DNA mass because ethidium is an intercalating dye
and converted to relative molar nanochromosome abundance by dividing by DNA length
[185].
Both methods produced similar overall length histograms. Overall, nanochromosomes
have a mean length of 2.2-2.5 kb, ranging up to 10-20 kb, whereas the stage 1 data have a
somewhat smaller mean length of 1.9 kb, ranging up to 13.8 kb. About 2% of nanochromosomes run out on a gel are larger than 7 kb, whereas only nine contigs in the stage 1 data
are longer than 7 kb (0.1%). This indicates substantial (20x) undersampling of the 2% tail
of longest nanochromosomes. About 15% on a gel are 4-7kb, where we have 202 contigs
in the stage 1 data (2%), indicating moderate (7-8x) undersampling in this length range.
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Figure 3.2: Length distribution of full-length nanochromosomes
The length distribution of the stage 1 dataset (solid line) and other reference length distributions; The dashed
line shows the actual nanochromosome length distribution as estimated from an agarose gel electropherogram, and the dotted line shows the actual nanochromosome length distribution as estimated by Swanton
et al. [170] from contour length in electron microscope images.

For the 80% of nanochromosomes that are <4kb, there is only a modest sampling bias.
The principal concern with a bias towards shorter nanochromosomes is that we could
overlook ncRNA genes like the recently described mammalian long intergenic noncoding
RNAs (lincRNAs) [88, 186]. However, lincRNAs are only “long” relative to other previously well-studied ncRNAs, which are often 100-400 nt. Mammalian lincRNAs seem to be
about the same length distribution as coding mRNAs. According to GENCODE v4 transcript annotation2 , human lincRNAs and protein-coding mRNA transcripts show a similar
length distribution, with mean lengths of 2.4 kb versus 2.3 kb, respectively (Figure 3.3).
The length distribution of the stage 1 dataset covers the great majority of coding nanochromosomes, so it is also expected to cover lincRNA-like ncRNA genes. Second, and more
2

http://www.gencodegenes.org/
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Figure 3.3: Cumulative length distribution of human genes
The solid line represents the cumulative length distribution of the transcripts of human protein-coding gene
and the dotted line shows the cumulative length distribution of the transcripts of human lincRNA genes. Two
vertical lines represent the median length of the each distribution.

generally, if a class of large ncRNA-containing nanochromosomes were present even at a
few percent, we would have expected to sample some noncoding nanochromosomes among
the 211 nanochromosomes longer than 4 kb in the stage 1 dataset.
We also expect a bias towards assembling more abundant (high-copy number) nanochromosomes, which get higher sequence coverage. Each Oxytricha nanochromosome occurs
with a mean of ∼1000 copies per macronucleus [153, 170], but some nanochromosomes
are known to be maintained at different copy numbers. The most extreme case is the rDNA
nanochromosome, found to be present at about 100,000 copies. The rDNA appears as
a prominent 7.6kb band on agarose gels of macronuclear DNA [153], where a distinctive species-specific pattern of 100-200 overrepresented bands is also seen [187]. Several
examples of about six-fold copy number differences have been observed when the copy
number of individual non-rDNA nanochromosomes has been measured [188, 189], and a
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few cases of extreme overamplifications have been observed during prolonged vegetative
growth [190]. However, reassociation kinetics experiments have shown that bulk macronuclear DNA reanneals as if the great majority of sequences occur in roughly equal numbers
[151, 169, 191]. In order to gauge the extent and impact of copy number control, we examined the distribution of sequencing coverage of individual assembled nanochromosomes in
the WGS subset of the stage 1 data. We found a right-skewed distribution ranging from
1.1- to 87.4-fold coverage, with mean 10.4, median 7.3, and a mode of about 5 (data not
shown). As expected from previous published results, this coverage distribution is consistent with nonuniform copy number varying over perhaps an order of magnitude, and it
appears we have likely sampled the bulk of that distribution. Combined with the estimate
of 40-65% completeness of the stage 1 dataset, it seems unlikely that a population of lowcopy ncRNA-carrying nanochromosomes exists that has been entirely missed, as opposed
to somewhat undersampled.
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Chapter 4
Computational screens for ncRNA genes
Our scheme relies on being able to sensitively identify protein-coding regions, in order to
screen out as many nanochromosomes containing protein-coding genes as possible. Homology searches are one way to identify probable coding regions, but while homology
searching is specific, it is not very sensitive. Many proteins may have no detectable homologs, either because they are clade-specific or rapidly evolving. Therefore we aimed to
use computational protein “genefinding” to sensitively identify protein-coding regions by
their statistical signals, and later homology search was done to remove the undetected by
genefinder but conserved protein coding genes. To find more probably functional ncRNA
candidate and define the ncRNA region within the non-coding nanochromosome, comparative analysis with Stylonychia was conducted. All the following processes to detect ncRNA
genes are summarized in Figure 4.1.
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Figure 4.1: Flowchart of the screen for noncoding nanochromosomes.
The graphs to the right show the length distribution of the dataset at each stage of the screen. Red arrows
indicate a peak of small (presumably artifactual) noncoding contigs that is initially enriched, then removed
when a requirement for DNA sequence conservation to Stylonychia is imposed.
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4.1

Non-coding nanochromosome classification

To winnow the protein-coding gene-containing nanochromosomes in respect of ncRNA
gene screen so as to make our screen effective, we need a coding genefinder to have high
sensitivity. We are less concerned with the comprehensiveness of our screen’s ability to
detect ncRNA genes – the stage 1 dataset is already only a sample – so we can tolerate
somewhat low specificity, which means relatively higher rate of miscalling a noncoding
nanochromosome as coding so to throw it away because signal/noise ratio in terms of
ncRNA genes is affected largely by the predominant protein-coding genes in gene population. We strived to develop a coding gene classifier with about 95% sensitivity and at
most a 20% false positive rate, based on the following “back of the envelope” argument.
Suppose there were 100 ncRNA-only nanochromosomes in the stage 1 dataset, with the balance (9547) containing one or more coding genes. At 95% sensitivity, about 475 (5%) of
nanochromosomes carrying coding genes would be misclassified as noncoding. At a 20%
false positive rate, 20 ncRNA nanochromosomes would be mistakenly discarded because
we falsely predict a coding region on them. Thus we would find about 555 “noncoding”
candidate nanochromosomes, only 80 of which contain true ncRNA genes (15%). This
would be a barely tolerable signal/noise level in a candidate set that we could sort out using
further computational and experimental analysis, while maintaining a reasonable sample
of ncRNA genes for novel ncRNA gene discovery. We are not concerned with the detailed
exon/intron accuracy of a genefinding prediction for this problem, only with the sensitivity
and specificity of classification of an entire nanochromosome.
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4.1.1 Test and training dataset
To evaluate how accurately these programs could distinguish coding nanochromosomes
from noncoding random sequences of the same size and composition, we constructed the
following training and test datasets. Here, we oriented into the protein gene detection
problem, so positive data contains protein coding genes and noncoding gene containing
nanochromosome is defined as a negative. For positive training and test data, we identified a
dataset of nanochromosomes which contain teh conserved region to known protein. A set of
2520 nanochromosomes were identified in the stage 1 dataset as follows. First, 6702 (69%)
stage 1 nanochromosomes had BLASTX hits of E ≤ 10−5 to proteins in the NR database
and were considered likely to contain coding genes. To reduce redundancy at the protein
similarity level, these 6702 nanochromosomes were compared all-vs-all by TBLASTX and
single linkage clustered at an E-value threshold of 10−20 , and one nanochromosome was
randomly selected from each of the 2520 clusters. Each was randomly assigned to one of
ten jackknife datasets of 252 sequences each. To train Oxytricha-relevant model parameters, we had to partially annotate coding exon/intron structure in the positive data. The top
scoring homologous protein sequence was aligned to the nanochromosome using the protein2genome program in Exonerate 1.2.0 [192]. To get fully annotated exon/intron structure, we also identified an additional training data set of all 26 annotated Oxytricha genes
of 24 nanochromosomes in Genbank, and 33 genes manually annotated using expressed
sequence tag (EST) coverage1 .
For negative test data, we generated 2500 random nanochromosome-sized sequences
flanked by simulated telomere repeats. We used an HMM model consisting of three states:
1
EST data was generated by the pilot project of protist EST program (PEP). By clustering and filtering
from 3066 EST reads, 1225 sequences were obtained. Among them, only 33 sequences can be annotated to
include the whole protein gene structure.
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5′ -telomere, sequence, and 3′ -telomere. Two 5′ and 3′ telomere states use explicit length
distributions derived from the draft sequencing data set and emit a complete telomere subsequence. The sequence state emits one nucleotide at a time using 2nd order Markov statistics
trained on the entire stage 1 dataset.
We jackknifed the positive and negative datasets to construct ten different test sets of
252 positives and 250 negatives, leaving 90% of the positive data for training on Exonerateannotated partial gene structures.

4.1.2 Available eukaryotic end-user trainable genefinders
To develop a high-sensitivity classifier, we first searched coding genefinding programs that
are already available. Eukaryotic protein genefinders depend on species-specific statistical
signals such as codon or hexamer bias, splice site signals, and intron length. Oxytricha
genefinding also presents a special problem because it uses a variant genetic code, reading
UAG and UAA codons as glutamine and only using UGA as a stop codon [193]. We surveyed available eukaryotic genefinding programs to identify programs that could deal with
the ciliate genetic code, that we could easily retrain ourselves for Oxytricha’s statistical
features, and that (ideally) we could train on limited datasets consisting of incomplete gene
structures, because we have few cDNA-validated gene structures for Oxytricha. We chose
Genezilla [194], Unveil[195], GeneID[196] and Augustus[197] for evaluation. Genezilla
was the program used for genefinding by the Tetrahymena thermophila genome project
[149], and GeneID was used by the Paramecium tetraurelia genome project [150]. Among
those available genefinders, only GeneID program can be trained with partial gene structures owing to the simple structure and detailed description of parameter files enabling to
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generate it by ourseleves.
We trained GeneID ten times on a combination of the 57 human-annotated sequences
with a different jackknifed training set of 90% of the positive data (2268+57=2325 sequences total). Genezilla, Unveil, and Augustus require complete gene structures for training, so we could not use the partially annotated positives for these programs. Instead we
only trained these three programs once, relying exclusively on the very limited set of 57
full-length Genbank+EST annotated genes. We expected these limited training data to put
these three programs at a significant disadvantage. Each genefinder was then tested ten
times on jackknifed sets of 252 positives and 250 negatives for its ability to discriminate
coding nanochromosomes from synthetic noncoding nanochromosome-like sequences.
Figure 4.2 shows the benchmarking results as a ROC (receiver operator characteristic)
plot. None of the genefinders we tested reached our desired level of sensitivity and specificity. We suspect it is due to the dearth of well-annotated Oxytricha gene structures for
training data. It may be possible to improve the performance of any of these genefinders
on this unorthodox application, if we had expert inside knowledge of their implementation.
However, we turned instead to developing our own specialized computational Oxytricha
“nanoclassifier” algorithm and software implementation.

4.1.3 The Oxytricha nanoclassifier
We used hidden Markov model methodology [198] to specify a probabilistic model of
Oxytricha nanochromosomes containing coding genes. Figure 4.2.B shows a schematic of
our model. It includes standard statistical features for eukaryotic genefinding [199], such
as 5th-order Markov (hexamer) statistics for residues in coding exons and an intron model
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A. Classification performance
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Figure 4.2: A hidden Markov model based coding nanoclassifier.
A. ROC curve of classification performance. 10CV exp - results of ten-fold cross-validation on jackknifed
test sets of 252 positive sequences and 250 negative sequences, showing the average (grey box) and range
of the ten test results as P-value threshold is varied. GeneID - results of ten-fold cross-validation of the
GeneID program, where a GeneID annotation of a complete coding gene structure is counted as a positive
coding classification. other genefinders - each point represents a result on one jackknifed test dataset, but
each of these genefinders was only trained once on a set of complete gene structures, not on the partial gene
structures of the jackknifed positive training data. Unveil, AugustusC, GeneZillaC points call a complete
coding gene structure annotation as a positive classification. AugustusA, GenezillaA points call a partial or a
complete gene structure annotation as a positive classification. B. Schematic of the HMM state architecture
of nanoclassifier gene model.
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consisting of hexamer 5′ and 3′ splice site consensus, a frame, a minimum length, and a geometric length distribution tailing off from the minimum length. The model consists of six
exon states, six intron states, 5′ and 3′ flanking sequence states and one intergenic state to
allow more than one protein gene per nanochromosome in the same or opposite orientation.
A start state emits an ATG (exactly), and a stop state emits a TGA codon (exactly). For intron signals, hexamer nucleotide frequencies including exact GT or AGs are estimated from
the training set. We included minimum length constraints on the intron state. The overall
model includes a mirror image of the coding gene model for the reverse strand, allowing
more than one coding region to occur per nanochromosome on either strand. Additional
states in the model generate noncoding extragenic and intragenic DNA segments, so the
overall model is that of a complete full-length nanochromosome containing one or more
coding genes. The background (null hypothesis) model has the same HMM state-structure
as the gene model, but the emission statistics of all states are changed to background: 5th
order Markov (hexamer) background statistics in the exon states (estimated from the entire stage 1 dataset), and 0th order background nucleotide frequencies in all other states
and also for start and stop codons and GT/AG splice sites. This preserves the same length
distribution for both coding and null models. If we used a different model structure for
the null hypothesis, it would be hard to match overall length distributions implied by the
two models, and sequences could get classified spuriously by length rather than statistical
coding signals.
One advantage of this model to us is that we fully control its parameterization, and
could tailor it for Oxytricha and for the types of partial data we had available for training.
Another is that we have full control over thresholding model scores, so we can trade off
sensitivity against specificity as needed.
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Here we are interested in nanochromosome classification rather than genefinding which
will be described in the later section. To solve classification problem more effectively, we
could improve its implementation rather than simply using genefinder methodology which
predicts the precise gene structure. First, it is advantageous to set up a hypothesis test
with two specified models, that is, having an explicit model of the “Null hypothesis”: a
coding gene model and a background model generating non-coding nanochromosomes as
described above. Second, it is advantageous to use the Forward algorithm rather than the
Viterbi algorithm which calculates the most probable path to fit the sequence into this
generative gene model to produce the parsing of the gene structure of one or more genes
in a nanochromosome. The Forward algorithm calculates the probability of all probable
paths to be fitted into the model, so it admits the possibility of the existence of uncertainty
in parsing as opposed to one exact parsing, which is appropriate for classification problem
to figure out whether protein coding genes exist or not.
Given a full-length nanochromosome sequence, we calculate a log likelihood for both
models by using the HMM Forward algorithm, and report the log-odds likelihood ratio
in units of nats (natural logs). A positive log-odds score indicates stronger evidence for
the coding model than the null hypothesis, and the higher the score, the more evidence
for coding potential. In principle, we could threshold the log-odds likelihood scores to
distinguish coding from noncoding nanochromosomes, but length and residue composition
effects in a given individual nanochromosome introduce biases into log-odds scores toward
the coding model. To mitigate these effects, we calculate a P-value statistic for each logodds score by order statistics (i.e. by brute force simulation), by shuffling the sequence
30,000 times by 3-mers to roughly preserve 2nd order statistics, calculating a score for
each shuffle, and reporting where the score of the real sequence falls in that simulated null
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distribution. A low P-value means higher confidence that a nanochromosome contains one
or more coding regions. Classification is based on thresholding the P-value.
We tested the classification performance of our nanoclassifier using the same jackknifed
training/test data used for GeneID. Figure 4.2.A shows the results for varying choices of
P-value threshold. At a P-value threshold of 0.09, the average of the 10 jackknifed experiments is 94% sensitivity and 17% false positive rate. This estimated performance was
acceptable for our screening strategy. We then retrained the classifier on the entire positive
dataset (not just a jackknifed subset) for subsequent use.

4.1.4 The nanochromosome classification screen
The results above establish the basis for the idea that we should be able to systematically
identify ncRNA genes in Oxytricha by computationally identifying coding genes in fulllength nanochromosomes, and subtracting these coding nanochromosomes to leave a subset
of apparently noncoding nanochromosomes for further analysis. We applied our nanoclassifier to each of the 9647 presumptive full-length nanochromosomes in the stage 1 dataset
(Figure 4.1). Unexpectedly, this identified a stage 2 dataset of only 507 noncoding contigs
(5.3%).
This small number is consistent with the expected false negative rate of the nanoclassifier, so many of these contigs are still likely to contain coding regions. Given the estimated
sensitivity of 94% for our nanoclassifier, if all 9647 contigs were coding, we expect about
580 (6%) to pass.

55

4.1.5 Exclusion of “known” protein coding genes
To further increase the stringency of the screen, we used BLASTX to identify nanochromosomes with significant similarity to known proteins with “wordmask=seg, wordmask=xnu”
options and with “E = 10−5 ” threshold on UniProt/Swissprot database which contains more
experimentally validated proteins in spite of its smaller size than the NR database. This
process removed 69 more contigs, leaving a stage 3 dataset of 438 noncoding contigs.
This small number is surprising, and a main result of the work. If Oxytricha contained large numbers of ncRNA genes, we would expect to find large numbers of noncoding
nanochromosomes at this stage of the screen, but we do not. Indeed, the actual number of
noncoding nanochromosomes is even smaller. The 438 stage 3 nanochromosomes still include undetected coding genes and assembly artifacts, as described below. We established
that ncRNA genes occur alone on single-gene nanochromosomes sufficiently often, that our
nanoclassifier is sufficiently accurate, and that the stage 1 sample of full-length nanochromosomes is sufficiently representative, that this result is expected to be robust. In what
follows, we exploit comparative analysis against the Stylonychia draft genome sequence
to look deeper at this set of 438 nanochromosomes to see whether we have nonetheless
sampled some interesting new ncRNA genes, and to further study possible sample biases.

4.1.6 A lightweight nanogenefinder
As mentioned in the nanoclassifier section, O. trifallax has different content and signal
statistics for gene structures compared to other eukaryotes, so pre-trained gene-finding
programs for other eukaryotes may work very poorly. For example, the Genscan [200]
program, one of the conventional ab initio HMM gene finders, with the human parameter
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files performed at 0.325 sensitivity and 0.996 specificity at the nucleotide level and 0.133
sensitivity and 0.182 specificity at the “exact” exon level when tested on the Oxytricha 26
protein genes deposited in GenBank among the additional training dataset of nanoclassifier.
A more difficult problem is the very small size of training dataset that annotated the whole
gene structure. Therefore, to make our own genefinder which can be tuned on Oxytricha
even with partial data might be advantageous.
Our genefinder, named “nanogenefinder” to reflect both the characteristics of its structural simplicity and the fact that it was trained specially for Oxytricha nanochromosome, is
based on the same HMM gene model in nanoclassifier. The differences are an unnecessity
of the background model, and using the Viterbi algorithm to calculate the probabilities from
the model as described in the nanoclassifier section. The nanogenefinder, a lightweight program having simple structure and relatively small number of parameters, can be trained on
a small amount of data.
The performance test result on nanogenefinder and other custom-trainable genefinders
which are the same programs which were used for comparing the performance of nanoclassifier due to the same reasons as mentioned above is shown at the Table 4.1. Two sets of
data both of which were used for training the genefinders as additional data in the above
classification problem were also used to train and test exchangeably: NCBI and EST. NCBI
dataset consists of all 26 genes on 24 nanochromosomes annotated in Genbank. It includes
total 16 single exons, 10 initial/final exons, and 10 internal exons. EST dataset consists of
33 manually fully annotated genes on 33 nanochromosomes using EST data. It includes
total 14 single exons, 19 initial/final exons, and 7 internal exons. As mentioned in the
nanoclassifier section, because the GeneID package does not provide a training program,
we generated parameter files for Oxytricha by hand. Rather than using the same parame57

ter complexity as the default, we reduced the size of signal information for start and stop
codon, donor and acceptor sites and changed transition probability matrix for trimer, not
for hexamer, to get a better performance on this small data set.
The nanogenefinder and Augustus show relatively better performance than other programs on this small size of training and test data although their performances are not satisfying compared to that of conventional genefinders trained on other eukaryotic genome.
For example, genscan reported 0.78/0.81 sensitivity/specificity at exon level and 0.93/0.93
at the nucleotide level on the 570 vertebrate gene sets [201]. The performance of Augustus trained on NCBI set and tested on EST set is similar to this level. If Augustus
and nanogenefinder are trained and tested both on NCBI and EST, their performances can
be achieved in the acceptable level although additional information from the partial data
which have no full gene-structure annotation and are the computationally predicted is supplemented for nanogenefinder training.
Two anecdotal examples shown at Figure 4.3 illustrate the performance of genefinders.
GeneZilla and GeneID have a tendency to over-predict genes and under-predict exons on
the nanochromosome. The fact that a lightweight nanogenefinder shows almost equivalent
performance to the more sophisticated genefinder Augustus might indicate some possible
need for custom-trainable and partial training data-acceptable lightweight genefinder in the
paucity of training data when a new genome is sequenced.
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Table 4.1: Performance test on the genefinders

Program
GeneZilla
Unveil
GeneID
Augustus

nanogenefinder

Training/Test set
NCBI/EST
EST/NCBI
NCBI/EST
EST/NCBI
NCBI/EST
EST/NCBI
NCBI/EST
EST/NCBI
All/All
NCBI/EST
EST/NCBI
All/All

Seq
0.03
0.25
0.394
0.269
0.03
0.042
0.727
0.333
0.895
0.485
0.5
0.789

Sensitivity
Gene Exon
0.03 0.034
0.231 0.13
0.394 0.288
0.269 0.174
0.03 0.034
0.077 0.043
0.727 0.763
0.308
0.5
0.881 0.914
0.485 0.458
0.462 0.478
0.797 0.895

Nuc
0.032
0.326
0.766
0.504
0.402
0.512
0.973
0.762
0.957
0.801
0.636
0.983

Seq
1.0
0.462
0.448
0.368
0.032
0.042
0.750
0.348
0.927
0.533
0.667
0.789

Specficicity
Gene Exon
1.0
1.0
0.429 0.375
0.351 0.459
0.259 0.286
0.03 0.061
0.054 0.054
0.727 0.804
0.333 0.242
0.912 0.914
0.533 0.711
0.667 0.711
0.746 0.855

Nuc
1.0
0.992
0.911
0.986
0.645
0.844
0.954
0.991
0.991
0.956
1.0
0.976

The sensitivities and specificities of each genefinder are shown in several levels: Nuc (in nucleotide level),
Exon (in exon level), Gene (in whole gene level) and Seq (in whole nanochromosome level). For instance,
Nuc sensitivity is the ratio of the number of correctly predicted nucleotides to the number of all annotated
nucleotides, and Nuc specificity is the ratio of the number of correctly predicted nucleotides to the number of
all predicted nucleotides.

4.2

Comparative analysis of the candidate nanochromosomes

We wanted to utilize comparative sequence analysis to identify conserved sequences likely
to encode functional ncRNA genes, to distinguish such conserved RNA sequences from the
distinctive codon-dependent conservation pattern of coding regions, to confine the possible ncRNA regions within the nanochromosome, and to assist in secondary structure prediction of any structural RNAs found. Therefore we sought the macronuclear genome
sequence of another ciliate at a suitable evolutionary distance for comparative sequence
analysis of Oxytricha. Ten stichotrich ciliate isolates were surveyed by our collaborators in
Princeton University through PCR and sequencing of four conserved protein-coding genes:
telomere-end binding proteins α and β, HSP70, and DNA polymerase α. The number of
59

B. omyb1 and orpb9 gene ( 696 nt)

A. L37 gene ( 696 nt)

NCBI

NCBI, Au, Na

Na
GeneZilla

Augustus

GeneID

GeneZilla

Unveil

GeneID
Unveil

Figure 4.3: Examples of the results from genefinders
Examples of genefinder results. NCBI represents the annotation from GenBank, Au represents Augustus
program, and Na represents our nanogenefinder. A. A small nanochromosome known to encode one gene. B.
A long nanochromosome known to encode two genes.

substitutions observed in synonymous four-box codons in alignments to homologous O.
trifallax sequence was used as a proxy of neutral evolutionary distance. We aimed to identify a species at about 0.4 neutral substitutions/site [202]. Two isolates (Oxytricha fallax
and Oxytricha “Bath”) were too closely related, but eight isolates (“Sterkiella histriomuscorum”, Oxytricha nova, Oxytricha Maryland, Stylonychia lemnae, Stylonychia mytilus,
Laurentellia sp., Paraurostyla sp., and Urostyla sp.) were all suitable, ranging from 0.3
to 0.6 substitutions/4box-site. We chose the stichotrich Stylonychia lemnae because it appears to have a neutral evolutionary distance of approximately 0.4 substitutions per site
to Oxytricha, roughly comparable to mouse/human sequence comparison, a distance well
suited both for detection of conserved coding exons and comparative analysis of conserved
RNA structure in pairwise alignments [202].
Like Oxytricha, Stylonychia is a stichotrich, and its biology is thus comparable to that
of Oxytricha. Because it is physically larger, it was used extensively in early cytogenetic
studies of macronuclear genome development [203–205].
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4.2.1 Stylonychia lemnae genome sequencing
We sequenced whole cell DNA obtained from Stylonychia lemnae strain 2x8/2, which was
kindly provided by Francziska Jönsson and Hans Lipps (University of Witten, Germany).
At the Genome Sequencing Center (Washington University in St. Louis), a sample was
sequenced in one 454FLX run without purification of macronuclear DNA away from micronuclear DNA because macronuclear DNA is in vast excess. This produced 568,094
reads (146 Mb), about 3x average shotgun coverage of the presumed ∼50Mb macronuclear genome with reads averaging 260 nt in length. The Newbler program, which can be
downloadable from [https://valicertext.roche.com/], assembled these reads
into 53,806 contigs (27.3 Mb) ranging in size from 95 to 9947 nt.
This Stylonychia assembly contain 131(∼53% coverage) CEGs, so we estimate this
assembly covers about 50% of the Stylonychia genome. We therefore expect to be able to
detect approximately 50% of single-copy evolutionary conserved regions in Oxytricha by
comparison with the Stylonychia dataset.

4.2.2 Sequence alignment to Stylonychia lemnae
We expect the steps to this point have also enriched for artifactual “noncoding” contigs
that arise either from sequence assembly errors or DNA processing errors in Oxytricha.
Figure 4.1 shows length distributions for the contigs in each dataset, which show the progressive enrichment of a peak of small (∼100 nt) contigs in the stage 3 data that are
likely assembly artifacts due to false overlaps in low-complexity subtelomeric sequence.
To enrich for nanochromosomes containing functional genes, we screened for contigs
with significant DNA similarity to our Stylonychia shotgun data. We produced pairwise
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Oxytricha/Stylonychia local alignments using WU-BLASTN with options “filter=seg filter=dust maskextra=10 M=4 N=-5” to detect relatively short alignments, which partially
resulted from low-continuity shotgun assembly of Stylonychia genome sequence and relatively small size of ncRNA genes, and selected alignments of ≥ 70% identity and E ≤ 10−5 .
This identified a dataset of 127 conserved noncoding nanochromosomes (stage 4 dataset;
Figure 4.1). The peak of small contigs disappears in this stage.
The stage 4 dataset is highly enriched for nanochromosomes carrying known ncRNA
genes (66/127, 52%). Although it is possible that these 66 nanochromosomes contain additional novel ncRNA genes, we excluded them from further analysis, leaving a set of 61
conserved noncoding nanochromosomes with no significant similarity to known ncRNA
genes. These are candidates for harboring novel ncRNAs.
Several of these appeared to be quasialleles or paralogs of each other. We clustered the
61 nanochromosomes by sequence similarity and chose a representative set of 46 distinct
loci. This clustering included both identifying “quasialleles” (11 contigs were considered
to be quasialleles of others), and also clustering obvious paralogs together. In particular,
9/61 of the nanochromosomes at this stage represent one family of ncRNAs which will
be described in the next chapter. Five of them are distinct loci (Onc91, Onc92, Onc94,
Onc95, Onc96) after clustering quasialleles. After clustering paralogs by sequence similarity, two of these nanochromosomes were chosen as representative (Onc91 represents a
cluster including Onc92; Onc94 represents Onc95 and Onc96).
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Figure 4.4: Comparative sequence analysis of sequence regions conserved with Stylonychia,
Examples of one known protein and four ncRNA genes were shown. Starting with a BLASTN alignment
of homologous Oxytricha and Stylonychia sequences, each residue represent each colum of the alignment,
and residue substitution events in three frames are colored into red, green, and blue. A whole sequence
alignment is splitted into several lines to display 60 characters per line. QRNA[126] classification results for
each alignment are shown in the right column, showing the best scoring class (“COD” for coding, “RNA”
for structural RNA, and “OTH” for other) and a QRNA classification log-odds score in bits. Coding regions
generally stand out both visually and by QRNA because of the periodicity of three in their substitution events
(i.e. the predominance of one color in a large region of the protein example).

4.2.3 Analysis of alignment patterns
Despite all the steps taken so far, we still expect that more than half of these 46 contigs will
carry coding genes that we have failed to recognize. Given that the BLASTX step at stage 3
removed 69 contigs, and we expect from the previous section that about 65% of Oxytricha
proteins have significant similarity to known proteins, then we expect approximately 37
coding regions to pass into stage 4. About 70% (26) of these would pass the stage 4
conservation screen against the incomplete Stylonychia dataset. Therefore, as a final step
to remove coding nanochromosomes, we used the pattern of residue substitution observed
in the region of DNA sequence conservation with Stylonychia.
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Because we selected Stylonychia to be at a neutral distance of about 0.4 substitutions
per site, we expect substitutions in many near-neutral codon third positions, and thus a
distinctive periodicity of three is seen in the pattern of observed substitutions in conserved
coding regions. Figure 4.4 shows examples of this periodic pattern in a known coding
region as opposed to known ncRNA genes. This pattern can be evaluated by brute force
comparing of numbers of the substitution in each codon position or by the RFC (reading
frame conservation) test [206] that measures the portion of nucleotides in a fully aligned
interval for which the reading-frame has been locally conserved. The RFC score calculation
was implemented by a Perl program according to the published description [206]. As
shown on Figure 4.5, it is not easy to discriminate the protein-coding gene like alignments
in Oxytricha and Stylonychia alignment, using RFC.
Instead, we scored this pattern by running “eqrna -a” to the pairwise BLASTN alignments processed by “blastn2qrnadepth.pl” in the QRNA [126] package, which has explicit
probabilistic protein-coding gene (codon position-dependent alignment), non-coding gene
(ncRNA structure-constrained alignment) and other class (position-independent alignment)
models for the pairwise alignment. Although QRNA was originally designed to identify
structural ncRNAs by comparative analysis, which is a task that remains difficult with
high false positive rate, its statistical model for discriminating conserved coding regions
from other types of sequence conservation is effective. Performance benchmarking of
QRNA’s ability to detect coding nanochromosomes was done using the same 2520 presumptive coding sequences in the positive test data for the nanoclassifier 10CV data set.
A total of 1517 pairwise alignments passed the above criteria. After splitting long alignments into alignments of a maximum length of 1000 columns, 5033 pairwise alignments
were used as a positive data set. For negative data, we produced the simulated noncoding
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Figure 4.5: RFC score distribution
The graphs show the distribution of RFC scores in the positive data set and the negative dataset (which consists of the shuffled alignments of the positive data set). The positive dataset is a set of BLASTN alignments
to Stylonychia of the same dataset used at 10-fold CV performance test of nanoclassifier. A. The average
RFC score of the multiple alignment segments of a sequence is used as a representative. B. The best RFC
score among the multiple alignment segments of a sequence is selected as a representative.
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Oxytricha/Stylonychia alignments by shuffling the pairwise alignments by columns thus
preserving mean base composition and percent identity. For longer alignment, it is split
into several pieces to match up the limitation of alignment length in QRNA program. On
this dataset, we estimated that QRNA has a true positive rate of 95% and a false positive
rate of 3% for distinguishing conserved coding regions.
QRNA classified the conserved regions in 29 of the 46 contigs (63%) as probable coding
regions, consistent with our statistical expectation. The final candidate set (stage 5) consists of 17 representative, distinct, conserved, full-length, apparently noncoding nanochromosomes.
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Chapter 5
Analysis of the final candidate
nanochromosomes

5.1

Experimental validation of ncRNA gene predictions

To test whether our 17 candidate nanochromosomes express RNA transcripts from the identified regions of sequence conservation, we performed Northern blots. As positive controls,
we also performed Northerns for 13 homologs of known ncRNAs (8 C/D snoRNAs, 4
tRNAs, and one U2 RNA locus) and identified small RNA transcripts of the expected size
for all 13. Images of these Northerns (Figure D.1) and probe sequences (Table D.1) are
provided in Appendix D. For positive candidates on Northerns, we performed 5′ and 3′
RACE-PCRs (Rapid Amplification of cDNA Ends) and sequenced multiple clones from
each in order to define complete transcript sequences.
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5.1.1 O. trifallax culture and RNA extraction
O. trifallax strain JRB310 [207] was cultured to ≥ 5000 cells/ml density in 8x12 inch
Pyrex dishes with 300 ml ciliate medium. They were fed a mixture of an alga (C. elongatum, University of Texas) grown in 500 ml flasks under light in Euglena medium, and
bacteria (K. pneumoniae). O. triallax cultures was split into two cultures with fresh vegetatively grown Oxytricha cells were collected on several layers of gauze to exclude clumps of
algae, then filtered on a Nitex nylon membrane to get rid of bacteria and culture medium.
For long term storage, inactive cyst forms of Oxytricha cells that were generated by starvation of the collected cells were stored at −70 ◦ C after mixing with equal volume of 20%
DMSO. To hatch up Oxytricha cells from cysts, cysts were diluted in an excess of ciliate
medium several times and fed. For RNA extraction, the medium of the collected cells is
brought to 0.05M EDTA to immobilize the motile cells and to reduce RNase activity, and
cells were collected by centrifugation at 4 ◦ C. Total RNA was extracted by a standard Trizol (Invitrogen) protocol that uses chloroform for phase separation and propanol for RNA
precipitation, and stored in 1mM EDTA at −20 ◦ C.

5.1.2 Testing the existence of RNA transcripts: Northern blot
Northern blot was initiated with runing 2 − 10 µg of total Oxytricha RNA on 4% acrylamide gels. Then, the gel was electroblotted using a semi-dry electrophoretic transfer unit
(BioRad), and UV crosslinked to a ZetaProbe charged membrane (BioRad). DNA oligonucleotide probes (38-44nt) were end-labeled with γP32 -ATP using T4 polynucleotide kinase
and hybridized to the Northern blots in UltraHyb Oligo solution (Ambion) at 42 ◦ C for
overnight at least 15 hours. Blots were washed twice in a solution of 2X saline-sodium
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citrate (SSC) buffer and 0.1% sodium dodecyl sulfate (SDS) solution at 55 ◦ C for 5 minutes and 15 minutes, then again twice in 0.1X SSC and 0.1% SDS solution at 55 ◦ C for 5
minutes and 15 minutes. Blots were either visualized by phosphorimager (Amersham Biosciences), or exposed at least one day on X-ray film (FujiFilm) at −80 ◦ C. For some probes
with lower calculated melting temperatures, an additional Northern blot was performed using less stringent hybridization and washing temperatures: 37 ◦ C for hybridization, 42 ◦ C
for washing. A

32

P-labeled 50bp dsDNA ladder (New England BioLabs) was used for

molecular weight standards.
Each candidate nanochromosome was tested with one or several single-stranded oligonucleotide probes directed against the conserved and/or relatively high GC-content regions of
the nanochromosome. We probed each strand separately to decipher the strand specificity,
using total RNA extracted in vegetative growth condition as described above. For 7 of the
17 candidates we detected small RNA transcripts (Figure 5.1). All probe sequences are
listed in Appendix D.

5.1.3 Verifying the ends of transcripts: RACE-PCR
To conduct RACE experiments on the Northern postive candidates, poly-A tails were added
to total RNA by terminal deoxynucleotidyl transferase to sample all RNA species in the following RACE protocols, which provide the anchor for transcript polymerization. We used
two different commercial RACE protocols: SMART-RACE (Clontech) and GeneRacer (Invitrogen). The SMART-RACE 5′ RACE protocol relies on the addition of 3-5 untemplated
C residues at the 3′ end of the first-strand cDNA synthesized by reverse transcriptase. This
protocol is less efficient in our hands, but may be relatively insensitive to unusual 5′ RNA
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Figure 5.1: Experimental confirmation of candidate ncRNA transcripts.
Sequences, predicted secondary structures, and Northern and RACE data for seven candidates with detected transcripts. Genomic
sequences are shown for each locus, with 5′ and 3′ ends of transcripts determined by RACE indicated by dark blue arrows. Arrows
pointing between nucleotides indicate an unambiguously determined end; arrows pointing at an 3′ end nucleotide A indicate an ambiguity
where we cannot distinguish an nucleotide A in the native transcript from the artificially appended poly-A tail. For Northern blots, 10/2 or
8/2 lanes indicate the amount of total RNA loaded in each lane (in µg). M indicates a radiolabeled 50bp DNA ladder. “Sense/antisense”
refers to the orientation of probes on the reference genome sequence, not the transcipt. For C/D box snoRNAs, only one probe was tested
because we predicted the correct strand by sequence analysis. Secondary structures of transcript were initially predicted by RNAalifold
[208] then manually modified based on comparative sequence analysis and other features (such as the predicted target sites for the
two H/ACA snoRNAs). Conservation of sequence and structure in Stylonychia alignments is annotated using a color scheme, with red
indicating a compensatory base pair substitution that supports the structure prediction, blue indicating a wobble base pair substitution
consistent with the structure prediction, and gray indicating all other substitutions, including those in single-stranded regions and those
that are inconsistent with the structure prediction.
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structure. The GeneRacer 5′ RACE protocol ligates an RNA oligo to the 5′ phosphate end
of an RNA transcript and uses that oligo as the amplification annealing site. Because this
protocol is optimized for capped mRNA transcripts, we skipped the first phosphatase step
and added a kinase step to assure that ncRNAs with a variety of possible capped and uncapped 5′ ends could be amplified. Both kits use the same approach for 3′ RACE, using
one oligo-dT primer against the added poly-A tail, and one gene-specific primer internal in
the transcript. RACE-PCR products were cloned and sequenced by standard methods.
We conducted RACE experiments on 6 of the 7 candidates detected by Northern, and
one C/D snoRNA, Onc85, was not examined because we had it classified as a “known
RNA” by its weak SNORD96 homology at the time we designed the RACE experiments.
In each case, except for the indeterminate 5′ ends of two loci described in the next chapter,
transcript sequence(s) implied by RACE-PCR sequencing were consistent with the band(s)
observed by Northern (Figure 5.1). All gene-specific probe sequences of the tested candidate genes are listed in Appendix E.

5.2

Manual examination

We analyzed each of the 17 candidate loci in detail, taking particular advantage of the pattern of Stylonychia conservation including multiple alignments where possible. Stylonychia
conservation patterns of the final candidate dataset are shown in Figure F in Appendix F.
For ncRNA loci that appear to conserve an intramolecular RNA secondary structure, we
used manual comparative analysis to infer the structure based on the RNAalifold [208]
prediction .
Of the ten candidates for which we detected no small RNA expression, upon detailed
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examination, five contain small fragments of coding genes found on other nanochromosomes. These nanochromosomes possibly arose as assembly errors or errors in macronuclear DNA processing. Two more appear to be fragments of nanochromosomes containing
pieces of conserved promoter sequence. Another has only a small patch of conservation.
Finally, 2 of these 10 candidates (Onc98, Onc106) have well-conserved regions that appear
to be plausible ncRNA genes, but because we did not observe any expression from these
loci, we cannot be sure of the bounds (or mature RNA sequence) of any transcript. We do
not consider them to be confirmed ncRNA loci.
Of the seven candidates for which we did detect small RNA expression, five are snoRNAs:
three C/D snoRNAs (Onc85, Onc86, Onc87) and two H/ACA snoRNAs (Onc89, Onc90)
(Figure 5.1). The C/D snoRNAs and the Onc89 H/ACA snoRNA have typical structures
for these classes of eukaryotic snoRNAs. Those snoRNAs are also detectable by snoscan
and snoGPS programs [134, 209] although the prediction score of Onc89 H/ACA snoRNA
is too low to be discernible from a noise. The predicted rRNA methylation sites of C/D
snoRNA Onc85, Onc86 and Onc87 are LSU832, SSU8 and/or LSU1242, and LSU678,
respectively. The Onc89 H/ACA snoRNA’s predicted target site is LSU2517; however,
its homologous position is a C residue in human and not pseudouridylated in yeast. A 3′
box regulatory motif which will be described in detail in the next chapter is detected in
the downstream of Onc89 H/ACA snoRNA. The Onc90 H/ACA snoRNA has an unusual
and distinctive structure, with large helices inserted in positions that H/ACA snoRNAs are
known to tolerate additional helices (known as the IH1 and IH2 locations; [210]). Based
on this unusual structure and the conservation of distinctive sequence elements (m1 and
m2) in a bulge in the 3′ -most stem, Onc90 is likely to be the Oxytricha homolog of the
“ubiquitous” eukaryotic U17/snR30 H/ACA snoRNA. This is the only H/ACA snoRNA
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that does not function as a pseudouridylation guide, but instead is involved in rRNA processing via a presumed interaction with SSU rRNA [211, 212]. The proposed interaction
for yeast snR30 and human U17 with their cognate SSU rRNAs is conserved for Onc90
with Oxytricha SSU rRNA (not shown) [213].
The remaining two candidates that show small RNA expression (Onc91 and Onc94)
share a well-conserved predicted RNA structure (Figure 5.1), but are not detectably homologous to any well-known eukaryotic small RNA families. A detailed description of these
ncRNAs is given in the next chapter.
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Chapter 6
Arisong ncRNA gene class
This computational screen found two related novel ncRNA genes: Onc91 and Onc94. Their
RNA transcripts exhibit well-defined bands on Northern blots, and their 3′ ends were readily mapped by RACE-PCR. However, we had difficulty obtaining 5′ RACE-PCR products
for them, and the products we did obtain mapped diffusely and failed to define consistent 5′
ends. We are unsure whether this represents mere technical failure although we had much
less difficulty with other RNAs, or if it reflects a peculiarity of the structure of these RNAs
that might interfere with a 5′ RACE protocol, such as a lariat structure or an unusual 5′ cap
although we used two different 5′ RACE protocols, one of which should be insensitive to
unusual 5′ end structure. Onc91 showed two distinctive Northern bands of approximately
equal intensity, while Northern of Onc94 revealed a single apparent band. Neither are
consistent with the 5′ end variance detected by RACE experiments.
In primary sequence level, Onc91 and Onc94 are 49% identical 1 over the region pre1

There is no consensus on exactly how to calculate the percent identity between two sequences. Here, we
showed the ClustalW2 [214] score in the primary sequence alignment by neglecting the secondary structure
conservation; explicitly, this score (in DNA) is similar to the percentage of the exactly matched columns in
the whole alignment.
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sented in Figure 6.1 in which most of variable 5′ end sequences are removed, and neither
can detect the other in a genomic BLASTN search with “W=5 E=10” option. However, they
share a common secondary structure, and in both cases, determining the mature 5′ end has
been problematic. Therefore, novel ncRNA Onc91 and Onc94 genes seem to belong to the
same small RNA family despite the primary sequences dissimilarity. We named these the
“Arisong” family of ncRNAs. “Arisong” is named after a Korean verb “arisong hada” that
means to be in an unsure or confusing status. This Arisong ncRNA family is expanded into
related ciliate genomes by an iterative search of homologs and investigated their conserved
secondary structure and regulating elements. To gain some understanding of their function,
we attempted to disrupt one or several ncRNAs in this family through RNAi knock-down.
In the absence of clear results, we speculated about the possible functions of Arisong RNA
genes based on the shared features.

6.1

Homologous gene search

We used Infernal [129] and BLASTN to iteratively search for additional Arisong RNA
homologs in the Oxytricha genome, our Stylonychia genome, and other available ciliate
genome sequences: Tetrahymena thermophila (Nov06 version) [149], Paramecium tetraurelia (Dec06(v1) version) [150, 215] and Nyctotherus ovalis [216]. We started with a modified RNAalifold [208] RNA secondary structure alignment prediction of Onc91, Onc94
and their quasialleles to build a covariance model for the conserved secondary structure.
As indicated above, we have not been able to determine a clear and consistent 5′ end by
RACE experiments. Further, the 5′ end sequence and also its length do not appear to be
conserved among family members. Thus, we chose to model only the conserved two con75

secutive stem-loop structure regions in the form of profile seed alignments by using “cmbuild” program in the Infernal package. As new homologs were identified, we refined our
covariance model of the consensus secondary structure, and tried to various models with
different combination of Arisong RNA sequences to search for new homologs. We found
a total of 15 Arisong loci in the entire Oxytricha dataset that include partially assembled
nanochromosomes. These loci can be clustered into 7 distinct loci (Onc91, Onc92, Onc94,
Onc95, Onc96, Onc155, Onc156) that appear to be paralogous rather than allelic. The peculiar nature of the spirotrich macronuclear nanochromosomes make it difficult to make a
definitive identification of alleles versus paralogs. However, subtelomeric sequence flanking each locus supports an organization of paralogous genes (data not shown). We found
8 loci in Stylonychia, 8 in Paramecium, and 1 in Nyctotherus. Six of the 8 Paramecium
loci have been previously predicted to be small RNA genes called PM01 1-6 by computationally identifying the RNA polymerase II signature such as a USE (upstream sequence
element) and TATA box of conserved sequences [217]. Oddly, we could not detect any
Arisong RNA homologs in another ciliate, Tetrahymena, even though the evolutionary distance between Oxytricha and Tetrahymena is similar to that of Oxytricha and Paramecium.
A total of 32 Arisong RNA genes was retrieved.

6.2

Consensus structure and regulatory elements

All of these loci were predicted to share a consensus secondary structure consisting of two
coaxially-stacked stems, with a highly conserved and well defined 3′ GUUC tail, and a
highly variable 5′ end (Figure 6.2). The length of the first stem is more conserved than that
of the second stem; it consists of six or seven base pairs. The second stem has bulges and an
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internal loop of variable size. But the base region of this stem, which is part of the stacked
junction, is relatively conserved in the length as well as the primary sequence. The high
primary sequence conservation of the stacked junction region leads us to conjecture that this
coaxially-stacked dumbbell structure could be a functionally important region and might
indicate a protein binding site. This proposed structure is well-supported by a number of
compensatory changes in base pairs observed in the multiple alignment (Figure 6.1).
All seven distinct Oxytricha Arisong loci are flanked on their nanochromosome by two
conserved motifs. A 17 nt motif TgACCCATnAAnnnTTA occurs about 50-60 nt upstream
of the putative 5′ end of Arisong genes. This motif is likely to be the Proximal Sequence
Element (PSE) found upstream of spliceosomal RNA genes in many organisms [219, 220]
including other ciliates [221]. A 19-20 nt motif AAAnGAAAnnGTTTGATTAg occurs 510 nt downstream of the putative 3′ end of Arisong RNA. This motif is likely the functional
analog (if not the homolog) of the 3′ box motif which is responsible for 3′ end processing
in snRNAs and other small RNAs in many organisms [222]. Other ncRNA genes such as
RNase P, telomerase RNA, and SRP RNA have upstream PSE elements. Moreover, most
splicesomal snRNAs and U3 snoRNA are flanked by both of PSE and 3′ box elements,
except for U6 and U6atac which show the hallmark Tn terminator of RNA polymerase IIItranscribed small RNAs instead of a 3′ box element. This suggests that the Arisong loci are
transcribed and processed similarly to spliceosomal RNAs, probably by RNA polymerase
II.
This consensus PSE element is much shorter than that of C. elegans [219]. However, the
core conserved “ACCC” in our Arisong PSEs (Figure 6.2) is relatively well conserved also
in C. elegans. Additionally, their relative distance from the start site of transcript (60-70 nt
upstream) is similar. As noted by Chen and colleagues [217], Arisong RNAs in Parame77

Onc91
uacuuUCGAGGUCUUAAGCCAGUGUAACUGGUUGCGGG GAGGG CCU.AUUC-GGGA CCUGA CCCGUUC
Onc91.2
uacuuUCGAGGUCUUAAGCCAGUGUAACUGGUUGCGGG GAGGG CCU.AUUC-GGGA CCUGA CCCGUUC
Onc92
auccuUCCAGGUCUUAAGCCAGUGUAACUGGCUGCGGGGGA GG CCU.AUUC-GGGA CC GAACCCGUUC
Onc92.2
auccuUCCAGGUCUUAAGCCAGUGUAACUGGCUGCGGGGGA GG CCU.AUUC-GGGA CC GAACCCGUUC
Onc92.3
auccuUCCAGGUCUUAAGCCAGUGUAACUGGCUGCGGGGGA GG CCU.AUUC-GGGA CC GAACCCGUUC
Onc94
guuaaUCCU-AACUUCAGA-GGUCCGGCC-UCUGCGG -- GGG C.ACAAAG -CCU -- CCGUUC
Onc95
guuaaUCCUAAACUUCAGA-GGUAUGGCC-UCUGCGGGG-- G CC.ACAAAGG - U --UCCCGUUC
Onc95.2
guuaaUCCUAAACUUCAGA-GGUAUGGCC-UCUGCGGGG-- GU CC.ACAAAGG - U --UCCCGUUC
Onc95.3
guuaaUCCUAAACUUCAGA-GGUAUGGCC-UCUGCGGGG-- G CC.ACAAAGG - U --UCCCGUUC
Onc96
uuuaaUUCU-UUUUUCAGC-AGUCCGGCU-GCUGCGGGG--A GG CC.AUAUUGG -UU U--CUCCGUUC
Onc155
aaauuUCCAAGUUUUAGGCCAGUUUAACUGGUCGCGGGGA-AUGG CCuUUUCUGG -CACUGAACCCGUUU
Onc155.2
aaauuUCCAAGUUUUAGGCCAGUUUAACUGGUCGCGGGGA-AUGG CCuUUUCUGG -CACUGAACCCGUUU
Onc155.3
aaauuUCCAAGUUUUAGGCCAGUUUAACUGGUCGCGGGGA-AUGG CCuUUUCUGG -CACUGAACCCGUUU
Onc156
uuuaaUUCU-UUUUUCAGC-AGUUCGGCU-GCUGCGGGG--A GG CC.AUAUUGG -UU U--CUCCGUUC
Onc156.2
uuuaaUUCU-CUUUUCAGC-AGUUCGGCU-GCUGCGGGG--A GG CC.AUAUUGG -UU U--CUCCGUUC
Stl|contig07687/132-196
.....UCGAAGUCUUAAGCCAGUGUAACUGGUUGCGGGCGA GG CCU.AUUC-GGGA UC GAACCCGUUC
Stl|contig07687/646-710
.....UAGAAGUCUUAAGCCAGUUUAACUGGUUGCGGGUGAUGG CCU.AUUC-GGGA CCUGACCCCGUUC
Stl|contig29728/235-171
.....UCCCAGUUCUAUGCCAGUUUAACUGGUAGCG GGGA GG CCU.AUUC-GGGC CC GAAC CGUUC
Stl|contig09855/859-923
.....UCGAAGUGUUAAGCCAGUUUAACUGGUUGCGGGAAGAG CCU.AUUC-GGGA CUUGCCCCGUUC
Stl|contig37331/136-200
.....UAGCAGUUCUUAACCAGUUUAACUGGUUGCGG UGAGGG CCU.AUUC-GGGA CCUGAC CCGUUC
Stl|contig15263/138-192
.....UUCU-AAUUUCAGA-GGUCCGGCC-UCUGCGG G-UCC.-UAA-GG---U CCGUUC
UCC.-UAA-GG---U CCGUUC
Stl|contig38690/136-190
.....UUCU-AAUUUCAGA-GGUCCGGCC-UCUGCGG G-Stl|contig05146/1257-1203
.....UUCU-AUUUUCAGA-UGUUCAGCA-UCUGCGGG ..
- C.CUAA-G -.. UCCGUUC
Pat|scaffold_63/404588-404525.....UCCA-AGUUUAAACCAAUAUAAUUGGUUG GGGGGA G CCU.AUUCCGG-A C GAGCCC UUU
Pat|scaffold_149/135969-136032....UCCA-AGUUUAAACCUAUUUAAUAGGUUGCGGG GAGG CCU.AUUCCGG-A CUAA CUCGUUC
Pat|scaffold_58/125078-125141.....UCCA-AGUUUAAACCUAUUUAAUAGGUUGCGGG AAGG CCU.AUUCCGG-A CUGA CUCGUUC
Pat|scaffold_58/139292-139229.....UCCA-AGUUUAAACCUAUUUAAUAGGUUGCGGG AAGG CCU.AUUCCGG-A CUGA CUCGUUC
Pat|scaffold_127/137631-137568....UCCA-AGUUUAAACCUAUUUAAUAGGUUGCGGG AAGG CCU.AUUCCGG-A CUAA CUCGUUC
Pat|scaffold_149/137102-137165....UCCA-AGUUUAAACCUAUUUAAUAGGUUGCGGG AAGG CCU.AUUCCGG-A CUAA CUCGUUC
Pat|scaffold_63/404799-404862.....UCCA-AGUUUAAACCAAUAUAAUUGGCUG GGGAGA G CCU.AUUCCGG-A C GAACCC UUU
Pat|scaffold_56/155470-155407.....UCCA-AGUUUAAACCUAUUUAAUAGGUUGCGGG GAGG CCU.AUUCCGG-A CUGA CUCGUUU
Nyo|AM890213/167-230
.....UCCU-AGCAUCGGCUAGUAUAACUAGUCGCGGG GGAGG CCU.AUUCCGG-A CCAAA CCCGUUU
#=GC SS_cons
.....:::::::::::<<<<<<<___>>>>>>><<<<<<--<<<<<<<._____>>>->>>>-->>>>>>::
#=GC RF
.....UCCuaaUuUUcAGCCaGuuuGgCuGGCUGCGGgggAagggcCC.AUAauGGgAcccuGAccCCGUUC

Figure 6.1: Sequence alignment of the Arisong RNA genes
The sequence portions which correspond to the conserved secondary structure (two consecutive stems) of all
ciliate Arisong RNA genes were aligned in a Stockholm format. Compensatory changes supporting the secondary structure are indicated by color in pair, and inconsistent changes in the conserved common secondary
structure are indicated by red filled boxes.
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Figure 6.2: Consensus secondary structure of the Arisong RNAs and their flanking regulatory elements.
The structure shown is extrapolated from the individual structures of Arisong RNAs (examples are shown in
Figure 5.1). Each sequence is the majority-rule sequence consensus of a multiple alignment of 32 Arisong
RNAs. Highly conserved residues (identical in ≥ 80% of aligned sequences) are shown in black; variable
residues (identical in < 50%) are shown as “N”; weakly conserved residues are in grey. Dotted lines for base
pairs indicate that not all sequences conserve those base pairs at that position. Consensus motifs for the PSE
and 3′ box regulatory elements were generated from multiple alignments using the WebLogo program [218],
after removing columns containing > 50% gaps.

cium were flanked by typical transcription and processing signals of RNA polymerase IItranscribed small RNAs, a USE, TATA box and a downstream distal element (DE). The
Paramecium Arisong RNA predictions and snRNAs have identical USE sequences and
have a TATA box at around 18 nt downstream of a USE. However, the PSE of Oxytricha
Arisong RNA has sequence variability and does not include an obvious downstream TATA
box. A PSE sequence very similar to Oxytricha also can be detected at 60 nt upstream
of Arisong genes in Stylonychia and Nyctotherus for cases where sufficient upstream sequence is available. Paramecium Arisong RNAs also have an identical downstream DE at
4-5nt downstream from the conserved “GTTY” 3′ end, which partially overlaps with the
Oxytricha 3′ box element, thus suggesting a different DE consensus.
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6.3

Possible functions of Arisong RNA genes

The Arisong RNA has no detectable homology to any “known” ncRNA gene families (in
Rfam). We attempted to determine the functions of Arisong RNA genes experimentally
and conceptually.

6.3.1 Gene knock-down - RNAi
As we began to investigate the functionality of Arisong RNA, we attempted to knock down
Arisong RNA expression by RNAi. This approaches has been adapted first for Paramecium [223, 224] and Tetrahymena [225], and recently for several protein-coding genes in
spirotrichous ciliates [226, 227] as well as specific long RNA species transcribed from the
macronucleus during conjugation in Oxytricha trifallax[161], though not for small ncRNA
genes in vegetative growth condition (L. Landweber, personal communication).
Using five Arisong RNA genes in the stage 4 dataset (Onc91, Onc91.2, Onc94, Onc95,
Onc96), we designed seven knock-down experiments that include knocking down each
Arisong RNA genes individually, all five Arisong RNA genes in combination, and a negative control. We selected a 500 nt partial sequence of bacteriophage λ DNA that has no
significant similarity to Oxytricha genome as a negative control. PCR fragments of almost
full-length regions of individual Arisong RNA gene were inserted into L4440 plasmid to
transform HT115 E. coli, and constructs were confirmed by PCR (data not shown). After induction of RNA transcription in the transformed E.coli using IPTG, we fed these
bacteria to Oxytricha along with a small algal aliquot only for the first feeding 2 . Knock2
The reason to supply the algal culture in the starting day of feeding the bacteria with RNAi construct is
that Oxytricha does not grow up well without them. (This was learned from Landweber’s lab in Princeton
University.)
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ing down any individual Arisong RNA gene did not result in any detectable phenotypes.
However, knocking down all five Arisong RNA genes caused sudden death after two and
half days feeding. Due to the sudden death, we could not isolate RNA to confirm in vivo
RNA knock-down. So, we replicated our experiments several times with total RNA extractions from samples of Oxytricha culture in time series, but these experiments gave us
inconsistent results: partial death (reduced size of Oxytricha population) or no observable
phenotype. Northern blots with extracted RNAs failed to show any detectable knock down
of the targeted Arisong RNA species (data not shown).

6.3.2 Speculation on the functions of Arisong RNA genes
From the features of conserved secondary structure, transcript, and regulatory elements,
we can speculate about the function of Arisong RNA genes. Several lines of weak evidence suggest that Arisong RNAs may have a function related to spliceosomal RNAs. The
Arisong RNAs have the same conserved flanking PSE and 3′ box motifs as spliceosomal
snRNAs. We identified U4atac and U6atac snRNAs in Oxytricha, which demonstrates the
presence of a minor spliceosome, but the U11 and U12 homologs remain unidentified. The
consensus structure of the Arisong RNAs does not appear to resemble U11 or U12, and the
draft genome assembly is not complete, so it is possible not to sample the minor snRNA
gene containing nanochromosomes partially or entirely. Furthermore, both flanking elements are not unique to splicesomal RNAs; for example, the U3 snoRNA gene has nothing
to do with the spliceosome, yet is also flanked by these elements.
The 5′ sequence variability of Arisong loci, and the two different sizes of the Onc91
Arisong RNA are somewhat evocative of splice leaders (SLs), a special class of spliceoso-
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mal snRNAs found in organisms that perform trans-splicing. A SL provides a splice donor
site in trans; thus, the 5′ end of the SL is spliced to a mRNA. The 3′ region of an SL gene
has snRNA-like features, including an Sm-binding site [228–230]. However, the structure
of the Arisong RNAs does not resemble other known splice leader RNAs, nor do we see a
convincing conserved Sm binding site although we do identify conserved putative Sm binding sites in Oxytricha traditional snRNAs. We do not see the 5′ sequence of Arisong RNAs
on Oxytricha ESTs or cDNAs, suggesting that it is not an SL gene though trans-splicing is
found to be quite rare in some organisms, for instance, Schistosoma mansoni [231].
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Chapter 7
Other known ncRNA genes in O. trifallax
In the course of this screen, we identified a total of 150 known ncRNA genes: 106 tRNAs
(51 distinctive loci), 13 5S rRNAs (1 loci), a rRNA, 6 snRNAs (2 loci), a SRP RNA, a
RNase MRP and 12 snoRNAs (9 loci). Through homology-based search by Infernal/Rfam
on incomplete nanochromosomes, other essential ncRNA genes were also detected: 3
RNase P (1 loci) and a telomerase RNA. Considering the 40-65% genome completeness of
the stage 1 data set, it is possible to miss other ncRNA genes such as miRNA genes. However, spliceosomal snRNA and snoRNA genes that are among the largest known ncRNA
gene families appear to still be underrepresented. So, we sought to study in more detail
how the spliceosomal small nuclear RNA (snRNA) gene family and small nucleolar RNA
(snoRNA) gene family behaved in the screen, in order to confirm that we were sampling
them at the expected frequency, and to look for any unexpected reasons why we might miss
ncRNA genes.
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7.1

Spliceosomal small nuclear RNA (snRNA) genes

Only the U2 and U6atac snRNAs were identified in the stage 1 dataset. If Oxytricha has
U2, it should have all RNA components of the major U1/U2 spliceosome. If it has U6atac,
it should also have all RNA components of the minor U11/U12 spliceosome [232]. This
was a surprising shortfall of knwon ncRNAs, and wanted to see if they could be found in
the non-full length nanochromosome data. We analyzed the incomplete contigs of the total
dataset using Rfam/Infernal homology searches and identified two additional distinct U2
snRNAs and one distinct locus each for U1, U4, U5, U6, and U4atac snRNA genes, essentially as expected. Additional sequence analysis including Stylonychia conservation and/or
upstream PSE elments supported these loci. The presence of both U4atac and U6atac
strongly suggests that Oxytricha possesses a minor spliceosome, although we were unable
to identify homologs of U11 or U12 snRNAs.
Thus only two of nine different distinct snRNA loci are contained in the stage 1 dataset.
We expected about half of them, given our coverage estimate of 40-65%. This finding could
indicate that the stage 1 data may contain a smaller fraction of the Oxytricha gene set than
we estimated earlier, but these numbers are small. Note that these five additional snRNA
genes were not missed by our screen. They were never included in the stage 1 data set
because they were not on fully sequenced nanochromosomes, and incomplete nanochromosomes interfered on this screen as it relied on identifying protein coding genes.
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7.2

Small nucleolar RNA (snoRNA) genes

In Eukarya and Archaea, two large families of snoRNAs direct site-specific nucleotide
modifications of rRNA and other target RNAs: C/D snoRNAs directing 2’-O-methylations,
and H/ACA snoRNAs directing pseudouridylations. We expect that like other eukaryotes,
Oxytricha has tens to hundreds of snoRNAs [12]. Oxytricha clearly has both snoRNAdependent modification systems, because we detect homologs of the conserved catalytic
protein components of the yeast C/D and H/ACA snoRNPs (Nop1/fibrillarin and Cbf5/dyskerin)
and other C/D and H/ACA snoRNP core proteins [233] in Oxytricha by TBLASTN. However, the similarity search analysis in Table 3.1 only identified four distinctive C/D snoRNAs
and no H/ACA snoRNAs, which was also a concern.
However, in contrast to the highly conserved spliceosomal snRNAs, it is not surprising that we would have difficulty identifying snoRNAs by homology searches. snoRNAs
evolve rapidly and are difficult to detect reliably and systematically by computational analysis alone [234]. We put additional effort into identifying a set of probable Oxytricha
snoRNAs in the WGS+pilot dataset, to see how snoRNA loci behaved in our screen. We
used a pair of gene class-specific genefinding programs: snoscan and snoGPS [134, 209].
These programs suffer from a high false positive rate. To reduce this, we require Stylonychia sequence conservation. In addtion, we performed low-stringency Rfam/Infernal
homology searches and searches for conserved regions flanked by the PSE motif identified
above as well as manual sequence analysis.
To search for the PSE promoter motif, we built an HMM model from upstream 28
nt sequences of 12 Oxytricha and Stylonychia “known” ncRNAs such as snRNAs, SRP
RNA, RNase P, telomerase RNA by using hmmbuild and hmmcalibrate in HMMER2.3.2
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package (Figure G.A in Appendix G). By running hmmsearch on all sequences and their
reverse complementary sequences in the WGS+pilot (total) dataset, 476 sequences were
found to contain one or more PSEs. The PSE has insufficient information content on its
own for distinguishing false positives particularly in an AT-rich genome. Thus, we required downstream conservation between Oxytricha and Stylonychia. We used BLASTN
with the “wordmask=dust wordmask=seg extramask=16 M=4 N=-5 E=10−5 ” option. A
total of 56 sequences have putative PSEs located within the BLASTN alignment area with
additional 10nt flanking sequences at both ends and in non-protein region predicted by
nanogenefinder. Among them, 13 PSE predictions are “known sites” which are located at
upstream of “known” ncRNAs and arisong RNAs. All these PSE motif contain exact “ACCCAT” subsequence in their match, and an additional PSE prediction contains it. However,
this unknown PSE prediction is located at the intronic region by nanogenefinder but protein region by BLASTX match. So solely relying on the PSE motif screen we could not
discriminate the false positives to find other snoRNA genes.
For the 3’ box motif search, we built an HMM model from downstream 21 nt sequences
of Oxytricha arisong RNAs, H/ACA snoRNAs (Onc89 and Onc90), snRNAs and some Stylonychia snRNAs by using hmmbuild and hmmcalibrate in HMMER1.8.5 package (Figure G.C in Appendix G). After running hmmsearch on the total dataset, we manually
investigated top 80 hits of which the lowest bit score is 24.22, wheares the highest bit score
acquired from the shuffled sequences (negative control) is 24.96. Among the examined
top 80 hits, 31 predictions are “known sites” which are located at downstream of known
ncRNAs and alleles of known ncRNAs. In the remained hits, 26 redundant predictions were
not examined because they are located at downstream of alleles of other loci, and 11 predictions of which upstream regions are not conserved in Stylonychia seem to be false positives.
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Only 4 new snoRNAs (3 C/D box snoRNAs and 1 H/ACA box snoRNA) which have conserved snoRNA features and structures in Stylonychia could be detected confidently from
the 3’ box predictions; however, 3’ box motif is conserved only in one C/D snoRNA. Remained predictions are located at downstream of suspicious ncRNA candidates which are
not conserved in Stylonychia.
For computational detection of apparently missing C/D snoRNAs, snoscan0.9b [134]
was run on the stage 1 data set, using Oxytricha LSU, SSU, 5.8S and 5S rRNAs as target
sequences. To reduce false positives, BLASTN was used for conservation detection in Stylonychia with a 10−10 E-value cutoff. The snoRNA gene candidiate containing nanochromosomes were examined for the possible existence of protein-conding genes and their
structures using our nanogenefinder and QRNA.
For computational detection of H/ACA snoRNAs, we ran snoGPS0.2 [209] on the stage
1 dataset. This software requires candidate pseudouridylation target sites. We provided 31
target sites in LSU and SSU rRNA that are conserved pseudouridylation target sites and also
conserved in Oxytricha1 . For estimating the false positive rate, we ran the program on 1000
randomly generated sequences, the same dataset used for the performance test of nanoclassifier, using all uridine ribonucleotide sequences as target sites. The haca2stemv7.table and
haca2stemv4a.desc files in the package were used as the score table and descriptor. To select candidates for further analysis, we used 38.5 score cutoff of which the estimated false
positive rate from random sequences is 8.9% in sequence level. H/ACA snoRNA genes
also have weak signals in primary sequence features and this software has a high false positive rate as determined by random sequence controls. So we applied stringent conservation
1
The conserved target pseudouridylation sites are infered by snoRNAs correspondence between human
and yeast which are listed in snoRNABase database website http://www-snorna.biotoul.fr/
human_yeast/
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requirements to Stylonychia by using BLASTN with the “wordmask=dust wordmask=seg
extramask=16 M=4 N=-5 E=10−5 ” option.
All told, after analyzing the entire assembly (not only stage 1 data), we predicted 35
distinct snoRNA loci. This includes 29 distinct methylation guide C/D snoRNAs, five distinct H/ACA snoRNAs, and one distinct U3 snoRNA locus, on 20 different contigs. Only
four of the 20 contigs (20%) are incomplete and fail to reach the stage 1 dataset, somewhat
fewer than expected from 40-65% coverage. Nine of 16 (56%) nanochromosomes in the
stage 1 dataset are are classified as coding, about what is expected from our observation
that 50% ncRNAs occur on noncoding nanochromosomes. Of the 7 lacking a clear protein
gene, one carries a known snoRNA (U18), and another has no sequence coverage in Stylonychia. Five nanochromosomes, each apparently carrying a single snoRNA gene, pass
the entire screen and are included in our stage 5 final candidate pool.
The majority of the identified C/D snoRNAs are in two large arrays on incomplete contigs: a 3.5 kb contig that contains 12 C/D snoRNAs and a 1.5 kb contig that contains 4 C/D
snoRNAs. snoRNAs are known to occur in clusters in many other organisms [235, 236],
sometimes because an entire cluster is carried on one long precursor noncoding RNA that
is processed to release multiple snoRNAs [65, 237]. In both identified arrays, the C/D
snoRNAs appear to be intronic within a noncoding RNA carrier transcript, as indicated by
the presence of strongly conserved 5′ splice sites and lack of other conservation or significant protein coding potential in the contigs. 3′ splice sites are less conserved and more difficult to identify in AT-rich Oxytricha sequence. In addition to these snoRNAs in two arrays,
other four C/D snoRNAs were intronic in coding genes in the stage 1 nanochromosomes,
and one (a U18 homolog) was flanked by a strong conserved consensus 5′ splice site and is
probably intronic as well. It therefore appears likely that many, perhaps most snoRNAs in
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Oxytricha are intron-encoded in a combination of coding genes and noncoding transcripts.
Large arrays may be on large contigs that are less likely to be fully assembled in the current
dataset: it was only back luck in assembly that these arryas did not appear in our stage 1
dataset. Intron-encoded ncRNAs in coding genes will consistently be screened out by the
coding gene classifier step; however, it is a “feature” of our screen to find independentlytranscribed functional ncRNA genes, which misses ncRNA genes processed out of introns
from protein coding genes. Although the screen successfully detects both C/D and H/ACA
snoRNAs, they are likely underrepresented for these reasons.
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Chapter 8
Conclusions
Our screen identified a novel family of at least 32 small Arisong RNA genes that are flanked
by detectable upstream and downstream regulatory elements in four ciliate species, which
encompass a previous prediction of six small RNA loci in Paramecium tetraurelia called
PM01 1-6 [217]. We confirm not only Chen et al.’s computational prediction of six novel
small RNAs, but also extend it by: a) expanding the Arisong RNA family by including
other paralogs in Paramecium and homologs in other three ciliate species; b) confirming
the expression and defining 3′ boundaries of transcripts of some representatives of this
family in Oxytricha by Northern and RACE-PCR; and c) recognizing that all members of
the family share a distinctive consensus secondary structure.
If we assume that there is no systematic bias in independent functional ncRNA gene distribution across nanochromosomes, we can estimate that the probability of sampling any
given ncRNA gene in the complete screen is roughly 10%. This estimate is calculated by
multiplying ∼50% completeness of the genome, ∼50% of known ncRNA genes found on
noncoding nanochromosomes (per the 134 known ncRNAs in Table 3.1), ∼80% specificity
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of the computational nanoclassifier (derived from the observed 0.17 FP rates for coding
predictions), and ∼50% Stylonychia coverage for detecting conserved regions (0.5 * 0.5 *
0.8 * 0.5 = 10%). Our estimated 10% overall sampling rate is roughly consistent with the
rate at which the major and minor spliceosomal RNAs made it to stage 4 in our screen (2
of 9). Including all full-length nanochromosome candidates which are not obviously coding fragments, a total of 88 “quasialleles” of independent functional ncRNA genes passed
through to stage 4 in our screen. Our screen identified no long mRNA-like ncRNA genes,
other than probable noncoding host transcripts for arrays of intronic snoRNAs. This result
suggests that O. trifallax has roughly a thousand alleles of independent functional ncRNA
genes. Note that “88” is not the number of genes, but rather the number of alleles - these
may include paralogs or orthologs from the other strain 510. The estimated number should
be lowered by two- to four fold to obtain the number of genes. In terms of ncRNA gene
families, the number should be reduced further. Otherwise, the slight sampling bias in the
stage 1 dataset as discussed in Chapter 3 might not cause an order of magnitude difference
in total ncRNA gene numbers. Therefore, if Oxytricha has large numbers of undiscovered
ncRNAs in its macronuclear genome, they are unlikely to be from independently transcribed ncRNA genes. Clearly some ncRNA genes are located within introns of protein
genes, which are invisible to our screen. Additional ncRNAs may come from nongenic
transcription or from processes associated with transcription of coding mRNAs in cis, including cis-antisense RNA and other cis-transcribed ncRNAs (overlapping coding regions
or regulatory regions for coding genes) such as RNAs involved in chromatin modification
or transcriptional interference. Our conclusion is consistent with recent arguments that
most of the “ncRNA” that has been observed in mammalian systems is a mixture of technical artifact, introns, alternatively processed polyA sites/promoters/exons and RNAs arising
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from cis-acting processes associated with transcription of nearby coding genes [103].
If novel independently transcribed ncRNA genes were numerous in eukaryotes, we
would have expected to see many noncoding nanochromosomes carrying single ncRNA
genes. Instead, our coding nanoclassifier immediately classified 95% of nanochromosomes
as protein-coding – which is essentially all of them, because the nanoclassifier has an estimated 6% false negative rate of misclassifying coding nanochromosomes. This conclusion
in Oxytricha, the relative paucity of independent functional ncRNA genes, might be expanded into other eukaryotes although there are the following limitations. One limitation
is that our approach does not look for the possibility of ncRNA genes in the micronucleus. Although the micronucleus is generally transcriptionally silent and not considered
to harbor active genes, it becomes briefly transcriptionally active after conjugation, during
the process of forming a new macronucleus. Among the micronuclear RNAs expressed
at this time are transcripts of a major transposon family (TBE1) [161]. To propagate in a
normally silent germ line, micronuclear-limited transposon genes presumably need special
adaptations. Another limitation is that the unicellular ciliates are evolutionarily distant from
the most commonly studied lineages of plants and animals. Ciliates clearly utilize functional but nongenic ncRNA transcripts extensively in DNA elimination and rearrangements
[160, 162–166]. Nonetheless ciliates might systematically lack ncRNA-dependent regulatory systems that are important in other lineages. A screen in a unicellular ciliate therefore
does not bear directly on the question of whether there are large numbers of ncRNA genes
specific to “complex” multicellular organisms [30, 238]. It does, however, have a bearing on the question of whether there are large numbers of undiscovered ncRNA genes in
eukaryotes in general.
Our study also illustrates some of the difficulties in distinguishing noncoding RNA
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genes from other RNA products, such as mRNAs for small, unusual, or rapidly evolving
coding genes. At each step of our screen – probabilistic genefinding, similarity to known
proteins, and using the evolutionary pattern of coding gene evolution in Oxytricha/Stylonychia
sequence alignments – we detected and removed a large proportion of apparent coding
genes. Even so, after all these steps, in the final set of 17 apparently noncoding conserved nanochromosomes, 5/17 appear to us upon manual analysis to contain fragments
of conserved coding sequence. Although some features are Oxytricha-specific due to the
extraordinary genome processing, this multistep analysis may be contrasted to studies that
have identified large numbers of putative “noncoding” RNAs using overly simple definitions such as the lack of an ORF > 100 aa [29, 144], or finding cDNA transcripts that do
not overlap with Ensembl gene predictions [239]. We believe one reason that we find so
few ncRNA genes, whereas other studies find so many, results from different standards in
computational analysis of coding genes. In light of our results here, we believe that “noncoding” RNA loci in other organisms merit careful reexamination, as others have argued
[97, 99, 141].
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Appendix A
Appendix: tRNA gene analysis on the
total dataset
tRNAscan-SE program [131] found total 243 tRNA genes in the total dataset: 40 tRNA
genes in the pilot dataset and 203 tRNA genes in WSG dataset. By removing redundancy,
we found 143 unique loci for tRNA genes which encode 78 unique tRNA genes; that is,
some of tRNA genes in different loci encode identical tRNA gene sequences. They represent all 20 amino acid tRNA types which include 1 pseudo-gene and 4 undefined tRNA
types. They also represent 48 anticodons. When considering wobble rules in the third position in codon, they still miss 2 anticodon types, wheares 3 anticodon types which don’t
follow wobble rules are included.
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Figure A.1: Oxytricha genetic code and associated tRNA genes
For each of the 64 codons, this figure shows following things: the corresponding amino acid, the observed
frequency of Oxytricha codon from the Prescott paper [171], the observed frequency of O. trifallax codon
from publicly available 26 genes in NCBI, predicted wobble pairing to a tRNA anticodon, an unmodified
tRNA anticodon sequence, and the number of tRNA genes found with the corresponding anticodon. Red
numbers indicate missed tRNA genes which have the corresponding anticodons. Blue numbers indicate
tRNA genes having the corresponding anticodons which don’t follow wobble rules.
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Appendix B
Appendix: Telomere endpoints
coordinates of contigs in the stage 3
dataset
Coordinates of telomere endpoints of contigs in WGS2.1.1 dataset among stage 3 dataset
(full-length nanochromosomes) are listed because all full-length nanochromosomes are too
much to be listed. These telomeres are detected by Smith/Waterman alignment with minimal sequences of 5′ and 3′ telomeres, so their end points might not be the genuine end
points of telomeres. In the list, “start” means the starting position of minimal 5′ telomere
and “end” means the ending position of minimal 3′ telomere, i.e. starting and endind point
of nanochromosomes inclusive of those telomeres.
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Table B.1: Coordinates of telomere ends

Contig name

start

end

Contig name

start

end

Contig name

start

end

Contig72558.2

1

1665

Contig71216.1

17

814

Contig44272.1

16

913

Contig65279.1

98

738

Contig12754.1

19

1201

Contig64166.1

182

791

Contig41939.1

14

1611

Contig57493.1

12

993

Contig90597

1

2508

Contig58322.1

15

746

Contig75252.1

1

2510

Contig47631.1

3

1016

Contig63601.1

6

670

Contig36794.2

459

1065

Contig72592.3

160

1258

Contig81663.1

21

1748

Contig56717.1

17

515

Contig44542.1

63

711

Contig54011.1

9

802

Contig40627.1

13

1442

Contig56466.1

24

637

Contig32977.1

1

1274

Contig63692.1

5

1433

Contig56085.1

12

1868

Contig63165.1

23

2037

Contig201758

18

1062

Contig350.1

24

640

Contig69833.1

16

1792

Contig36467.1

1

2551

Contig62738.1

1

1440

Contig42360.1

6

1093

Contig65036.1

167

773

Contig52618.1

1

2081

Contig45979.1

2

1417

Contig70704.1

12

898

Contig36544.2

23

1605

Contig64625.1

58

2002

Contig53544.1

9

1768

Contig33474.1

135

874

Contig46462.1

59

1336

Contig40060.1

13

1855

Contig42218.1

89

1466

Contig64682.1

4

1639

Contig20293.1

57

1800

Contig71362.1

12

1314

Contig79287.2

367

836

Contig77349.1

201

1024

Contig60577.1

12

2134

Contig37941.1

65

3047

Contig68529.1

58

1950

Contig66981.1

12

1773

Contig80041.1

12

1182

Contig30968.1

1

1076

Contig38743.1

58

1481

Contig41267.1

57

1674

Contig54158.1

1

789

Contig20377.1

13

1181

Contig63886.1

1

1285

Contig65897.1

57

1486

Contig70376.1

21

1398

Contig73674.2

263

879

Contig46616.1

14

630

Contig63474.1

12

1522

Contig45079.1

57

1822

Contig70731.1

12

803

Contig71432.1

8

597

Contig80821.1

366

1286

Contig56341.1

59

1644

Contig54157.1

13

1118

Contig34132.1

1

1160

Contig19117.1

166

841

Contig37944.1

59

1655

Continued on next page
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Table B.1 – continued from previous page
Contig name

start

end

Contig name

start

end

Contig name

start

end

Contig56473.2

246

859

Contig67238.1

13

871

Contig50047.1

8

1307

Contig21168.1

2

773

Contig90796

58

1452

Contig57364.1

13

1819

Contig71359.1

24

845

Contig27888.1

424

1152

Contig62704.1

9

1384

Contig42299.1

15

916

Contig55772.1

56

1035

Contig61428.1

18

934

Contig79483.1

16

838

Contig71781.1

9

1150

Contig15953.1

57

1587

Contig28252.1

12

1023

Contig27958.1

20

1110

Contig50209.1

209

842

Contig57707.1

15

1150

Contig64767.1

9

963

Contig65115.1

1

1306

Contig77913.1

62

1892

Contig38310.2

58

2110

Contig42625.1

56

1465

Contig38449.1

428

1007

Contig47514.1

390

1106

Contig37041.1

57

1602

Contig82949.1

1

3491

Contig37987.1

56

1731

Contig7084.1

184

830

Contig47030.2

8

1174

Contig57787.1

5

1198

Contig73911.1

62

1530

Contig40198.1

128

732

Contig49984.1

17

1067

Contig47714.1

212

848

Contig44659.1

8

890

Contig64181.1

10

1057

Contig23611.1

15

936

Contig53962.1

229

790

Contig53992.1

178

820

Contig49976.1

6

455

Contig27153.1

20

1532

Contig63683.1

41

844

Contig52483.1

57

1635

Contig41931.1

182

1528

Contig44069.1

16

913

Contig62533.1

14

601

Contig64310.1

8

559

Contig36242.1

147

854

Contig63998.1

350

1224

Contig55752.1

57

1445

Contig57521.1

69

1929

Contig52959.1

1

1405

Contig76009.1

1

1553

Contig42303.1

8

1062

Contig69957.1

6

672

Contig41708.1

56

1464

Contig42246.1

60

933

Contig200270

20

914

Contig15155.2

449

1896

Contig71999.1

9

1502

Contig46853.1

4

1454

Contig47794.1

56

2351

Contig71398.1

530

999

Contig82141.1

5

746

Contig74167.1

15

1664

Contig50244.2

172

821

Contig63694.1

14

754

Contig46532.1

16

1050

Contig52250.1

52

2178

Contig11669.1

20

1182

Contig70680.1

3

1237

Contig50051.1

127

801

Contig22505.1

1

1609

Continued on next page
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Table B.1 – continued from previous page
Contig name

start

end

Contig name

start

end

Contig name

start

end

Contig71072.1

8

867

Contig83246.1

59

2391

Contig71315.1

2

904

Contig71215.1

233

720

Contig64079.1

13

1046

Contig62742.1

11

1346

Contig28854.1

224

761

Contig64780.1

281

1581

Contig38453.1

348

1057

Contig55875.1

11

1756

Contig63032.1

1

597

Contig51710.1

9

1535

Contig63348.1

14

614

Contig50237.1

13

662

Contig63260.1

5

1403

Contig85069.1

59

1452

Contig27013.1

9

737

Contig11508.1

3

1484

Contig53197.1

316

814

Contig8162.1

55

2725

Contig44402.1

250

863

Contig58094.1

1

1460

Contig20965.1

8

753

Contig13832.1

254

887

Contig56080.1

1

1130

Contig63545.1

13

797

Contig63671.1

14

1173

Contig84680.1

57

2366

Contig60049.1

252

1681

Contig39846.1

1

1335

Contig42494.1

1

1458

Contig57944.1

12

757

Contig53310.1

17

1096

Contig52417.1

58

1585

Contig37908.2

256

872

Contig64187.1

89

862

Contig45510.1

181

861

Contig49716.1

17

827

Contig62743.1

10

1130

Contig21532.1

170

805

Contig20923.1

16

909

Contig58516.1

65

782

Contig4340.2

58

1334

Contig72585.2

227

859

Contig54150.1

8

1436

Contig53762.1

9

1009

Contig71212.1

12

1325

Contig57129.1

26

1867

Contig72791.1

367

838

Contig49753.1

7

908

Contig44757.1

1

1019

Contig49185.1

8

741

Contig49074.1

1

1392

Contig79964.2

4

767

Contig40129.1

17

1110

Contig201267

322

881

Contig78823.1

3

1254

Contig70148.1

20

609

Contig57150.1

7

1227

Contig202913

9

1100

Contig42445.1

54

2400

Contig9982.1

270

1319

Contig200640

9

1125

Contig47479.1

15

934

Contig52992.1

502

832

Contig56296.1

58

2605

Contig46225.1

58

1633

Contig72727.1

376

1538

Contig63727.1

15

912

Contig47353.1

3

1630

Contig42454.1

17

918

Contig16863.1

10

1068

Contig34069.1

8

836

Contig57675.1

119

840

Contig24276.1

56

943

Continued on next page
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Table B.1 – continued from previous page
Contig name

start

end

Contig name

start

end

Contig name

start

end

Contig84022.1

486

2774

Contig76779.1

223

802

Contig20685.1

93

881

Contig45856.1

60

1013

Contig74674.2

113

788

Contig204907

282

788

Contig42078.1

552

1778

Contig63555.1

14

932

Contig71254.1

8

1154

Contig45583.1

15

628

Contig63306.1

3

1169

Contig53857.1

9

1042

Contig16891.1

19

1121

Contig25788.1

4

1091

Contig44349.1

11

952

Contig64742.1

16

1604

Contig79253.2

246

862

Contig93299

58

2197

Contig57619.1

312

783

Contig44235.1

10

812

Contig66475.1

9

842

Contig14700.1

11

2135

Contig42186.1

2

1500

Contig54139.1

9

637

Contig64473.1

54

1722

Contig52231.1

55

1897

Contig57109.2

461

2342

Contig27559.1

13

928

Contig72503.1

13

1170

Contig5306.1

70

1217

Contig202880

233

812

Contig204375

10

1509

Contig63304.1

14

1384

Contig80981.1

16

1494

Contig35667.1

204

834

Contig36615.1

7

2208

Contig44498.1

13

1345

Contig41841.1

55

1696

Contig50763.1

2

1960

Contig90468

13

1035

Contig47258.1

9

832

Contig47315.1

214

726

Contig45590.2

256

869

Contig54172.1

1

853

Contig53584.1

277

1277

Contig82969.1

292

875

Contig202273

22

1537

Contig72578.1

244

875

Contig58176.1

8

1414

Contig35598.1

12

2255

Contig60019.1

12

1144

Contig69506.1

29

1528

Contig91146

272

749

Contig54004.1

14

810

Contig24059.1

52

1336

Contig83373.1

295

921

Contig57769.1

21

868

Contig27097.1

14

836
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Appendix C
Appendix: Oxytricha gene list
101
Oxytricha trifallax gene list contains the following fields:
1. Locus name. ”Distinct” loci are called “OncXX”; other loci in the same “quasiallelic” group are called “OncXX.y”.
2. coordinates. start..end If start is greater than end, locus is on Crick strand.
3. Source contig. A sequence name in the WGS+pilot dataset.
4. Stage. Highest stage the contig reached in the screen: 0-5. 0=incomplete contigs in WGS+pilot; 1-5 = stage 1..stage 5 datasets.
5. Locus type. Semi-controlled classification vocabulary: U2 snRNA or C/D snoRNA, for example.
6. Length. Length of the locus in nt.

7. Experiments. N = size, expression confirmed on Northern; R = size, expression, ends confirmed by overlapping 5′ , 3′ RACEPCRs. N,R=both .=neither. (The lowercase letters indicate that the experiments were not done directly at these loci but results
were infered from a representative locus, because transcripts of them are same.)
8. Etc. Homologous Rfam family name detected by cmsearch and its evalue or other detection method

Although the OncXX numbering reaches Onc154, the numbers are not all used. For example,there are not 154 distinct loci in
this file. The assignment of “distinct loci” is subjective, and we rearranged it late in our analysis when we realized there’s a pretty
clear pattern of up to four ”alleles” per quasiallelic group - suggesting that the macronuclear genome is tetraploid. This converted
102

many loci from ”distinct” to ”quasialleles”. Also, the OncXX numbers are not consecutive in this file. OncXX numbers were
assigned as we discovered new loci, whereas the list is arranged into sensible sections: tRNAs, rRNAs, miscRNAs, snRNAs,
snoRNAs, and finally the “novel” candidates identified by the nanogenefinder screen.

Table C.1: Summary of all Oxytricha trifallax loci

Locus name

Coordinate

Contig name

Stage

Locus type

Length

Experiments

Etc

Onc1

377..449

Contig19117.1

4

tRNA(Asn,GTT)

73nt

.

Rfam:RF00005:1e-13

Onc1.2

324..396

Contig74674.2

4

tRNA(Asn,GTT)

73nt

.

Rfam:RF00005:1e-13

Onc2

701..629

Contig76935.2

1

tRNA(Asn,GTT)

73nt

.

Rfam:RF00005:1e-13
Continued on next page

Table C.1 – continued from previous page
Locus name

Coordinate

Contig name

Stage

Locus type

Length

Experiments

Etc

Onc3

259..188

Contig200270

4

tRNA(Lys,TTT)

72nt

N

Rfam:RF00005:4e-14

Onc3.2

265..194

Contig40129.1

4

tRNA(Lys,TTT)

72nt

n

Rfam:RF00005:4e-14

Onc3.3

257..186

Contig53310.1

4

tRNA(Lys,TTT)

72nt

n

Rfam:RF00005:4e-14

Onc53

176..248

OXAO-aab15f07

4

tRNA(Lys,CTT)

73nt

N

Rfam:RF00005:5e-13

Onc53.2

229..301

Contig35865.1

1

tRNA(Lys,CTT)

73nt

n

Rfam:RF00005:5e-13

Onc53.3

1184..1112

OXAO-aab17e12

1

tRNA(Lys,CTT)

73nt

n

Rfam:RF00005:5e-13
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Onc7

381..453

Contig38385.1

1

tRNA(Lys,CTT)

73nt

n

Rfam:RF00005:5e-13

Onc7.2

188..260

Contig91659

1

tRNA(Lys,CTT)

73nt

n

Rfam:RF00005:5e-13

Onc8

607..535

Contig42095.1

1

tRNA(Lys,CTT)

73nt

n

Rfam:RF00005:5e-13

Onc8.2

197..269

UGC1O0003 C05 F

1

tRNA(Lys,CTT)

73nt

n

Rfam:RF00005:5e-13

Onc9

451..524

Contig201758

4

tRNA(Val,AAC)

74nt

.

Rfam:RF00005:8e-12

Onc9.2

619..546

OXAC-aaa03e08

4

tRNA(Val,AAC)

74nt

.

Rfam:RF00005:8e-12

Onc11

266..194

Contig82806.1

1

tRNA(Val,TAC)

73nt

.

Rfam:RF00005:9e-14

Onc12

2257..2185

Contig75612.1

1

tRNA(Val,CAC)

73nt

.

Rfam:RF00005:7e-11

Onc12.2

2259..2187

Contig81063.2

1

tRNA(Val,CAC)

73nt

.

Rfam:RF00005:7e-11

Onc13

433..363

Contig202880

4

tRNA(Gln,CTG)

71nt

.

Rfam:RF00005:3e-13

Onc13.2

423..353

Contig76779.1

4

tRNA(Gln,CTG)

71nt

.

Rfam:RF00005:3e-13
Continued on next page

Table C.1 – continued from previous page
Locus name

Coordinate

Contig name

Stage

Locus type

Length

Experiments

Etc

Onc13.3

492..422

Contig82969.1

4

tRNA(Gln,CTG)

71nt

.

Rfam:RF00005:3e-13

Onc14

248..177

Contig78714.1

1

tRNA(Gln,TTG)

72nt

.

Rfam:RF00005:3e-14

Onc14.2

302..231

Contig79809.1

1

tRNA(Gln,TTG)

72nt

.

Rfam:RF00005:3e-14

Onc15

1064..1134

Contig42065.1

1

tRNA(Gln,CTA)

71nt

.

Rfam:RF00005:3e-12

Onc15.2

1064..1134

Contig50398.1

1

tRNA(Gln,CTA)

71nt

.

Rfam:RF00005:5e-12

104

Onc39

243..172

OXAD-aaa02e11

4

tRNA(Gln,TTA)

72nt

.

Rfam:RF00005:3e-14

Onc39.2

243..172

OXAD-aaa04h06

4

tRNA(Gln,TTA)

72nt

.

Rfam:RF00005:3e-14

Onc16

419..490

Contig35667.1

4

tRNA(Gly,TCC)

72nt

n

Rfam:RF00005:2e-13

Onc16.2

232..303

OXAE-aad39c12

4

tRNA(Gly,TCC)

72nt

n

Rfam:RF00005:2e-13

Onc16.3

224..295

UGC1O0005 L02 F

4

tRNA(Gly,TCC)

72nt

n

Rfam:RF00005:2e-13

Onc17

458..529

Contig72578.1

4

tRNA(Gly,TCC)

72nt

N

Rfam:RF00005:2e-13

Onc17.2

442..513

Contig72585.2

4

tRNA(Gly,TCC)

72nt

n

Rfam:RF00005:2e-13

Onc17.3

375..446

Contig72592.3

4

tRNA(Gly,TCC)

72nt

n

Rfam:RF00005:2e-13

Onc18

617..547

Contig38449.1

4

tRNA(Gly,GCC)

71nt

.

Rfam:RF00005:4e-12

Onc18.2

388..458

OXAO-aaa61c10

4

tRNA(Gly,GCC)

71nt

.

Rfam:RF00005:4e-12

Onc18.3

196..126

Contig93074

1

tRNA(Gly,GCC)

71nt

.

Rfam:RF00005:4e-12

Onc20

367..439

Contig41931.1

4

tRNA(Thr,AGT)

73nt

.

Rfam:RF00005:1e-11
Continued on next page
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Locus name

Coordinate

Contig name

Stage

Locus type

Length

Experiments

Etc
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Onc21

206..135

OXAB-aaa03d02

1

tRNA(Thr,TGT)

72nt

.

Rfam:RF00005:5e-14

Onc21.2

989..1060

Contig36821.1

1

tRNA(Thr,TGT)

72nt

.

Rfam:RF00005:5e-14

Onc23

230..159

Contig42299.1

4

tRNA(Met,CAT)

72nt

.

Rfam:RF00005:5e-10

Onc23.2

216..145

OXAO-aab16f12

4

tRNA(Met,CAT)

72nt

.

Rfam:RF00005:5e-10

Onc23.3

233..162

Contig42454.1

4

tRNA(Met,CAT)

72nt

.

Rfam:RF00005:5e-10

Onc24

221..293

Contig78307.1

1

tRNA(Met,CAT)

73nt

.

Rfam:RF00005:4e-12

Onc25

192..120

Contig44069.1

4

tRNA(Ala,AGC)

73nt

.

Rfam:RF00005:1e-09

Onc25.2

737..809

Contig44272.1

4

tRNA(Ala,AGC)

73nt

.

Rfam:RF00005:1e-09

Onc25.3

176..104

OXAE-aae01d07

4

tRNA(Ala,AGC)

73nt

.

Rfam:RF00005:1e-09

Onc25.4

724..796

OXAC-aaa08h01

4

tRNA(Ala,AGC)

73nt

.

Rfam:RF00005:1e-09

Onc26

185..113

Contig202071

1

tRNA(Ala,AGC)

73nt

.

Rfam:RF00005:1e-09

2253..2181

Contig7063.1

1

tRNA(Ala,AGC)

73nt

.

Rfam:RF00005:1e-09

Onc28

210..281

Contig83003.1

1

tRNA(Ala,TGC)

72nt

.

Rfam:RF00005:5e-13

Onc28.2

252..323

Contig83010.2

1

tRNA(Ala,TGC)

72nt

.

Rfam:RF00005:5e-13

Onc29

1032..961

Contig56335.1

1

tRNA(Ala,CGC)

72nt

.

Rfam:RF00005:8e-13

Onc29.2

193..264

Contig57947.1

1

tRNA(Ala,CGC)

72nt

.

Rfam:RF00005:8e-13

Onc31

655..727

Contig50209.1

4

tRNA(Pro,TGG)

73nt

.

Rfam:RF00005:2e-09

Onc26.2
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Onc31.2

183..111

OXAO-aab17f04

4

tRNA(Pro,TGG)

73nt

.

Rfam:RF00005:2e-09

Onc31.3

183..111

OXAD-aaa08e07

4

tRNA(Pro,TGG)

73nt

.

Rfam:RF00005:2e-09

106

Onc34

1363..1434

Contig63474.1

4

tRNA(Pro,AGG)

72nt

.

Rfam:RF00005:2e-09

Onc35

3309..3238

Contig53709.1

1

tRNA(Pro,CGG)

72nt

.

Rfam:RF00005:4e-11

Onc36

662..590

Contig67238.1

4

tRNA(Phe,GAA)

73nt

.

Rfam:RF00005:6e-12

Onc37

234..162

Contig71359.1

4

tRNA(Arg,TCT)

73nt

N

Rfam:RF00005:2e-12

Onc37.2

226..154

Contig79483.1

4

tRNA(Arg,TCT)

73nt

n

Rfam:RF00005:2e-12

Onc37.3

815..887

Contig77349.1

4

tRNA(Arg,TCT)

73nt

n

Rfam:RF00005:2e-12

Onc37.4

211..139

OXAD-aaa04e08

4

tRNA(Arg,TCT)

73nt

n

Rfam:RF00005:2e-12

Onc38

6108..6180

Contig45919.1

1

tRNA(Arg,CCT)

73nt

.

Rfam:RF00005:6e-13

Onc40

284..213

Contig50373.1

1

tRNA(Cys,GCA)

72nt

.

Rfam:RF00005:1e-13

Onc40.2

292..221

Contig79368.1

1

tRNA(Cys,GCA)

72nt

.

Rfam:RF00005:1e-13

Onc41

204..132

OXAE-aaa18e02

4

tRNA(Ile,AAT)

73nt

.

Rfam:RF00005:2e-13

Onc41.2

616..688

OXAD-aaa01f07

1

tRNA(Ile,AAT)

73nt

.

Rfam:RF00005:2e-13

Onc41.3

186..114

OXAD-aaa07f12

1

tRNA(Ile,AAT)

73nt

.

Rfam:RF00005:2e-13

Onc41.4

228..156

UGC1O0003 P04 R

4

tRNA(Ile,AAT)

73nt

.

Rfam:RF00005:2e-13

Contig2009.1

1

tRNA(Ile,TAT)

73nt

.

Rfam:RF00005:6e-14

Onc43

3333..3405
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Onc44

246..167

OXAE-aad49e12

4

tRNA(Leu,AAG)

80nt

.

Rfam:RF00005:4e-11

Onc44.2

255..176

UGC1O0002 B18 R

4

tRNA(Leu,AAG)

80nt

.

Rfam:RF00005:4e-11

Onc46

231..148

OXAE-aad58g07

1

tRNA(Leu,CAA)

84nt

.

Rfam:RF00005:5e-11

Onc46.2

921..1004

OXAD-aaa01e03

1

tRNA(Leu,CAA)

84nt

.

Rfam:RF00005:5e-11

Onc48

2804..2725

Contig81525.1

1

tRNA(Leu,CAG)

80nt

.

Rfam:RF00005:1e-11

Onc49

2298..2215

Contig41162.1

1

tRNA(Leu,TAA)

84nt

.

Rfam:RF00005:4e-10

Onc49.2

1911..1828

Contig60633.1

1

tRNA(Leu,TAA)

84nt

.

Rfam:RF00005:4e-10

107

Onc50

207..122

OXAO-aaa58g12

4

tRNA(Tyr,GTA)

86nt

.

Rfam:RF00005:1e-09

Onc50.2

201..116

UGC1O0001 O16 R

4

tRNA(Tyr,GTA)

86nt

.

Rfam:RF00005:1e-09

Onc50.3

246..161

Contig66860.1

1

tRNA(Tyr,GTA)

86nt

.

Rfam:RF00005:1e-09

Onc56

180..252

OXAO-aab16e01

4

tRNA(Glu,TTC)

73nt

.

Rfam:RF00005:3e-10

Onc56.2

806..733

OXAO-aab16g01

1

tRNA(Glu,TTC)

74nt

.

Rfam:RF00005:4e-10

Onc57

307..379

Contig42902.1

1

tRNA(Glu,TTC)

73nt

.

Rfam:RF00005:3e-10

Onc57.2

207..279

Contig47833.1

1

tRNA(Glu,TTC)

73nt

.

Rfam:RF00005:3e-10

Onc57.3

256..328

Contig61332.1

1

tRNA(Glu,TTC)

73nt

.

Rfam:RF00005:3e-10

Onc58

204..132

OXAE-aaa06f08

1

tRNA(Glu,CTC)

73nt

.

Rfam:RF00005:5e-12

Onc58.2

211..139

UGC1O0002 B22 R

1

tRNA(Glu,CTC)

73nt

.

Rfam:RF00005:5e-12
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Onc60

174..246

Contig44957.1

1

tRNA(Glu,CTC)

73nt

.

Rfam:RF00005:5e-12

Onc61

199..128

OXAE-aaf79d05

4

tRNA(Asp,GTC)

72nt

.

Rfam:RF00005:2e-12

Onc61.2

499..570

OXAO-aab15d01

4

tRNA(Asp,GTC)

72nt

.

Rfam:RF00005:2e-12

Onc63

276..205

Contig52579.1

1

tRNA(Asp,GTC)

72nt

.

Rfam:RF00005:2e-12

Onc63.2

220..149

Contig74115.1

1

tRNA(Asp,GTC)

72nt

.

Rfam:RF00005:2e-12

108

Onc65

1082..1011

OXAE-aaa29d04

1

tRNA(His,GTG)

72nt

.

Rfam:RF00005:3e-11

Onc65.2

2271..2200

Contig51714.1

1

tRNA(His,GTG)

72nt

.

Rfam:RF00005:3e-11

Onc65.3

2253..2182

Contig73221.2

1

tRNA(His,GTG)

72nt

.

Rfam:RF00005:3e-11

Onc67

1214..1143

Contig37344.1

1

tRNA(His,GTG)

72nt

.

Rfam:RF00005:3e-11

Onc68

2162..2082

Contig47137.1

1

tRNA(Ser,AGA)

81nt

.

Rfam:RF00005:5e-12

Onc68.2

2155..2075

Contig76987.1

1

tRNA(Ser,AGA)

81nt

.

Rfam:RF00005:5e-12

Onc69

2304..2386

Contig74257.1

1

tRNA(Ser,GCT)

83nt

.

Rfam:RF00005:3e-11

Onc69.2

2293..2375

Contig84423.1

1

tRNA(Ser,GCT)

83nt

.

Rfam:RF00005:3e-11

312..393

Contig35394.1

1

tRNA(Ser,TGA)

82nt

.

Rfam:RF00005:2e-10

1744..1663

Contig37182.1

1

tRNA(Ser,TGA)

82nt

.

Rfam:RF00005:2e-10

Onc72

244..316

Contig41301.1

1

tRNA(Trp,CCA)

73nt

.

Rfam:RF00005:8e-12

Onc72.2

240..312

Contig85126.1

1

tRNA(Trp,CCA)

73nt

.

Rfam:RF00005:8e-12

Onc70
Onc70.2
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Onc74

192..262

Contig72432.1

1

tRNA(Undet)

71nt

.

Rfam:RF00005:1e-06

Onc75

441..323

Contig350.1

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.2

462..580

Contig73674.2

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.3

427..309

UGC1O0003 F04 R

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.4

429..311

Contig45583.1

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.5

670..552

Contig45590.2

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.6

438..320

Contig56466.1

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.7

660..542

Contig56473.2

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.8

458..576

Contig37908.2

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.9

216..334

Contig46616.1

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.10

660..542

Contig79253.2

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.11

449..567

Contig44402.1

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.12

199..317

OXAO-aab14b11

4

5S rRNA

119nt

.

Rfam:RF00001:3e-23

Onc75.13

411..293

OXAO-aaa59b10

4

5S rRNA

119nt

.

Rfam:RF00001:1e-22

Onc113

3652..3804

rDNA

2

5.8S rRNA

153nt

.

Rfam:RF00002:6e-40

Onc152

1750..3521

rDNA

2

SSU rRNA

1772nt

.

gb:FJ545743.1
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Onc153

4008..7392

Onc81

Etc

rDNA

2

LSU rRNA

3385nt

.

gb:FJ545743.1

2567..2850

Contig82592.1

1

SRP euk arch

284nt

.

Rfam:RF00017:1e-36

Onc81.2

557..274

Contig56789.1

0

SRP euk arch

284nt

.

Rfam:RF00017:1e-36

Onc82

1118..790

OXAO-aaa59f01

1

RNase MRP

329nt

.

Rfam:RF00030:4e-32

Onc82.2

1141..812

Contig77949.2

0

RNase MRP

330nt

.

Rfam:RF00030:4e-32

Onc82.3

1181..853

Contig77942.1

0

RNase MRP

329nt

.

Rfam:RF00030:4e-32

Onc82.4

143..471

Contig84242.1

0

RNase MRP

329nt

.

Rfam:RF00030:4e-32

Onc149

573..246

Contig62031.2

0

RNaseP nuc

328nt

.

Rfam:RF00009:3e-27

Onc149.2

270..597

Contig39152.2

0

RNaseP nuc

328nt

.

Rfam:RF00009:2e-26

Onc149.3

582..255

Contig62024.1

0

RNaseP nuc

328nt

.

Rfam:RF00009:3e-19

Onc150

419..234

Contig41445.1

0

Telomerase cil

186nt

.

Rfam:RF00025:3e-14

Onc120

1860..1698

Contig51351.1

0

U1 snRNA

163nt

.

Rfam:RF00003:7e-24

Onc120.2

149..311

Contig75046.1

0

U1 snRNA

163nt

.

Rfam:RF00003:7e-24

Onc120.3

223..386

Contig206433

0

U1 snRNA

164nt

.

Rfam:RF00003:7e-24

Onc121

979..790

Contig36667.2

0

U2 snRNA

190nt

.

Rfam:RF00004:4e-42

Onc121.2

627..438

Contig58942.2

0

U2 snRNA

190nt

.

Rfam:RF00004:4e-42

Onc77

465..654

Contig57619.1

4

U2 snRNA

190nt

N

Rfam:RF00004:2e-37
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111

Onc77.2

558..369

Contig71215.1

4

U2 snRNA

190nt

n

Rfam:RF00004:2e-37

Onc77.3

675..486

Contig72791.1

4

U2 snRNA

190nt

n

Rfam:RF00004:2e-37

Onc77.4

163..352

OXAO-aab15a03

4

U2 snRNA

190nt

n

Rfam:RF00004:2e-37

Onc123

527..721

Contig201159

0

U2 snRNA

195nt

.

Rfam:RF00004:2e-34

Onc123.2

195..389

Contig201160

0

U2 snRNA

195nt

.

Rfam:RF00004:2e-34

Onc125

393..265

Contig51899.1

0

U4 snRNA

129nt

.

Rfam:RF00015:1e-20

Onc125.2

3763..3891

Contig71125.2

0

U4 snRNA

129nt

.

Rfam:RF00015:1e-20

Onc125.3

530..658

Contig54249.2

0

U4 snRNA

129nt

.

Rfam:RF00015:1e-20

Onc127

649..537

Contig44339.2

0

U5 snRNA

113nt

.

Rfam:RF00020:3e-12

Onc128

485..382

Contig70576.1

0

U6 snRNA

104nt

.

Rfam:RF00026:5e-29

Onc151

1312..1247

Contig200992

0

U4atac snRNA

66nt

.

Rfam:RF00618:3e-3

Onc151.2

764..829

Contig42569.2

0

U4atac snRNA

66nt

.

Rfam:RF00618:2e-3

Onc151.3

1676..1741

Contig76036.2

0

U4atac snRNA

66nt

.

Rfam:RF00618:3e-3

Onc151.4

630..565

Contig71676.2

0

U4atac snRNA

66nt

.

Rfam:RF00618:3e-3

Onc114

171..273

Contig73994.1

1

U6atac snRNA

103nt

.

Rfam:RF00619:8e-06

2568..2466

Contig74999.1

1

U6atac snRNA

103nt

.

Rfam:RF00619:8e-06

Onc114.2
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168..270

Contig60127.1

0

U6atac snRNA

103nt

.

Rfam:RF00619:8e-06

Onc124

2618..2387

Contig66111.1

0

U3 snoRNA

232nt

.

Rfam:RF00012:1e-18

Onc124.2

3175..2944

Contig68732.1

0

U3 snoRNA

232nt

.

Rfam:RF00012:1e-18

Onc78

1134..1206

Contig9982.1

4

C/D snoRNA: U18

73nt

N

Rfam:RF01159:2e-05

112

Onc78.2

144..216

OXAE-aae58h12

4

C/D snoRNA: U18

73nt

n

Rfam:RF01159:2e-05

Onc78.3

181..109

OXAO-aab15a01

1

C/D snoRNA: U18

73nt

n

Rfam:RF01159:2e-05

Onc78.4

209..137

Contig36677.1

0

C/D snoRNA: U18

73nt

n

Rfam:RF01159:2e-05

Onc78.5

242..170

Contig36684.2

0

C/D snoRNA: U18

73nt

n

Rfam:RF01159:2e-05

Onc78.6

197..125

UGC1O0005 I02 R

0

C/D snoRNA: U18

73nt

n

Rfam:RF01159:2e-05

Onc83

325..240

OXAO-aaa59f01

1

C/D snoRNA: snoZ196

86nt

N

Rfam:RF00134:3e-06

Onc83.2

381..296

Contig77942.1

0

C/D snoRNA: snoZ196

86nt

n

Rfam:RF00134:3e-06

Onc83.3

340..255

Contig77949.2

0

C/D snoRNA: snoZ196

86nt

n

Rfam:RF00134:3e-06

Onc83.4

943..1028

Contig84242.1

0

C/D snoRNA: snoZ196

86nt

n

Rfam:RF00134:3e-06

Onc84

1953..2040

Contig147.1

1

C/D snoRNA: snoR38

88nt

N

Rfam:RF00213:3e-05

Onc84.2

1948..2035

Contig90550

0

C/D snoRNA: snoR38

88nt

n

Rfam:RF00213:5e-05

Onc84.3

599..686

Contig90551

0

C/D snoRNA: snoR38

88nt

n

Rfam:RF00213:5e-05

Onc84.4

1915..2002

Contig81691.1

0

C/D snoRNA: snoR38

88nt

n

Rfam:RF00213:5e-05
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113

Onc84.5

523..610

Contig81698.2

0

C/D snoRNA: snoR38

88nt

n

Rfam:RF00213:5e-05

Onc116

665..587

Contig60671.1

1

C/D snoRNA: snoMe28S-Cm2645

79nt

.

Rfam:RF00530:2e-3

Onc116.2

1056..1134

Contig74810.1

1

C/D snoRNA: snoMe28S-Cm2645

79nt

.

Rfam:RF00530:2e-3

Onc116.3

698..620

Contig74184.1

0

C/D snoRNA: snoMe28S-Cm2645

79nt

.

Rfam:RF00530:2e-3

Onc108

688..609

Contig83501.3

0

C/D snoRNA: SNORD36

80nt

N

Rfam:RF00049:4e-3

Onc109

1777..1691

Contig201200

0

C/D snoRNA: SNORD24

87nt

N

Rfam:RF00069:2e-04

Onc110

1389..1318

Contig76679.1

1

C/D snoRNA

72nt

N

snoscan

Onc110.2

1054..1123

Contig46873.1

1

C/D snoRNA

70nt

n

snoscan

Onc110.3

1658..1589

Contig77473.1

0

C/D snoRNA

70nt

n

snoscan

Onc111

4173..4099

Contig70178.1

1

C/D snoRNA

75nt

N

snoscan

Contig546.2

0

C/D snoRNA

75nt

n

snoscan

Onc111.2

116..190

Onc112

1164..1066

Contig80897.1

1

C/D snoRNA

99nt

N

snoscan

Onc112.2

2005..2103

Contig51398.1

0

C/D snoRNA

99nt

n

snoscan

Onc112.3

2403..2501

Contig66429.1

0

C/D snoRNA

99nt

n

snoscan

Onc130

3208..3126

Contig201200

0

C/D snoRNA: snR77

83nt

.

array:Onc109

Onc131

2866..2794

Contig201200

0

C/D snoRNA

73nt

.

array:Onc109

Onc132

2494..2410

Contig201200

0

C/D snoRNA

85nt

.

array:Onc109
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Onc133

2249..2124

Contig201200

0

C/D snoRNA

126nt

.

array:Onc109

Onc134

1930..1871

Contig201200

0

C/D snoRNA

60nt

.

array:Onc109

Onc135

1541..1474

Contig201200

0

C/D snoRNA

68nt

.

array:Onc109

Onc136

1362..1301

Contig201200

0

C/D snoRNA

62nt

.

array:Onc109

Onc137

1225..1136

Contig201200

0

C/D snoRNA

90nt

.

array:Onc109

Onc138

962..878

Contig201200

0

C/D snoRNA

85nt

.

array:Onc109

Onc139

689..615

Contig201200

0

C/D snoRNA

75nt

.

array:Onc109

Onc140

416..332

Contig201200

0

C/D snoRNA

85nt

.

array:Onc109

Onc141

1263..1180

Contig83501.3

0

C/D snoRNA

84nt

.

array:Onc108

Onc142

923..830

Contig83501.3

0

C/D snoRNA

94nt

.

array:Onc108

Onc143

342..428

Contig83501.3

0

C/D snoRNA

87nt

.

array:Onc108

Onc144

754..836

Contig4340.2

5

H/ACA snoRNA

83nt

.

array:Onc86

Onc130.2

1885..1803

Contig1162.2

0

C/D snoRNA: snR77

83nt

.

array

Onc131.2

1547..1475

Contig1162.2

0

C/D snoRNA

73nt

.

array

Onc132.2

1176..1092

Contig1162.2

0

C/D snoRNA

85nt

.

array

Onc133.2

931..806

Contig1162.2

0

C/D snoRNA

126nt

.

array

Onc134.2

612..553

Contig1162.2

0

C/D snoRNA

60nt

.

array
Continued on next page
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Coordinate

Contig name

Stage

Locus type

Length

Experiments

Etc

Onc109.2

459..373

Contig1162.2

0

C/D snoRNA

87nt

.

array

Onc135.2

224..158

Contig1162.2

0

C/D snoRNA

67nt

.

array

Onc130.3

224..306

Contig19537.1

0

C/D snoRNA: snR77

83nt

.

array

Onc131.3

562..634

Contig19537.1

0

C/D snoRNA

73nt

.

array

Onc132.3

933..1017

Contig19537.1

0

C/D snoRNA

85nt

.

array

Onc133.3

1178..1303

Contig19537.1

0

C/D snoRNA

126nt

.

array

Onc130.4

442..360

Contig201201

0

C/D snoRNA: snR77

83nt

.

array

Onc131.4

103..31

Contig201201

0

C/D snoRNA

73nt

.

array

Onc137.2

1209..1129

Contig1162.1

0

C/D snoRNA

81nt

.

array

Onc138.2

954..871

Contig1162.1

0

C/D snoRNA

84nt

.

array

Onc139.2

682..608

Contig1162.1

0

C/D snoRNA

75nt

.

array

Onc140.2

409..325

Contig1162.1

0

C/D snoRNA

85nt

.

array

Onc137.3

1218..1130

Contig46059.1

0

C/D snoRNA

89nt

.

array

Onc138.3

954..871

Contig46059.1

0

C/D snoRNA

84nt

.

array

Onc139.3

682..608

Contig46059.1

0

C/D snoRNA

75nt

.

array

Onc140.3

409..325

Contig46059.1

0

C/D snoRNA

85nt

.

array

Onc145

492..562

Contig6909.1

1

C/D snoRNA

71nt

-

3box screen
Continued on next page

Table C.1 – continued from previous page
Locus name

Coordinate

Contig name

Stage

Locus type

Length

Experiments

Onc146

1972..1887

Onc146.2

Contig47518.1

1

C/D snoRNA

86nt

.

3box screen

1037..1122

Contig92891

0

C/D snoRNA

86nt

.

3box screen

Onc146.3

1965..1880

Contig42170.1

0

C/D snoRNA

86nt

.

3box screen

Onc146.4

167..252

Contig92893

0

C/D snoRNA

86nt

.

3box screen

3094..2955

Contig48640.1

0

H/ACA snoRNA

140nt

.

3box screen

Onc147.2

709..570

Contig61584.1

0

H/ACA snoRNA

140nt

.

3box screen

Onc147.3

999..1138

Contig8120.2

0

H/ACA snoRNA

140nt

.

3box screen

Onc147.4

1003..1142

Contig74386.1

0

H/ACA snoRNA

140nt

.

3box screen

Onc148

2280..2223

Contig79173.1

1

C/D snoRNA

58nt

.

3box screen

Onc148.2

163..220

Contig36772.1

0

C/D snoRNA

58nt

.

3box screen

Onc154

674..545

Contig50244.2

3

H/ACA snoRNA

130nt

.

3box screen

Onc154.2

706..577

Contig47714.1

3

H/ACA snoRNA

130nt

.

3box screen

Onc154.3

330..459

Contig7084.1

3

H/ACA snoRNA

130nt

.

3box screen

Onc154.4

515..386

Contig50237.1

3

H/ACA snoRNA

130nt

.

3box screen

Onc85

395..317

Contig93299

5

C/D snoRNA: SNORD96

79nt

N

nano screen

Onc85.2

393..315

Contig76610.1

0

C/D snoRNA: SNORD96

79nt

n

nano screen

Onc86

360..431

Contig4340.2

5

C/D snoRNA

72nt

N/R

nano screen

Onc147

Etc

116
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Locus name

Coordinate

Contig name

Stage

Locus type

Length

Experiments

Etc
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Onc87

418..496

Contig23611.1

5

C/D snoRNA

79nt

N/R

nano screen

Onc87.2

772..850

Contig80821.1

4

C/D snoRNA

79nt

n/r

nano screen

Onc87.3

407..485

OXAC-aaa05b11

4

C/D snoRNA

79nt

n/r

nano screen

Onc87.4

515..437

OXAE-aaa21b05

4

C/D snoRNA

79nt

n/r

nano screen

Onc87.5

419..497

Contig47479.1

4

C/D snoRNA

79nt

n/r

nano screen

Onc87.6

530..452

Contig63555.1

4

C/D snoRNA

79nt

n/r

nano screen

Onc89

550..418

Contig204907

5

H/ACA snoRNA

133nt

N/R

nano screen

Onc89.2

280..148

Contig63528.1

0

H/ACA snoRNA

133nt

n/r

nano screen

Onc89.3

301..169

Contig204908

0

H/ACA snoRNA

133nt

n/r

nano screen

Onc89.4

281..149

Contig60002.1

0

H/ACA snoRNA

133nt

n/r

nano screen

Onc89.5

550..682

Contig42459.2

0

H/ACA snoRNA

133nt

n/r

nano screen

Onc90

485..241

UGC1O0002 K14 R

5

H/ACA snoRNA: U17/snR30

245nt

N/R

nano screen

Onc90.2

527..283

Contig49311.1

0

H/ACA snoRNA

245nt

n/r

nano screen

Onc90.3

607..363

Contig68403.1

0

H/ACA snoRNA

245nt

n/r

nano screen

Onc90.4

3492..3736

Contig53912.1

0

H/ACA snoRNA

245nt

n/r

nano screen

Onc91

165..253

Contig63727.1

5

arisong

89nt

N/R

nano screen

Onc91.2

752..664

Contig71315.1

4

arisong

89nt

n/r

nano screen
Continued on next page
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Locus name

Coordinate

Contig name

Stage

Locus type

Length

Experiments

Etc
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Onc92

693..610

Contig36242.1

4

arisong

84nt

.

nano screen

Onc92.2

534..451

OXAO-aab16b04

4

arisong

84nt

.

nano screen

Onc92.3

543..460

Contig65300.1

0

arisong

84nt

.

nano screen

Onc94

761..670

Contig13832.1

5

arisong

92nt

N/R

nano screen

Onc95

580..496

Contig44542.1

4

arisong

85nt

R

nano screen

Onc95.2

132..216

OXAD-aaa04a12

4

arisong

85nt

r

nano screen

Onc95.3

531..447

Contig57964.1

0

arisong

85nt

r

nano screen

Onc96

285..146

OXAO-aab17f07

4

arisong

140nt

R

nano screen

Onc155

343..428

Contig48963.1

1

arisong

86nt

.

nano screen

Onc155.2

255..340

Contig65636.1

0

arisong

86nt

.

nano screen

Onc155.3

209..294

Contig38772.1

0

arisong

86nt

.

nano screen

1587..1719

Contig203665

1

arisong

133nt

.

nano screen

Onc156.2

628..760

Contig203666

0

arisong

133nt

.

nano screen

Onc97

371..499

Contig91146

5

?

129nt

-

nano screen

Onc98

444..554

Contig63260.1

5

?

111nt

-

nano screen

Onc99

18..123

OXAE-aae57g05

5

?

106nt

-

nano screen

Onc100

281..396

Contig40627.1

5

?

116nt

-

nano screen

Onc156

Continued on next page
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Locus name
Onc100.2

Coordinate
325..440

Contig name

Stage

Locus type

Length

Experiments

Etc

Contig65897.1

4

?

116nt

-

nano screen

OXAE-aae64g09

5

?

74nt

-

nano screen
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Onc102

21..94

Onc103

657..717

Contig47258.1

5

?

61nt

-

nano screen

Onc104

1447..1675

Contig64625.1

5

?

229nt

-

nano screen

Onc105

489..553

Contig63601.1

5

?

65nt

-

nano screen

Onc105.2

241..279

Contig69957.1

4

?

39nt

-

nano screen

Onc106

480..554

Contig54011.1

5

?

75nt

-

nano screen

Onc107

40..130

OXAE-aaa57c10

5

?

91nt

-

nano screen
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Appendix: Northern blot experiments

D.1 Northern blot results for the known genes
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73 nt
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Onc3
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80 nt
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87 nt
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Onc78
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Onc121
U2 snRNA

Onc53
tRNA Lys(CUU)

Onc37
tRNA Arg(UCU)

100

M 10 2

72 nt

50

Onc83
Onc84
Onc108
Onc109
Onc110
snoZ196 C/D snoRNA snoR38 C/D snoRNA SNORD36 C/D snoRNA SNORD24 C/D snoRNA C/D snoRNA

M 10 2
100

M 10 2
100
99 nt

75 nt

50

50
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C/D snoRNA

Onc112
C/D snoRNA

Figure D.1: Experimental confirmation of known RNA gene transcripts.
10/2 lanes indicate the amount of total RNA loaded in each lane (in µg). M indicates a radiolabeled 50bp
DNA ladder. The arrow indicates the transcript band in blot.
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D.2 List of probe sequences for Northern blots.
“AS” in the “direction” column in tables indicates that the probe sequence is reverse-complementary to the reference genome
sequence.

D.2.1 Northern blot probes for the final candidate genes

Table D.1: Northern blot probes for the final candidate genes
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Contig name

Gene name

Direction

Probe Size

Contig93299

Onc85(SNORD96)

Contig4340.2

Sequence

S

40 nt

CACATAGTTCAGCCCCGAAAGATGACAGTTTTATAGAATC

Onc86(C/D snoRNA)

AS

42 nt

AGACACGAGGAATTCAGTTGGTTGATCCGGTTTTTTCATCAT

Contig23611.1

Onc87(C/D snoRNA)

AS

44 nt

CAGTAGGAGTGGAGTTATATTTATCAACACGTTTGATTCTGTTG

Contig204907

Onc89(H/ACA snoRNA)

S

41 nt

CCACAGCCGAATCAATAGTCAACTGCGGTCCATTAAATTCC

UGC1O0002 K14 R

Onc90(snR30/U17)

S

41 nt

CACGGCAGGAGCGAGCGAATCAACTCAACCACCTCTCTCCT

Contig63727.1

Onc91(Arisong)

S

42 nt

GTCTTAAGCCAGTGTAACTGGTTGCGGGTGAGGGACCTATTC

Contig13832.1.1

Onc94(Arisong)

S

39 nt

CTCAGGAACTTTGTGTCCCCAAGCCGCAGAGGCCGGACC

D.2.2 Northern blot probes for known genes
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Table D.2: Northern blot probes for known genes

Class

Contig name

Gene name

Direction

Probe Size

Contig200270

Sequence

Onc3(tRNA/Lys)

S

39 nt

GATTAAAAGTCTGGCGCTCTACCACTGAGCTAGACGGGC

Contig72578.1

Onc17(tRNA/Gly)

AS

42 nt

CCGGGTCAAGTGCTTGGAAGGCACCTATCCTAACCACTAGAC

Contig71359.1

Onc37(tRNA/Arg)

S

40 nt

GATTAGAAGTCTGATGCGCTATCCATTGCGCCACGAAGAC

OXAO-aab15f07

Onc53(tRNA/Lys)

AS

40 nt

GGTTAAGAGCCAAGCGCTCTACCGACTGAGCTAGACGGGC

Contig9982.1

Onc78(U18)

AS

40 nt

TGAGTTAGAGTCAGACATTGGACAGGTTATCGTCAATCGA

OXAO-aaa59f01

Onc83(snoZ196)

S

41 nt

GGTGTGTATGAGTTGTATCATCAATGAATGACTCAGTGTGG

Contig147.1

Onc84(snoR38)

AS

38 nt

CTCATCAATGATCTTGTCTATGACAGGGATAACTGTTG

Contig83501.3

Onc108(SNORD36)

S

43 nt

GTTCATCAAGAAAATTATGTCGTAAAATAACAAGTGTATCATC

Contig201200

Onc109(SNORD24)

S

40 nt

GGCCCTTTCGAGTCATGATCAGAAGTAGCAATTATTTTTG

Contig76679.1

Onc110(C/D snoRNA)

S

40 nt

GTCAGAATTGCAGAACCATATATCGTCAAATTGATTTCAG

Contig70178.1

Onc111(C/D snoRNA)

S

38 nt

GTAAGAATCACAGGGATTGTCATAAAGAACGCAGCAAC

Contig80897.1

Onc112(C/D snoRNA)

S

40 nt

CGCCAATGGGTTCATGTATCAGCGACAATAGCCAACCTTC

Contig36667.2

Onc121(U2)

S

42 nt

AAAGTGTAGGTCCAAGGCGACTCTGTAAGAGTGATGCGCAAG

tRNA

123
C/D snoRNA

snRNA

D.2.3 Probes sequences for negative Northern blots
For snoRNA candidate, Northern blot was done on the predicted region. For the final candidates in stage 5 dataset, Northern blot
was done twice with sense and antisense probe sequence on the same candidate region of which G/C contents is relatively high.

Table D.3: Northern blot probes for the tested snoRNA candidates
Contig name
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Gene name

Direction

Probe Size

Sequence

OXAO-aaa59f01

.

S

39 nt

CTTGGTTTCAATTCAGAAGAACGAAAGTAAATTAGCATC

Contig76351.1

.

AS

41 nt

GAGTGAGCCTGACTATAATAATGATCTATAAAATGAGAGCC

Contig6909.1

Onc145

AS

40 nt

CAGAGTAACTATGACGGCATCCATCTCATTTAGAGTCATG

Table D.4: Northern blot probes for the tested final candidates
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Contig name

Gene name

Probe Size

Sequence

Contig91146

Onc97

42 nt

CTAATTAACACAGTCTTAATTAAAATATTAATATTCCCTCTC

Contig63260.1

Onc98

42 nt

CTCCAAAAACCTAGCCAACCTCACTTAAAATAAAGCAGATGG

OXAE-aae57g05

Onc99

46 nt

CCACATTTTTAGATTTAGTTTTTATATCTTTTTTATGGTTAATTTG

Contig40627.1

Onc100

39 nt

CTTGAGTGGCCCCCTGAAATGTGAAAGAGTCACAAAGCC

39 nt

CCTCGAAGACGAAGACAGCAGACAGAGAACTTTGAAGAC

OXAE-aae64g09

Onc102
43 nt

GAACGGAAAGTACGAAGTTCCCTTAGGACTCAACCTCGAAGAC

Contig47258.1

Onc103

40 nt

GAAGCACAATGGATCTTATTTAGAGTAGAGAATGAAAATG

Contig64625.1

Onc104

41 nt

CCAGTACCGTGGAGTCTCAAAGAACGGGATTTAATGGCAGG

Contig63601.1

Onc105

40 nt

CAACTCATTACATGGACGAAGCTGATATTCTTGTTGAGAG

Contig54011.1

Onc106

38 nt

GTTGGAGTTTAAATGTTTGATTAAAGAAAATTTAGTAG

OXAE-aaa57c10

Onc107

39 nt

CATTAATAATTTGAAAATATAAAGTTCTTAATAACATCC

Appendix E
Appendix: RACE probes
List of gene specific probe (GSP) sequences of RACE experiments.
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Table E.1: RACE-PCR GSPs for the final candidate genes
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Contig name

Gene name

Probe

Probe Size

Sequence

Contig4340.2

Onc86 (C/D snoRNA)

5GSP

35

GTCAGGTTATAGATCTGTCTACATGAAGACACGAG

Contig4340.2

Onc86 (C/D snoRNA)

3GSP

30

CCGGATCAACCAACTGAATTCCTCGTGTCT

Contig23611.1

Onc87 (C/D snoRNA)

5GSP

35

CAGTAGGAGTGGAGTTATATTTATCAACACGTTTG

Contig23611.1

Onc87 (C/D snoRNA)

3GSP

33

ACGATGAAGTAGTTTATAATCCGTGTTTCAACA

Contig204907

Onc89 (H/ACA snoRNA)

5GSP

33

CCACAGCCGAATCAATAGTCAACTGCGGTCCAT

Contig204907

Onc89 (H/ACA snoRNA)

3GSP

29

GTTGACTATTGATTCGGCTGTGGTTAAGT

UGC1O0002K 14 R

Onc90 (H/ACA snoRNA)

5GSP

29

GAGGACCCGTAAGTCACGGCAGGAGCGAG

UGC1O0002K 14 R

Onc90 (H/ACA snoRNA)

3GSP

32

GGAGAGAGGTGGTTGAGTTGATTCGCTCGCTC

UGC1O0002K 14 R

Onc90 (H/ACA snoRNA)

3GSP2

25

GCCTTGGACTGATTAGGACTCCGTC

Contig63727.1

Onc91 (classII)

5GSP

31

CGGGTTCAGGATCCCGAATAGGTCCCTCACC

Contig63727.1

Onc91 (classII)

3GSP

31

GGTCTTAAGCCAGTGTAACTGGTTGCGGGTG

Contig63727.1

Onc91 (classII)

3GSP2

24

CAACAGTAACCAATACTTTCGAGG

Contig13832.1

Onc94 (classII)

5GSP

29

CAGGAACTTTGTGTCCCCAAGCCGCAGAG

Contig13832.1

Onc94 (classII)

3GSP

31

GGTCCGGCCTCTGCGGCTTGGGGACACAAAG

Contig44542.1

Onc95 (classII)

5GSP

31

CCTTTGTGGAAACACCCCGCAGAGGCCATAC

Contig44542.1

Onc95 (classII)

3GSP

31

GGTATGGCCTCTGCGGGGTGTTTCCACAAAG

OXAO aab17f07

Onc96 (classII)

5SGP

29

ATATGGCCCATCCCCGCAGCAGCCGGACT

OXAO aab17f07

Onc96 (classII)

3GSP

30

GTCCGGCTGCTGCGGGGATGGGCCATATTG

Appendix F
Appendix: Comparative analysis on the
stage 5 dataset
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Candidate sets (stage5)

RFC QRNA tblastx

RFC QRNA tblastx
Onc94 (Contig13832.1)

Onc85 (Contig93299)
0.532 COD 10-13
8.585
Sbs %: 0.333 0.333 0.333

Sbs %: 0.379 0.293 0.328

Onc97 (Contig91146)

Sbs %: 0.457 0.261 0.283
Sbs %: 0.302 0.419 0.279

Onc86 (Contig4340.2)
Sbs %: 0.382 0.324 0.294

0.648 RNA 10-4
3.975

0.573 OTH 10-16
2.93

0.654 OTH
0.052

10-4

0.907 OTH
3.13

10-32

Onc98 (Contig63260.1)
Sbs %: 0.292 0.375 0.333

Onc99 (OXAE-aae57g05)

Sbs %: 0.356 0.278 0.367

0.523 OTH 0.12

Onc100 (Contig40627.1)

Sbs %: 0.323 0.317 0.359
Sbs %: 0.321 0.315 0.363

Sbs %: 0.325 0.325 0.350

Onc87 (Contig23611.1)
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4.033

Sbs %: 0.353 0.235 0.412

0.907 OTH 0.0055
6.021

Onc103 (Contig47258.1)

Onc89 (Contig204907)
Sbs %: 0.286 0.333 0.381

0.604 OTH 0.0064
3.067

Onc102 (OXAE-aae64g09)
0.472 OTH 0.01

Sbs %: 0.309 0.338 0.353

5.092

Sbs %: 0.383 0.213 0.404

Sbs %: 0.340 0.320 0.340

0.603 RNA 0.092
16.079

Sbs %: 0.500 0.200 0.300

0.589 OTH 10-5
2.119

Onc104 (Contig64625.1)
Onc90 (UGC1O0002_K14_R)

Sbs %: 0.309 0.368 0.324

0.789 OTH 10-13
3.659

Sbs %: 0.292 0.208 0.500

0.905 OTH 10-25
3.428

Sbs %: 0.160 0.320 0.520

Onc105 (Contig63601.1)
Sbs %: 0.295 0.337 0.368

Onc91 (Contig63727.1)

Sbs %: 0.349 0.317 0.333

1

OTH 0.0008
4.174

1

OTH 0.024
4.565

0.8

OTH 0.13
0.101

Sbs %: 1.000 0.000 0.000

0.675 OTH
3.15

10-4

Onc106 (Contig54011.1)
Sbs %: 0.421 0.368 0.211

Onc107 (OXAE-aaa57c10)
Sbs %: 0.359 0.293 0.348
Sbs %: 0.381 0.381 0.238

Figure F.1: Stylonychia conservation patterns of the final candidate nanochromosomes
The left column on the alignment shows the RFC score, QRNA’s class and score and the best evalue of tblastx to the NR database

Appendix G
Appendix: Sequences of regulatory
motifs
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A. Sequences for PSE motif search
U1
U2
U3
U4
U5
U6
SRP
RNaseP
Telomerase
styU6
StyRNaseP
StySRP

TATTTATGACCCATAAATATTTAGGCCA
AAAATATGACCCATTAATATTTAACGGA
AATAGTTAACCCATTAATAATTTGGTAG
TAAAATTAACCCATAAATATTTAAGTGG
TAAATATGACCCATTAATATTTAAATCA
ATAATTTAACCCATTAATATTTAAGGTG
TATAACTAACCCATAAACTTTTAATTAA
AATAAATGACCCATTAACTATTAATCTG
AAATATTGACCCATAAATATTTAAGCGG
TAATTCTGACCCATTAACAAATAGCGAG
AATAAGCAACCCATTAACTTTTAATTCT
AAAATATGACCCATAAACTATTAGAATT

C. Sequences for 3’ box motif search
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Onc120.1/U1
Onc121/U2
Onc123.1/U2
Onc77.1/U2
Onc125.1/U4
Onc127/U5
StyOnc120/U1
StyOnc127/U5
Onc124.1/U3
Onc91.1/ClassII
Onc92/ClassII
Onc94/ClassII
Onc95/ClassII
Onc96/ClassII
Onc95.3/ClassII
Onc89/HACA
Onc90/HACA

AAATGAAaa.GTTTGA.TTAG
AAAGGAtaatGTTTGA.TTAT
AAATGATaatGTTTGA.TTAG
AAAGGAtaatGTTTGA.TTAG
AAATGAAat.GTTTGA.TTAG
AAATGAAattGTTTGA.TTAG
AAATGAAtt.GTTTGAaTTAG
AAATGAAtt.GTTTGAaTTAA
AAAGGAAttaGTTTGA.TTAG
AAATGAACTTGTTTGA.TTAG
AAATGAACTCGTTTGA.TTAT
AAATGAAAT.GTTTGA.ATAA
AAATGAAATAGTTTGA.GTAG
AAATGAAAA.GTTTGATTTAG
AAATGAAAA.GTTTGA.TTAG
AAGGGAAATTGTTTGA.TTAG
AAATGAAAACGTGTGA.TTAG

B. Sequences of Oxytricha PSE
Onc120/U1
Onc121/U2
Onc123/U2
Onc77/U2
Onc124.1/U3
Onc125/U4
Onc127/U5
Onc128/U6
Onc151/U4atac
Onc114/U6atac
Onc81/SRP
Onc149/RNaseP
Onc150/Telomerase
Onc91/classII
Onc92/classII
Onc94/classII
Onc95/classII
Onc96/classII
Onc155/classII
Onc156/classII

TGACCCATAAATATTTA
TGACCCATTAATATTTA
TGACCCATTAGTATTTA
TGACCCATTAGTATTTA
TAACCCATTAATAATTT
TGACCCATTAATATTTA
TGACCCATTAATATTTA
TAACCCATTAATATTTA
TAACCCATAGAAACTTA
TGACCCATAGAAAATTA
TAACCCATAAACTTTTA
TGACCCATTAACTATTA
TGACCCATAAATATTTA
TGACCCATGAATTATTA
TAACCCATAAATAATTA
TTACCCATAAACAATTA
TGACCCATTAATATTTA
TGACCCATTAAAAGTTA
GATCCCATCAATTTTAT
TAACCCATTAATAATTA

D. Sequences of Oxytricha 3’ box
Onc120/U1
Onc121/U2
Onc123.1/U2
Onc77.1/U2
Onc124/U3
Onc125/U4
Onc127/U5
Onc151/U4atac
Onc91/ClassII
Onc92/ClassII
Onc94/ClassII
Onc95/ClassII
Onc96/ClassII
Onc155/ClassII
Onc156/classII
Onc89/HACA
Onc90/HACA
Onc145/CD
Onc146/CD
Onc147/HACA
Onc148/CD
Onc154/HACA

AAATGAAAA.GTTTGA..TTAG
AAAGGATAAtGTTTGA..TTAT
AAATGATAAtGTTTGA..TTAG
AAAGGATAAtGTTTGA..TTAG
AAAGGAATTaGTTTGA..TTAG
AAATGAAAT.GTTTGA..TTAG
AAATGAAATtGTTTGA..TTAG
AAATGAAAAtGTTTGTttTTAT
AAATGAACTaGTTTGA..TTAG
AAATGAACTcGTTTGA..TTAT
AAATGAAAT.GTTTGA..ATAA
AAATGAAATaGTTTGA..GTAG
AAATGAAAA.GTTTGAt.TTAG
AAATGAAAA.GTTTGA..TTAG
AAATGAAAT.GTATGA..GTAA
AAGGGAAATtGTTTGA..TTAG
AAATGAAAAcGTGTGA..TTAG
AAAGGAAATaGTTTGA..TTAG
AAATGAAATgGTTTGA..TTAG
AAATGAAATgGTTTGA..GTAG
AAATGAAAAaATTTGA..TTAG
AAAGGAATAtGTTTGA..TTAT

Figure G.1: Instances of PSE and 3’ box motif sequences
A and C are sequence alignments used to build HMM models for PSE and 3’ box screening, respectively. (”Sty” in front of gene name indicates the
Stylonychia sequences.) B and D are sequence alignments of O. trifallax PSE and 3’ box motifs, respectively.

Appendix H
Appendix: Information for programs,
databases and datasets

H.1

Programs and databases

Infernal 1.0.2 was used for RNA similarity searches [129]. Infernal models of known
ncRNA families were from the Rfam 9.1 database [178]. For routine sequence manipulations we used a variety of miniapps provided by the Easel library package included
in Infernal 1.0.2. All BLAST comparisons used Washington University BLAST (WUBLAST) version 2.0MP-WashU [04-May-2006]. All comparisons to the NCBI NR protein
database used a version of NR downloaded on 13 April 2009. In the screen, to remove
nanochromosomes containing a detectable homolog of known protein, UniProt/Swissprot
database version 50.8 downloaded on October 2006 was used. To evaluate the performance
for nanochromosome classification, Genezilla [194], Unveil v1.0 [195], GeneID v1.2 [196]
and Augustus 2.0 [197] were examined. To evaluate the performance for nanogenefinder,
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the same programs and additionally Genscan [200] were used. PSE and 3′ box consensus
motif searches were done with HMMER 2.3.2. Multiple alignments were produced using
MUSCLE [240] or CLUSTALW [214] and manually edited in Emacs using the RALEE
alignment editing mode [241]. For a computational prediction of additional snoRNAs,
snoGPS 0.2 [209] and snoscan 0.9b [134] were used. List of conserved pseudouridylation target sites in human and yeast is extracted from the SnoRNABase database version3
website http://www-snorna.biotoul.fr. Analysis of cDNA/genome alignments
used Exonerate 1.0.2 [192], and unpublished cDNA/EST data. For comparative analysis of
coding gene sequence conservation patterns, we used QRNA 2.0.3c [126]. Sequence logos
were generated with WebLogo 2.8.2 [218].

H.2

Dataset availability.

A compressed tar archive containing the Oxytricha and Stylonychia sequence data, the nanoclassifier source code, training and test data, parsable tables of results, and other datasets
described in the paper are available for download at http://selab.janelia.org/
publications.html/#JungEddy11.

H.3

Accession number

A modified version of the Stylonychia data was deposited to DDBJ/EMBL/GenBank (accession ADNZ01000000) after trimming terminal Ns and removing 951 contigs deemed to
be low-quality or foreign contamination.
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Drosophila melanogaster: Identification of 66 candidates for novel non-messenger
RNAs. Nucl. Acids Res., 31:2495–2507, 2003.
[75] J. Vogel, V. Bartels, T. H. Tang, G. Churakov, J. G. Slagter-Jager, A. Hüttenhofer,
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K. Bouhouche, F. Câmara, S. Duharcourt, R. Guigo, D. Gogendeau, M. Katinka,
A. M.Keller, R. Kissmehl, C. Klotz, F. Koll, A. Le Mouël, G. Lepère, S. Malinsky,
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[201] M. Burset and R. Guigò. Evaluation of gene structure prediction programs. Genomics, 34:353–367, 1996.
164

[202] S. R. Eddy. A model of the statistical power of comparative genome sequence analysis. PLoS Biol., 3:e10, 2005.
[203] C. Maercker and H. J. Lipps. Analysis of the subtelomeric regions of macronuclear
gene-sized DNA molecules of the hypotrichous ciliate Stylonychia lemnae: Implications for the DNA fragmentation process during macronuclear development? Dev.
Genet., 14:378–384, 1993.
[204] C. Eder, C. Maercker, J. Meyer, and H. J. Lipps. The processing of macronuclear
DNA sequences during macronuclear development of the hypotrichous ciliate Stylonychia lemnae. Int. J. Dev. Biol., 37:473–477, 1993.
[205] J. Wen, C. Maercker, and H. J. Lipps. Sequential excision of internal eliminated
DNA sequences inthe differentiating macronucleus of the hypotrichous ciliate Stylonychia lemnae. Nucl. Acids Res., 24:4415–4419, 1996.
[206] M. Kellis, N. Patterson, M. Endrizzi, B. Birren, and E. S. Lander. Sequencing and
comparison of yeast species to identify genes and regulatory elements. Nature, 423:
241–254, 2003.
[207] K. Williams, T. G. Doak, and G. Herrick.

Developmental precise excision of

Oxytricha trifallax telomere-bearing elements and formation of circles closed by
a copy of the flanking target duplication. EMBO J., 12:4593–4601, 1993.
[208] S. H. Bernhart, I. L. Hofacker, S. Will, A. R. Gruber, and P. F. Stadler. RNAalifold:
improved consensus structure prediction for RNA alignments. BMC Bioinformatics,
9:474, 2008.

165

[209] P. Schattner, W. A. Decatur, C. A. Davis, M. Ares, M. J. Fournier, and T. M. Lowe.
Genome-wide searching for pseudouridylation guide snoRNAs: analysis of the Saccharomyces cerevisiae genome. Nucl. Acids Res., 32:4281–4296, 2004.
[210] P. Ganot, M. Caizergues-Ferrer, and T. Kiss. The family of box ACA small nucleolar
RNAs is defined by an evolutionarily conserved secondary structure and ubiquitous
sequence elements essential for RNA accumulation. Genes Dev., 11:941–956, 1997.
[211] V. Atzorn, P. Fragapane, and T. Kiss. U17/snR30 is a ubiquitous snoRNA with two
conserved sequence motifs essential for 18S rRNA production. Mol. Cell. Biol., 24:
1769–1778, 2004.
[212] G. L. Eliceiri. The vertebrate E1/U17 small nucleolar ribonucleoprotein particle. J.
Cell. Biochem., 98:486–495, 2006.
[213] E. Fayet-Lebaron, V. Atzorn, Y. Henry, and T. Kiss. 18S rRNA processing requires base pairings of snR30 H/ACA snoRNA to eukaryote-specific 18S sequences.
EMBO J., 28:1260–1270, 2009.
[214] M. A. Larkin, G. Blackshields, N. P. Brown, R. Chenna, P. A. McGettigan,
H. McWilliam, F. Valentin, I. M. Wallace, A.Wilm, R. Lopez, J. D. Thompson, T. J.
Gibson, and D. G. Higgins. Clustal W and Clustal X version 2.0. Bioinformatics,
23:2947–2948, 2007.
[215] O. Arnaiz, S. Cain, J. Cohen, and L. Sperling. ParameciumDB: a community resource that integrates the Paramecium tetraurelia genome sequence with genetic
data. Nucl. Acids Res., 35:D439–D444, 2007.

166

[216] G. Ricard, R. M. de Graaf, B. E. Dutilh, I. Duarte, T. A. van Alen, A. H. van Hoek,
B. Boxma, G. W. van der Staay, S. Y. Moon van der Staay, W. J. Chang, L. F.
Landweber, J. H. Hackstein, and M. A. Huynen. Macronuclear genome structure
of the ciliate Nyctotherus ovalis: Single-gene chromosomes and tiny introns. BMC
Genomics, 9:587, 2008.
[217] C. L. Chen, H. Zhou, J. Y. Liao, L. H. Qu, and L. Amar. Genome-wide evolutionary
analysis of the noncoding RNA genes and noncoding DNA of Paramecium tetraurelia. RNA, 15:503–514, 2009.
[218] G. E. Crooks, G. Hon, J. M. Chandonia, and S. E. Brenner. WebLogo: a sequence
logo generator. Genome Res., 14:1188–1190, 2004.
[219] J. Thomas, K. Lea, E. Zucker-Aprison, and T. Blumenthal. The spliceosomal snRNAs of Caenorhabditis elegans. Nucl. Acids Res., 18:2633–2642, 1990.
[220] S. L. Stricklin, S. Griffiths-Jones, and S. R. Eddy.
RNA genes.

C. elegans noncoding

In The C. elegans Research Community, editor, WormBook.

doi/10.1895/wormbook.1.7.1, http://www.wormbook.org, 2005.
[221] B. W. Hargrove, A. Bhattacharyya, A. M. Domitrovich, G. M. Kapler, K. Kirk,
D. E. Shippen, and G. R. Kunkel. Identification of an essential proximal sequence
element in the promoter of the telomerase RNA gene of Tetrahymena thermophila.
Nucl. Acids Res., 27:4269–4275, 1999.
[222] S. Egloff, D. O’Reilly, and S. Murphy. Expression of human snRNA genes from
beginning to end. Biochem. Soc. Trans., 36:590–594, 2008.

167

[223] R. D. Hinrichsen, D. Fraga, and M. W. Reed. 3’-modified antisense oligodeoxyribonucleotides complementary to calmodulin mRNA alter behavioral responses in
Paramecium. Proc. Natl. Acad. Sci. USA, 89:8601–8605, 1992.
[224] A. Galvani and L. Sperling. RNA interference by feeding in Paramecium. Trends
Genet., 18:11–12, 2002.
[225] R. Sweeney, Q. Fan, and M. C. Yao. Antisense in abundance: the ribosome as a
vehicle for antisense RNA. Genet. Eng. N.Y., 20:143–151, 1998.
[226] A. G. Paschka, F. Jönsson, V. Maier, M. Möllenbeck, K. Paeschke, J. Postberg,
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